WO2009146214A1 - Method and apparatus to measure bioelectric impedance of patient tissue - Google Patents
Method and apparatus to measure bioelectric impedance of patient tissue Download PDFInfo
- Publication number
- WO2009146214A1 WO2009146214A1 PCT/US2009/041143 US2009041143W WO2009146214A1 WO 2009146214 A1 WO2009146214 A1 WO 2009146214A1 US 2009041143 W US2009041143 W US 2009041143W WO 2009146214 A1 WO2009146214 A1 WO 2009146214A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- circuitry
- calibration
- tissue
- impedance
- signal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/251—Means for maintaining electrode contact with the body
- A61B5/257—Means for maintaining electrode contact with the body using adhesive means, e.g. adhesive pads or tapes
- A61B5/259—Means for maintaining electrode contact with the body using adhesive means, e.g. adhesive pads or tapes using conductive adhesive means, e.g. gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0531—Measuring skin impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
- A61B5/0006—ECG or EEG signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0809—Detecting, measuring or recording devices for evaluating the respiratory organs by impedance pneumography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/28—Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
- A61B5/282—Holders for multiple electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/30—Input circuits therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0223—Operational features of calibration, e.g. protocols for calibrating sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7253—Details of waveform analysis characterised by using transforms
- A61B5/7257—Details of waveform analysis characterised by using transforms using Fourier transforms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B7/00—Instruments for auscultation
Definitions
- the present invention relates to patient monitoring.
- embodiments make specific reference to monitoring impedance and electrocardiogram signals with an adherent patch, the system methods and device described herein may be applicable to many applications in which physiological monitoring is used, for example physiological monitoring with implantable devices.
- Patients are often treated for diseases and/or conditions associated with a compromised status of the patient, for example a compromised physiologic status.
- a patient may report symptoms that require diagnosis to determine the underlying cause.
- a patient may report fainting or dizziness that requires diagnosis, in which long term monitoring of the patient can provide useful information as to the physiologic status of the patient.
- a patient may have suffered a heart attack and require care and/or monitoring after release from the hospital.
- One example of a device to provide long term monitoring of a patient is the Holter monitor, or ambulatory electrocardiography device.
- known physiologic measurements include impedance measurements that can be used to assess the status of the patient.
- Impedance measurements can be used to measure hydration and respiration of a patient.
- Long term impedance measurements used to determine patient hydration in relation to cardiac status represents one area where impedance measurements may be useful.
- current methodologies have been somewhat successful in measuring hydration, work in relation to embodiments of the present invention suggests that known methods and apparatus for monitoring patient hydration with impedance may be less than ideal. Some current devices may not accurately measure the impedance of the internal tissue of the patient, thereby making accurate hydration measurements more difficult.
- the skin of the patient and/or coupling of electrodes to the skin may affect the impedance measurements. For example, environmental factors external to the patient may effect the measurements, for example when the patient showers.
- the electronics used to measure complex impedance signals of the patient may be somewhat larger than ideal and may not provide as much accuracy as would be ideal.
- devices that are worn by the patient may be somewhat uncomfortable, which may lead to patients not wearing the devices and not complying with direction from the health care provider, such that data collected may be less than ideal.
- some devices to measure impedance may use circuitry that measures part of the tissue impedance without determining the resistance and reactance components of the complex impedance of the tissue.
- implantable devices may be used in some instances, many of these devices can be invasive and/or costly, and may suffer at least some of the shortcomings of known wearable devices described above. In addition, implantable devices can be invasive and/or costly such that many patients cannot receive a therapeutic benefit. Although injectable devices may decrease invasiveness, the size requirements of injectable devices can place limitations on the circuitry and may limit the accuracy of such devices.
- the present invention relates to patient monitoring.
- embodiments make specific reference to monitoring impedance and electrocardiogram signals with an adherent patch
- the system methods and device described herein may be applicable to many applications in which physiological monitoring with impedance measurements are used, for example physiological monitoring with implantable devices.
- tissue impedance is determined in response a calibration signal from calibration circuitry and a tissue impedance signal from the tissue. Because the tissue impedance can be determined from both a tissue impedance signal and a calibration signal, errors can be minimized, for example errors that correspond to fluctuations in drive current, variations in measurement circuitry gain, time delays of the drive circuitry, time delays of the measurement circuitry, and parasitic impedance of the tissue, for example skin.
- the drive circuitry can be coupled to the calibration circuitry and at least two drive electrodes so as to drive current through the tissue and the calibration circuitry.
- a calibration signal from the calibration circuitry can be measured when the electrodes are connected to the patient, such that the calibration signal substantially corresponds to the current actually delivered through the tissue.
- Measurement circuitry can be connected to at least two measurement electrodes so as to measure a tissue impedance signal in response to the impedance of the tissue and the current through the tissue.
- the measurement circuitry can also be coupled to the calibration circuitry to measure the calibration signal, such that the tissue impedance can be determined in response to the measured calibration signal and the measured tissue impedance signal.
- Processor circuitry comprising a tangible medium can be configured to determine a complex tissue impedance in response to the calibration signal and the tissue impedance signal, such errors are minimized which correspond to fluctuations in drive current, variations in measurement circuitry gain, time delays of the drive circuitry, time delays of the measurement circuitry, and parasitic impedance of the tissue.
- the calibration resistor can be provided with the drive circuitry and measurement circuitry, the system can be self calibrating, thereby eliminating a time consuming step at manufacture and minimizing memory resources of the controlling computer and/or processor.
- the processor can be configured to select a frequency for the drive current, and the drive circuitry can be configured to increase the amount of drive current with increasing frequency, such that the signal to noise ratio can be improved.
- the amount of drive current at a selected increased frequency may even exceed a safety threshold for the amount of drive current at a lower frequency.
- the measurement circuitry can be configured to decrease the gain of the impedance signal with increasing frequency, such that the increased amount of current does not saturated the measurement circuitry and/or digitization electronics such as an analog to digital converter.
- embodiments of the present invention provide a device for measuring an impedance of a tissue of a patient.
- the calibration circuitry comprises an impedance.
- At least four electrodes are configured to couple to the tissue of the patient.
- the at least four electrodes may comprise at least two measurement electrodes and at least two drive electrodes.
- Drive circuitry is coupled to the at least two drive electrodes and the calibration circuitry to pass a current through the at least two drive electrodes and the calibration circuitry.
- Measurement circuitry is configured to couple to the at least two measurement electrodes and the calibration circuitry, such that the measurement circuitry can be configured to measure a calibration signal from the calibration circuitry and a tissue impedance signal from the at least two measurement electrodes.
- Processor circuitry comprising a tangible medium is configured to determine the impedance of the tissue in response to the calibration signal and the tissue impedance signal.
- the processor circuitry comprises as least one of an impedance converter or a microcontroller.
- the processor circuitry can be configured to determine the impedance of the tissue with a discrete Fourier transform of at least one of measurement signal or the current signal.
- the calibration circuitry can be connected in series between the drive circuitry and the at least two measurement electrodes to calibrate the tissue impedance measurement when the at least two electrodes are connected to the patient.
- the drive circuitry can be configured to pass the current through the tissue and the calibration circuitry to generate the tissue measurement signal and the calibration signal when the at least four electrodes are connected to the tissue.
- the calibration circuitry may comprise a calibration resistor, and the measurement circuitry can be configured to measure the calibration signal in response to the current through the calibration resistor and the tissue.
- the measurement circuitry can be configured to measure the tissue measurement signal in response to the current through the tissue and the calibration resistor.
- the processor can be configured to determine the tissue impedance from the calibration signal and the tissue measurement signal.
- At least one switch is coupled to the drive circuitry, the measurement circuitry, the calibration circuitry and the at least four electrodes.
- the at least one switch comprises a first configuration and a second configuration, In the first configuration the at least one switch couples the measurement circuitry to the calibration circuitry to measure the calibration signal. In the second configuration the at least one switch couples the measurement circuitry to the at least two measurement electrodes to measure the tissue impedance signal.
- the processor circuitry can be coupled to the at least one switch to select the first configuration or the second configuration.
- the measurement circuitry comprises a first measurement circuit configured to measure the calibration signal and a second measurement circuit configured to measure the tissue impedance signal.
- the calibration circuitry comprises at least one resistor connected in series to the drive circuitry and the at least two drive electrodes, such that a resistance of the resistor corresponds to at least 90% the impedance of the calibration circuitry.
- the calibration circuitry may comprise a resistance
- the calibration signal may comprise a complex calibration signal.
- the tissue impedance signal may comprise a complex tissue impedance signal
- the processor can be configured to determine a complex impedance of the tissue in response to the complex calibration signal and the complex tissue impedance signal.
- the processor is configured to store a calibration value comprising a resistance of the calibration circuitry that corresponds to a real number, and the calibration signal corresponds to the resistance of the calibration circuitry, delays of the drive circuitry and delays of the measurement circuitry.
- the processor can be configured to determine a complex calibration coefficient in response to the calibration value and the calibration signal.
- the tissue impedance may comprise a complex tissue impedance and processor can be configured to determine the complex tissue impedance in response to the complex calibration coefficient and the tissue impedance signal.
- the processor can be configured to determine a complex tissue parameter from the tissue impedance signal, and the processor can be configured to determine the complex tissue impedance with at least one of a complex multiplication or a complex division of the complex calibration coefficient and the complex tissue parameter.
- the processor can be configured to determine the complex tissue parameter with a discrete Fourier transform of the tissue impedance signal and determine the complex calibration coefficient with a discrete Fourier transform of the calibration signal.
- the delays of the drive circuitry and the measurement circuitry can correspond to a phase angle of the calibration signal of at least about 90 degrees.
- the processor is configured to select a first frequency and a second frequency to measure impedance signals of the calibration circuitry at each of the first frequency and the second frequency, and the processor is configured to measure impedance signals of the tissue at each of the first frequency and the second frequency.
- the processor can be configured to determine an impedance of the tissue at the each of the first frequency and the second frequency in response to the impedance signals of the calibration circuitry measured at each of the first frequency and the second frequency and the impedance signals of the tissue measured at each of the first frequency and the second frequency.
- the processor is configured to store a tolerance range and measure the calibration circuitry in response to the impedance signal of the tissue and the tolerance range.
- the tolerance range may comprise plus or minus twenty percent of a baseline tissue impedance measurement, and the processor can be configured to measure the calibration circuitry in response to the tissue impedance outside the tolerance range.
- embodiments of the present invention provide a device for measuring an impedance of a tissue of a patient.
- the device comprises at least four electrodes configured to couple to the tissue of the patient.
- the at least four electrodes comprising at least two drive electrodes, and at least two measurement electrodes.
- Drive circuitry is coupled to the at least two drive electrodes to pass a variable current through the tissue to generate a tissue measurement signal.
- the drive circuitry is configured to increase the current from a first current amount at a first frequency to a second current amount at a second frequency, in which the second frequency greater than the first frequency.
- Measurement circuitry is coupled to the at least two measurement electrodes to determine the impedance of the tissue in response to the tissue measurement signal.
- the measurement circuitry comprises a variable gain of the measurement signal, and the variable gain is configured to decrease from a first gain at the first frequency to a second gain at the second frequency.
- variable current of the drive circuitry comprises a drive current frequency response
- variable gain of the measurement circuitry comprises variable gain frequency response, in which the variable gain frequency response comprises an inverse of the drive current frequency response
- the drive circuitry is configured to increase the second current amount to at least four times the first current amount, and the measurement circuitry is configured to decrease the second gain to no more than about one half of the first gain.
- the drive circuitry is configured to increase the second current amount to at least ten times the first current amount, and the measurement circuitry is configured to decrease the second gain to no more than about one third of the first gain.
- the second frequency is at least 1 kHz, and the second current amount is at least 10 ⁇ A and no more than 1000 ⁇ A.
- the first frequency corresponds to a first safety threshold of the first current
- the second frequency corresponds to a second safety threshold of the second current.
- the drive circuitry can be configured to exceed the first safety threshold with the second current amount and not to exceed the second safety threshold with the second current amount.
- the drive circuitry can be configured to exceed the first safety threshold with the second current by at least a factor of two.
- the safety threshold of the first current may correspond to 10 ⁇ A or a product of the first current in ⁇ A times the first frequency in kHz, whichever is greater.
- embodiments of the present invention provide a method of measuring patient impedance.
- the method comprises providing at least four electrodes comprising at least two drive electrodes and at least two measurement electrodes.
- the at least two drive electrodes can be connected in series to a calibration resistor.
- Measurement circuitry is provided to measure a tissue impedance signal from the measurement electrodes.
- a drive current is passed through the at least two drive electrodes and the calibration resistor with drive circuitry.
- a current signal is measured from the calibration resistor in response to the current through the calibration resistor.
- the tissue impedance signal is measured from the measurement electrodes.
- the tissue impedance is determined in response to the current signal and the tissue impedance signal.
- the current signal from the calibration resistor is measured with the measurement circuitry.
- the tissue impedance can be determined with an impedance converter.
- the current signal from the calibration resistor may comprise a first voltage that is converted into a first current and the first current can be fed into the impedance converter.
- the tissue impedance signal from the measurement electrodes may comprise a second voltage that can be converted to a second current and the second current fed into the impedance converter.
- the drive circuitry may comprise a network to limit the drive current through the patient, such that the network increases the drive current through the patient as a frequency of the drive current increases.
- the measurement circuitry may comprise a variable gain that decreases when the frequency is increases and the drive current increases.
- Figure IA shows a patient and a monitoring system comprising an adherent device, according to embodiments of the present invention
- Figure I B shows a bottom view of the adherent device as in Figure IA comprising an adherent patch
- Figure 1C shows a top view of the adherent patch, as in Figure 1 B;
- Figure I D shows a printed circuit boards and electronic components over the adherent patch, as in Figure 1 C; [0030] Figure I Dl shows an equivalent circuit that can be used to determine optimal frequencies for determining patient hydration, according to embodiments of the present invention;
- Figure IE shows batteries positioned over the printed circuit board and electronic components as in Figure ID;
- Figure IF shows a top view of an electronics housing and a breathable cover over the batteries, electronic components and printed circuit board as in Figure I E;
- Figure IG shows a side view of the adherent device as in Figures IA to I F;
- Figure 1 H shown a bottom isometric view of the adherent device as in Figures IA to I G;
- Figures 11 and IJ show a side cross-sectional view and an exploded view, respectively, of the adherent device as in Figures IA to IH;
- Figure 1 K shows at least one electrode configured to electrically couple to a skin of the patient through a breathable tape, according to embodiments of the present invention
- Figure 2A shows a simplified schematic illustration of a circuit diagram for measuring patient impedance, according to embodiments of the present invention
- Figure 2B shows an inverse frequency response of the drive circuitry and measurement circuitry, according to embodiments of the present invention
- Figure 3A shows circuitry for measuring patient impedance with an impedance converter, according to embodiments of the present invention
- Figure 3B shows a model for measuring patient impedance with circuitry as in Figure
- Figure 3C shows a model equivalent to the model of Figure 3B that allows for correction of parasitic impedance, according to embodiments of the present invention
- Figure 4 shows a method of measuring patient impedance, according to embodiments of the present invention.
- Embodiments of the present invention relate to patient monitoring. Although embodiments make specific reference to monitoring impedance and electrocardiogram signals with an adherent patch, the system methods and device described herein may be applicable to many application in which physiological monitoring is used, for example physiological monitoring with implantable devices.
- the adherent devices described herein may be used for 90 day monitoring, or more, and may comprise completely disposable components and/or reusable components, and can provide reliable data acquisition and transfer.
- the patch is configured for patient comfort, such that the patch can be worn and/or tolerated by the patient for extended periods, for example 90 days or more.
- the adherent patch comprises a tape, which comprises a material, preferably breathable, with an adhesive, such that trauma to the patient skin can be minimized while the patch is worn for the extended period.
- the printed circuit board comprises a flex printed circuit board that can flex with the patient to provide improved patient comfort.
- Figure IA shows a patient P and a monitoring system 10.
- Patient P comprises a midline M, a first side Sl , for example a right side, and a second side S2, for example a left side.
- Monitoring system 10 comprises an adherent device 100.
- Adherent device 100 can be adhered to a patient P at many locations, for example thorax T of patient P. In many embodiments, the adherent device may adhere to one side of the patient, from which side data can be collected. Work in relation with embodiments of the present invention suggests that location on a side of the patient can provide comfort for the patient while the device is adhered to the patient.
- Monitoring system 10 includes components to transmit data to a remote center 106.
- Adherent device 100 can communicate wirelessly to an intermediate device 102, for example with a single wireless hop from the adherent device on the patient to the intermediate device.
- Intermediate device 102 can communicate with remote center 106 in many ways, for example with an internet connection.
- monitoring system 10 comprises a distributed processing system with at least one processor on device 100, at least one processor on intermediate device 102, and at least one process at remote center 106, each of which processors is in electronic communication with the other processors.
- Remote center 106 can be in communication with a health care provider 108A with a communication system 107A, such as the Internet, an intranet, phone lines, wireless and/or satellite phone.
- Health care provider 108A for example a family member, can be in communication with patient P with a communication, for example with a two way communication system, as indicated by arrow 109A, for example by cell phone, email, landline.
- Remote center 106 can be in communication with a health care professional, for example a physician 108B, with a communication system 107B, such as the Internet, an intranet, phone lines, wireless and/or satellite phone.
- Physician 108B can be in communication with patient P with a communication, for example with a two way communication system, as indicated by arrow 109B, for example by cell phone, email, landline.
- Remote center 106 can be in communication with an emergency responder 108C, for example a 91 1 operator and/or paramedic, with a communication system 107C, such as the Internet, an intranet, phone lines, wireless and/or satellite phone.
- Emergency responder 108C can travel to the patient as indicated by arrow 109C.
- monitoring system 10 comprises a closed loop system in which patient care can be monitored and implemented from the remote center in response to signals from the adherent device.
- the adherent device may continuously monitor physiological parameters, communicate wirelessly with a remote center, and provide alerts when necessary.
- the system may comprise an adherent patch, which attaches to the patient's thorax and contains sensing electrodes, battery, memory, logic, and wireless communication capabilities.
- the patch can communicates with the remote center, via the intermediate device in the patient's home.
- the remote center receives the data and applies the prediction algorithm. When a flag is raised, the center may communicate with the patient, hospital, nurse, and/or physician to allow for therapeutic intervention to prevent decompensation.
- the adherent device may be affixed and/or adhered to the body in many ways. For example, with at least one of the following an adhesive tape, a constant-force spring, suspenders around shoulders, a screw-in microneedle electrode, a pre-shaped electronics module to shape fabric to a thorax, a pinch onto roll of skin, or transcutaneous anchoring.
- Patch and/or device replacement may occur with a keyed patch (e.g. two-part patch), an outline or anatomical mark, a low-adhesive guide (place guide
- the patch and/or device may comprise an adhesiveless embodiment (e.g. chest strap), and/or a low-irritation adhesive model for sensitive skin.
- the adherent patch and/or device can comprise many shapes, for example at least one of a dogbone, an hourglass, an oblong, a circular or an oval shape.
- the adherent device may comprise a reusable electronics module with replaceable patches (the module collects cumulative data for approximately 90 days) and/or the entire adherent component (electronics + patch) may be disposable.
- a "baton" mechanism may be used for data transfer and retention, for example baton transfer may include baseline information.
- the device may have a rechargeable module, and may use dual battery and/or electronics modules, wherein one module 101 A can be recharged using a charging station 103 while the other module 101 B is placed on the adherent device.
- the intermediate device 102 may comprise the charging module, data transfer, storage and/or transmission, such that one of the electronics modules can be placed in the intermediate device for charging and/or data transfer while the other electronics module is worn by the patient.
- the system can perform the following functions: initiation, programming, measuring, storing, analyzing, communicating, predicting, and displaying.
- the adherent device may contain a subset of the following physiological sensors: bioimpedance, respiration, respiration rate variability, heart rate (ave, min, max), heart rhythm, HRV, HRT, heart sounds (e.g. S3), respiratory sounds, blood pressure, activity, posture, wake/sleep, orthopnea, temperature/heat flux, and weight.
- the activity sensor may be one of the following: ball switch, accelerometer, minute ventilation, HR, bioimpedance noise, skin temperature/heat flux, BP, muscle noise, posture.
- the patch wirelessly communicates with a remote center.
- the communication may occur directly (via a cellular or Wi-Fi network), or indirectly through intermediate device 102.
- Intermediate device 102 may consist of multiple devices which communicate wired or wirelessly to relay data to remote center 106.
- instructions are transmitted from a remote site to a processor supported with the patient, and the processor supported with the patient can receive updated instructions for the patient treatment and/or monitoring, for example while worn by the patient.
- Figure I B shows a bottom view of adherent device 100 as in Figure IA comprising an adherent patch 1 10.
- Adherent patch 1 10 comprises a first side, or a lower side 1 1 OA, that is oriented toward the skin of the patient when placed on the patient.
- adherent patch 1 10 comprises a tape 1 1 OT which is a material, preferably breathable, with an adhesive 1 16A.
- Patient side 1 1OA comprises adhesive 1 16A to adhere the patch 1 10 and adherent device 100 to patient P.
- Electrodes 1 12A, 1 12B, 1 12C and 1 12D are affixed to adherent patch 1 10. In many embodiments, at least four electrodes are attached to the patch, for example six electrodes.
- the patch comprises two electrodes, for example two electrodes to measure the electrocardiogram (ECG) of the patient.
- Gel 1 14A, gel 1 14B, gel 1 14C and gel 1 14D can each be positioned over electrodes 1 12A, 1 12B, 1 12C and 1 12D, respectively, to provide electrical conductivity between the electrodes and the skin of the patient.
- the electrodes can be affixed to the patch 1 10, for example with known methods and structures such as rivets, adhesive, stitches, etc.
- patch 1 10 comprises a breathable material to permit air and/or vapor to flow to and from the surface of the skin.
- FIG 1 C shows a top view of the adherent patch 100, as in Figure I B.
- Adherent patch 100 comprises a second side, or upper side 1 1 OB.
- electrodes 1 1 OA, 1 1 OB, 1 1 OC and 1 1 OD extend from lower side 1 1 OA through the adherent patch to upper side 1 1 OB.
- an adhesive 1 16B can be applied to upper side 1 1 OB to adhere structures, for example electronic structures, to the patch such that the patch can support the electronics and other structures when the patch is adhered to the patient.
- the PCB comprise completely flex PCB, rigid PCB combined flex PCB and/or rigid PCB boards connected by cable.
- Figure 1 D shows a printed circuit boards and electronic components over adherent patch 1 10, as in Figure 1 C.
- a printed circuit board for example flex PCB 120
- Flex PCB 120 may be connected to upper side I OOB of patch 1 10 with connectors 122 A, 122B, 122C and 122D.
- Flex PCB 120 can include traces 123 A, 123B, 123C and 123 D that extend to connectors 122A, 122B, 122C and 122D, respectively, on the flex PCB.
- Connectors 122A, 122B, 122C and 122D can be positioned on flex PCB 120 in alignment with electrodes 1 12A, 1 12B, 1 12C and 1 12D so as to electrically couple the flex PCB with the electrodes.
- connectors 122A, 122B, 122C and 122D may comprise insulated wires that provide strain relief between the PCB and the electrodes.
- additional PCB's for example rigid PCB's 120A, 120B, 120C and 120D, can be connected to flex PCB 120.
- Electronic components 130 can be connected to flex PCB 120 and/or mounted thereon. In some embodiments, electronic components 130 can be mounted on the additional PCB's.
- Electronic components 130 comprise components to take physiologic measurements, transmit data to remote center 106 and receive commands from remote center 106.
- electronics components 130 may comprise known low power circuitry, for example complementary metal oxide semiconductor (CMOS) circuitry components.
- Electronics components 130 comprise an activity sensor and activity circuitry 134, impedance circuitry 136 and electrocardiogram circuitry, for example ECG circuitry 136.
- electronics circuitry 130 may comprise a microphone and microphone circuitry 142 to detect an audio signal from within the patient, and the audio signal may comprise a heart sound and/or a respiratory sound, for example an S3 heart sound and a respiratory sound with rales and/or crackles.
- Electronics circuitry 130 may comprise a temperature sensor, for example a thermistor, and temperature sensor circuitry 144 to measure a temperature of the patient, for example a temperature of a skin of the patient.
- Processor 146 comprises a tangible medium, for example read only memory (ROM), electrically erasable programmable read only memory (EEPROM) and/or random access memory (RAM).
- Electronic circuitry 130 may comprise real time clock and frequency generator circuitry 148.
- processor 136 may comprise the frequency generator and real time clock.
- the processor can be configured to control a collection and transmission of data from the impedance circuitry electrocardiogram circuitry and the accelerometer.
- device 100 comprise a distributed processor system, for example with multiple processors on device 100.
- electronics components 130 comprise wireless communications circuitry 132 to communicate with remote center 106.
- the wireless communication circuitry can be coupled to the impedance circuitry, the electrocardiogram circuitry and the accelerometer to transmit to a remote center with a communication protocol at least one of the hydration signal, the electrocardiogram signal or the inclination signal.
- wireless communication circuitry is configured to transmit the hydration signal, the electrocardiogram signal and the inclination signal to the remote center with a single wireless hop, for example from wireless communication circuitry 132 to intermediate device 102.
- the communication protocol comprises at least one of Bluetooth, Zigbee, WiFi, WiMax, IR, amplitude modulation or frequency modulation.
- the communications protocol comprises a two way protocol such that the remote center is capable of issuing commands to control data collection.
- intermediate device 102 comprises a data collection system to collect and store data from the wireless transmitter.
- the data collection system can be configured to communicate periodically with the remote center.
- the data collection system can transmit data in response to commands from remote center 106 and/or in response to commands from the adherent device.
- Activity sensor and activity circuitry 134 can comprise many known activity sensors and circuitry.
- the accelerometer comprises at least one of a piezoelectric accelerometer, capacitive accelerometer or electromechanical accelerometer.
- the accelerometer may comprises a 3-axis accelerometer to measure at least one of an inclination, a position, an orientation or acceleration of the patient in three dimensions. Work in relation to embodiments of the present invention suggests that three dimensional orientation of the patient and associated positions, for example sitting, standing, lying down, can be very useful when combined with data from other sensors, for example ECG data and/or hydration data.
- Impedance circuitry 136 can generate both hydration data and respiration data.
- impedance circuitry 136 is electrically connected to electrodes 1 12A, 1 12B, 1 12C and 1 12D such that electrodes 1 12A and 1 12D comprise outer electrodes that are driven with a current, or force electrodes.
- the current delivered between electrodes 1 12A and 1 12D generates a measurable voltage between electrodes 1 12B and 1 12C, such that electrodes 1 12B and 1 12C comprise inner electrodes, or measurement electrodes that measure the voltage in response to the current from the force electrodes.
- the voltage measured by the measurement electrodes can be used to determine the hydration of the patient.
- Figure I Dl shows an equivalent circuit 152 that can be used to determine optimal frequencies for measuring patient hydration.
- Work in relation to embodiments of the present invention indicates that the frequency of the current and/or voltage at the force electrodes can be selected so as to provide impedance signals related to the extracellular and/or intracellular hydration of the patient tissue.
- Equivalent circuit 152 comprises an intracellular resistance 156, or R(ICW) in series with a capacitor 154, and an extracellular resistance 158, or R(ECW). Extracellular resistance 158 is in parallel with intracellular resistance 156 and capacitor 154 related to capacitance of cell membranes.
- impedances can be measured and provide useful information over a wide range of frequencies, for example from about 0.5 kHz to about 200 KHz.
- Work in relation to embodiments of the present invention suggests that extracellular resistance 158 can be significantly related extracellular fluid and to cardiac decompensation, and that extracellular resistance 158 and extracellular fluid can be effectively measured with frequencies in a range from about 0.5 kHz to about 20 kHz, for example from about 1 kHz to about 10 kHz.
- a single frequency can be used to determine the extracellular resistance and/or fluid.
- many embodiments of the present invention employ measure hydration with frequencies from about 0.5 kHz to about 20 kHz to determine patient hydration.
- impedance circuitry 136 can be configured to determine respiration of the patient.
- the impedance circuitry can measure the hydration at 25 Hz intervals, for example at 25 Hz intervals using impedance measurements with a frequency from about 0.5 kHz to about 20 kHz.
- ECG circuitry 138 can generate electrocardiogram signals and data from electrodes 1 12A, 1 12B, 1 12C and 1 12D.
- ECG circuitry 138 is connected to inner electrodes 1 12B and 122C, which may comprise measurement electrodes of the impedance circuitry as described above.
- the inner electrodes may be positioned near the outer electrodes to increase the voltage of the ECG signal measured by ECG circuitry 138.
- the ECG circuitry can share components with the impedance circuitry.
- Figure 1 E shows batteries 150 positioned over the flex printed circuit board and electronic components as in Figure I D.
- Batteries 150 may comprise rechargeable batteries that can be removed and/or recharged. In some embodiments, batteries 150 can be removed from the adherent patch and recharged and/or replaced.
- Figure IF shows a top view of a cover 162 over the batteries, electronic components and flex printed circuit board as in Figure I E.
- an electronics housing 160 may be disposed under cover 162 to protect the electronic components, and in some embodiments electronics housing 160 may comprise an encapsulant over the electronic components and PCB.
- cover 162 can be adhered to adhesive patch with an adhesive 164 on an underside of cover 162.
- electronics housing 160 can be adhered to cover 162 with an adhesive 166 where cover 162 contacts electronics housing 160.
- electronics housing 160 may comprise a water proof material, for example a sealant adhesive such as epoxy or silicone coated over the electronics components and/or PCB.
- electronics housing 160 may comprise metal and/or plastic. Metal or plastic may be potted with a material such as epoxy or silicone.
- Cover 162 may comprise many known biocompatible cover, casing and/or housing materials, such as elastomers, for example silicone.
- the elastomer may be fenestrated to improve breathability.
- cover 162 may comprise many known breathable materials, for example polyester, polyamide, and/or elastane (Spandex).
- the breathable fabric may be coated to make it water resistant, waterproof, and/or to aid in wicking moisture away from the patch.
- Figure I G shows a side view of adherent device 100 as in Figures IA to I F.
- Adherent device 100 comprises a maximum dimension, for example a length 170 from about 4 to 10 inches (from about 100 mm to about 250mm), for example from about 6 to 8 inches (from about 150 mm to about 200 mm). In some embodiments, length 170 may be no more than about 6 inches (no more than about 150 mm).
- Adherent device 100 comprises a thickness 172. Thickness 172 may comprise a maximum thickness along a profile of the device. Thickness 172 can be from about 0.2 inches to about 0.4 inches (from about 5 mm to about 10 mm), for example about 0.3 inches (about 7.5 mm) .
- FIG. 1 H shown a bottom isometric view of adherent device 100 as in Figures IA to I G.
- Adherent device 100 comprises a width 174, for example a maximum width along a width profile of adherent device 100.
- Width 174 can be from about 2 to about 4 inches (from about 50 mm to 100 mm), for example about 3 inches (about 75 mm).
- Figures 1 1 and U show a side cross-sectional view and an exploded view, respectively, of adherent device 100 as in Figures IA to I H.
- Device 100 comprises several layers.
- Gel 1 14A, or gel layer, is positioned on electrode 1 12A to provide electrical conductivity between the electrode and the skin.
- Electrode 1 12A may comprise an electrode layer.
- Adhesive patch 1 10 may comprise a layer of breathable tape 1 1 OT, for example a known breathable tape, such as tricot-knit polyester fabric.
- An adhesive 1 16A for example a layer of aery late pressure sensitive adhesive, can be disposed on underside 1 1 OA of patch 1 10.
- a gel cover 180 can be positioned over patch 1 10 comprising the breathable tape.
- a PCB layer for example flex PCB 120, or flex PCB layer, can be positioned over gel cover 180 with electronic components 130 connected and/or mounted to flex PCB 120, for example mounted on flex PCB so as to comprise an electronics layer disposed on the flex PCB.
- the adherent device may comprise a segmented inner component, for example the PCB, for limited flexibility.
- the electronics layer may be encapsulated in electronics housing 160 which may comprise a waterproof material, for example silicone or epoxy.
- the electrodes are connected to the PCB with a flex connection, for example trace 123 A of flex PCB 120, so as to provide strain relive between the electrodes 1 12A, 1 12B, 1 12C and 1 12D and the PCB.
- Gel cover 180 can inhibit flow of gel 1 14A and liquid. In many embodiments, gel cover 180 can inhibit gel 1 14A from seeping through breathable tape 1 1OT to maintain gel integrity over time. Gel cover 180 can also keep external moisture from penetrating into gel 1 14A.
- cover 162 can encase the flex PCB and/or electronics and can be adhered to at least one of the electronics, the flex
- cover 162 attaches to adhesive patch 1 10 with adhesive 1 16B, and cover 162 is adhered to the PCB module with an adhesive 161 on the upper surface of the electronics housing.
- Cover 162 can comprise many known biocompatible cover, housing and/or casing materials, for example silicone.
- cover 162 comprises an outer polymer cover to provide smooth contour without limiting flexibility.
- cover 162 may comprise a breathable fabric.
- Cover 162 may comprise many known breathable fabrics, for example breathable fabrics as described above.
- the breathable fabric may comprise polyester, polyamide, and/or elastane (Spandex) to allow the breathable fabric to stretch with body movement.
- the breathable tape may contain and elute a pharmaceutical agent, such as an antibiotic, anti-inflammatory or antifungal agent, when the adherent device is placed on the patient.
- the breathable tape of adhesive patch 1 10 comprises a first mesh with a first porosity and gel cover 180 comprises a breathable tape with a second mesh porosity, in which the second porosity is less than the first porosity to inhibit flow of the gel through the breathable tape.
- a gap 169 extends from adherent patch 1 10 to the electronics module and/or PCB, such that breathable tape 1 1 OT can breath to provide patient comfort.
- the adherent device comprises a patch component and at least one electronics module.
- the patch component may comprise adhesive patch 1 10 comprising the breathable tape with adhesive coating 1 16A, at least one electrode 1 14A and gel 1 14, for example a gel coating.
- the at least one electronics module can be is separable from the patch component.
- the at least one electronics module comprises the flex printed circuit board 120, electronic component 130, electronics housing 160 and waterproof cover 162, such that the flex printed circuit board, electronic components electronics housing and water proof cover are reusable and/or removable for recharging and data transfer, for example as described above.
- adhesive 1 16B is coated on upper side 1 1 OA of adhesive patch 1 1 OB, such that the electronics module, or electronics layers, can be adhered to and/or separated from the adhesive component, or adhesive layers.
- the electronic module can be adhered to the patch component with a releasable connection, for example with VelcroTM, a known hook and loop connection, and/or snap directly to the electrodes.
- two electronics modules can be provided, such that one electronics module can be worn by the patient while the other is charged as described above.
- At least one electrode 1 12A extends through at least one aperture in the breathable tape 1 10.
- the adhesive patch may comprise a medicated patch that releases a medicament, such as antibiotic, beta-blocker, ACE inhibitor, diuretic, or steroid to reduce skin irritation.
- the adhesive patch may comprise a thin, flexible, breathable patch with a polymer grid for stiffening. This grid may be anisotropic, may use electronic components to act as a stiffener, may use electronics-enhanced adhesive elution, and may use an alternating elution of adhesive and steroid.
- Figure I K shows at least one electrode 190 configured to electrically couple to a skin of the patient through a breathable tape 192.
- at least one electrode 190 and breathable tape 192 comprise electrodes and materials similar to those described above. Electrode 190 and breathable tape 192 can be incorporated into adherent devices as described above, so as to provide electrical coupling between the skin an electrode through the breathable tape, for example with the gel.
- Figure 2A shows a simplified schematic illustration of circuitry 200 for measuring patient signals, such as impedance signals to measure hydration, ECG signals.
- Circuitry 200 comprises drive circuitry 210 to drive a current through the patient tissue, and measurement circuitry 250 to measure an impedance signal from the patient tissue.
- Circuitry 200 may comprise at least four electrodes 240 to couple drive circuitry 210 and measurement circuitry 250 to the patient tissue.
- Circuitry 200 comprises calibration circuitry 220 to calibrate the drive circuitry and measurement circuitry.
- Circuitry 200 may comprise a processor system 260 that comprises at least one processor, for example a processor 262 on the adherent device as described above.
- Circuitry 200 may comprise at least one switch 230 that can be used to select for measurement either on board calibration circuitry 220 or electrodes 240 that are coupled to the skin of the patient.
- Circuitry 200 may comprise ECG circuitry 270 to measure electrocardiogram signals from the patient, accelerometer 280 to measure patient position and/or activity, and wireless circuitry 290 to transmit the data.
- Drive circuitry 210 may comprise a drive module 212.
- Drive module 212 can be used to generate a drive current at a selected frequency.
- drive module 212 may comprise direct digital synthesis (DDS) and digital to analog conversion (DAC) and amplifiers to generate the drive current at the selected frequency.
- the amplifiers to generate the drive current may comprise a gain, and in some embodiments the gain of the drive current amplifiers increases with increasing frequency.
- drive module 212 may comprise analog electronics, for example a frequency generator to generate the drive current at the selected frequency.
- the drive current may comprise an AC component at the selected frequency and a DC component.
- Drive circuitry 210 comprises circuitry to adjust the current delivered to the patient in response to the selected frequency.
- drive circuitry 210 can increase the current delivered to the patient as the drive frequency increases, such that the amount of current complies with safe current requirements, for example known AAMI ESl requirements.
- the drive current is generally below a safety threshold that corresponds to 10 ⁇ A for frequencies below 1 kHz, increases by 10 ⁇ A per decade kHz from 1 kHz to 100 kHz, and remains at 1 mA for frequencies above 100 kHz, for example from 100 kHz to 1 MHz.
- drive circuitry 210 comprises an attenuation network that decreases current from the drive module to the tissue. In many embodiments, the attenuation of drive current from the drive module decreases with increasing frequency, such that the amount of current delivered to the patient increases with increasing frequency.
- Attenuation circuitry 212 may comprise a high pass RC circuit network such that the current delivered to tissue increases from about 200 Hz to about 1 kHz, for example with a corner frequency, f c , within a range from about 200 Hz to about 1 kHz.
- drive circuitry 210 may comprise a high pass amplifier that increases the gain of current delivered to the patient as the selected frequency increases.
- Calibration circuitry 220 can comprise components of known impedance to calibrate circuitry 200. Calibration circuitry 220 can be connected to drive circuitry 210 and measurement circuitry 250 to calibrate the electronics of circuitry 200, for example drive circuitry 210 and measurement circuitry 250.
- calibration circuitry 220 comprises a resistor of known resistance that can be used to calibrate drive circuitry 210 and measurement circuitry 250.
- Calibration circuitry 220 may comprise a substantial resistance with very little reactance, for example resistance may comprise at least 90% of the magnitude of the impedance of calibration circuitry 220.
- the use of calibration circuitry that comprises substantial resistance can facilitate calibration, as phase delay and amplitude changes in the measured calibration signal may be attributed to changes in drive circuitry 210 and measurement circuitry 250.
- the resistor of calibration circuitry 220 comprises a known resistance that is close to the impedance of tissue measured such that the calibration circuitry comprises an impedance with a magnitude within the range of physiologic tissue impedances likely to be measured with the electrodes, for example from about 10 Ohms to about 200 Ohms.
- calibration circuitry 220 may comprises a plurality of selectable resistors to select a resistance that is close to the measured tissue impedance.
- At least one electrode 240 comprises at least two drive electrodes, for example V+ electrode 244 and V- electrode 248.
- the at least two drive electrodes can be coupled to drive circuitry 210 to pass a current through the tissue of the patient.
- At least one electrode 240 comprises at least two measurement electrodes, for example 1+ electrode 244 and I- electrode 246.
- the at least two measurement electrodes can be coupled to measurement circuitry 250 to measure an impedance signal from the tissue, for example a voltage drop across the tissue from the current passed through the tissue.
- Circuitry 200 may comprise at least one switch 230.
- At least one switch 230 may comprise a first package of high performance switches SWl , a second package of high performance switches SW2 and a third package of high performance switches SW3.
- At least one switch 230 can be configured in many ways.
- a first configuration of at least one switch 230 couples drive circuitry 210 and measurement circuitry 250 to calibration circuitry 230 to measure an impedance signal from calibration circuitry 230 to calibrate the circuitry.
- a second configuration of at least one switch 230 couples drive circuitry 210 to the at least two drive electrodes and measurement circuitry 250 to the at least two measurement electrodes to measure the impedance of the tissue of the patient.
- drive circuitry 210 may comprise substantially similar parallel drive circuits with one of the parallel drive circuits coupled to the resistance circuitry and the other of the parallel drive circuits coupled to the tissue with the drive electrodes.
- Measurement circuitry 250 may comprise substantially similar measurement circuits with one of the substantially similar measurement circuits coupled to the resistance circuitry and the other of the substantially similar measurement circuits coupled to the tissue with the measurement electrodes.
- Measurement circuitry 250 may comprise a differential amplifier, for example an instrumentation amplifier 252 with high input impedance. Instrumentation amplifier 252 may comprise known instrumentation amplifier circuits. Measurement circuitry can be configured with a variable gain that decreases as the current to the tissue increases. Measurement circuitry 250 may comprise a pre-emphasis before analog to digital converter 256, for example de- emphasis network that decreases the gain of the measurement circuitry as the frequency increases. In specific embodiments, an RC network can be used to provide a decrease in gain of the measurement circuitry with an increase in drive frequency and drive current. Measurement circuitry 250 may comprise an analog to digital converter 256 (A/D) to convert the analog measurement signal to a digital measurement signal the analog to digital converter communicates the digitized measurement signal to the processor system.
- A/D analog to digital converter 256
- Circuitry 200 may comprise ECG circuitry 270.
- ECG circuitry 270 can be connected to the drive electrodes of at least one electrode 240 and may be connected to the measurement electrodes of at least one electrode 240 to measure the ECG signal from the patient.
- ECG circuitry may comprise known ECG circuitry with variable gain, for example known instrumentation amplifiers and known bandpass filters to select the frequencies of the ECG signal with variable gain.
- ECG circuitry 270 can be connected to processor 262 to process the ECG signals.
- Circuitry 200 may comprise an accelerometer 280 to measure patient orientation, acceleration and/or activity of the patient.
- Accelerometer 280 may comprise many known accelerometers. Accelerometer 280 may be connected to processor 262 to process signals from accelerometer 280.
- Circuitry 200 may comprise wireless circuitry 290.
- Wireless circuitry 290 may comprise known wireless circuitry for wireless communication from the device.
- Wireless communications circuitry 290 can communicate with remote center as described above.
- the wireless communication circuitry can be coupled to the impedance circuitry, the electrocardiogram circuitry and the accelerometer to transmit to a remote center with a communication protocol at least one of the hydration signal, the electrocardiogram signal or the inclination signal from the accelerometer.
- wireless communication circuitry is configured to transmit the hydration signal, the electrocardiogram signal and the inclination signal to the remote center with a single wireless hop, for example from wireless communication circuitry 290 to the intermediate device as described above.
- the communication protocol may comprise at least one of Bluetooth, Zigbee, WiFi, WiMax, IR, amplitude modulation or frequency modulation.
- the communications protocol comprises a two way protocol such that the remote center is capable of issuing commands to control data collection.
- Processor system 260 may comprise processors in addition to processor 262, for example a remote processor as described above.
- Processor 262 comprises a tangible medium that can be configured with instructions, for example known processor memory.
- Processor 262 may comprise a known single chip processor with random access memory (RAM), read only memory (ROM), erasable read only memory (EPROM) and a central processing unit.
- Processor system 260 may also comprise an onboard impedance converter 264, for example AD5934 commercially available from Analog Devices of Norwood, MA, USA.
- Impedance converter 264 and/or processor 262 can be configured to synthesize a drive signal with drive circuitry 212 comprising direct digital synthesis (DDS) and digital to analog conversion (DAC).
- Impedance converter 262 and/or processor 262 can also be configured to measure the impedance signal with analog to digital conversion (ADC) and a digital Fourier transform (DFT).
- processor 262 is connected to a precision oscillator, for example a know quartz 16 MHz oscillator, so as to provide an accurate and synchronous time base.
- the synchronous time base is provided for the drive signal and analog to digital conversion, such that time and/or phase delay of the circuitry and tissue impedance measurement can be accurately determined.
- the measured phase angle of a signal may correspond to the time delay from digitization of the drive signal at the DAC to measurement of the signal at the ADC.
- time delays of the drive circuitry and time delays of the measurement circuitry can correspond to a phase angle of 270 degrees at some measurement frequencies, such that calibration that includes delays of the drive circuitry and measurement circuitry can provide improved accuracy of the determined complex tissue impedance.
- the four wire, for four electrode, impedance determination uses that property that current through a series circuit will create a voltage drop across each component that is proportional to their respective impedances.
- the general form of this, realizing that each variable is a complex number, is:
- Z u ⁇ k ⁇ own comprises the unkown impedance, or tissue impedance
- R ca i comprises the resistance of the calibration circuitry
- V u comprises the voltage signal across the unknown impedance
- V 1 - comprises the voltage across the calibration resistor
- Processor system 260 can be configured to make complex calibration and tissue impedance measurements at many frequencies as described above.
- processor system 262 can store a known value of the resistance of calibration circuitry in memory of the processor.
- the calibration circuitry may comprise a known resistance, R ca ⁇ , that can be measured with an ohm meter and stored in processor memory as a real number.
- the processor system can select calibration circuitry 220 in a first configuration of at least one switch 230, as described above.
- a drive current is passed through calibration circuitry 220 and an impedance signal measured with measurement circuitry 250.
- the impedance signal is digitized with the analog to digital converter 256, for example with quadrature sampling for about 256 cycles corresponding to 1024 samples of the measurement calibration signal.
- Processor system 260 calculates a digital transform of the signal, for example at least one of a discrete Fourier transform (DFT), a cosine transform or a sine transform of the measurement signal.
- processor 262 calculates a cosine transform of the measurement signal and a sine transform of the measurement signal at the tissue excitation frequency with the current.
- the cosine transform comprises a known transform and calculating the cosine transform of the measurement signal may comprise multiplying the measurement signal by the cosine of the phase of the drive signal at each sampled data point and summing the values.
- the sine transform comprises a known transform and calculating the sine transform of the measurement signal may comprise multiplying the measurement signal by the sine of the phase of the drive signal at each sampled data point and summing the values.
- the cosine transform of the measured impedance calibration signal, C 0 corresponds to the real component, or resistance, of the measured impedance calibration signal
- the sine transform of the measured impedance calibration signal, C s corresponds to the imaginary component, or reactance, of the measured impedance calibration signal.
- the measured complex impedance calibration signal can be expressed as [0096]
- the complex calibration coefficient, Z coef can be expressed as [0097]
- the complex calibration coefficient may include a substantial reactance component due to the phase and/or time delay of the drive circuitry, time delay of the measurement circuitry, and/or additional parasitic impedances such as the electrode to tissue coupling.
- the complex calibration coefficient can be used to calculate the tissue impedance, such that the phase and/or time delays can be calibrated out of the tissue impedance measurement along with the parasitic impedances such as the electrode to tissue coupling.
- phase delay due to the drive circuitry and/or measurement circuitry can be 90 degrees or more, for example 270 degrees, such that a much more accurate determination impedance can be made using the calibration circuitry and complex calibration coefficient.
- the tissue can be selected for measurement with the at least one switch in the second configuration, as described above.
- a drive current can be passed through measurement electrodes with measurement circuitry 210 and a tissue impedance signal measured from the measurement electrodes with measurement circuitry 250.
- the tissue impedance signal is digitized and the cosine and sine transforms of the measured tissue impedance signal calculated.
- the cosine transform of the tissue measured tissue impedance signal, T c corresponds to the real component, or resistance, of the measured tissue impedance signal
- the sine transform of the measured tissue impedance signal, T s corresponds to the imaginary component, or reactance, of the measured tissue impedance signal.
- the complex tissue impedance signal, Z ts can be expressed as
- the complex impedance of the tissue can be determined and/or calculated in response to the complex impedance calibration signal and the complex tissue impedance signal.
- the complex impedance of the tissue can be calculated in response to the measured complex calibration coefficient and the measured complex tissue impedance signal by multiplying the measured complex calibration coefficient and the measured complex tissue impedance signal, expressed as
- the complex impedance of the tissue can be calculated in response to the measured calibration impedance signal and the measured tissue impedance signal, such that phase and/or time delays of the drive circuitry, measurement circuitry and/or parasitic impedance of tissue are corrected.
- the complex impedance of the tissue can be determined from the complex ratio of the complex tissue impedance signal over the complex calibration impedance signal times the resistance of the calibration resistor.
- the changes in the current applied to the tissue with the drive circuitry and changes in the gain of the measurement circuitry can be corrected by repeating the above measurements and calculations at additional frequencies.
- the impedance of the calibration circuitry for example the calibration resistor, remains substantially constant at different measurement frequencies these additional measurements can provide very accurate measurements of tissue impedance at many frequencies.
- lock-in detection with first and second lock-in amplifiers can be driven at the measurement frequency, in which the first and second lock-in amplifiers are phase shifted by ninety degrees to obtain the real and imaginary components, respectively, of the measured impedance signal.
- a switch as described above, can select the calibration circuitry or the tissue electrodes for measurement with the phase shifted lock-in amplifiers.
- Figure 2B shows an inverse frequency response of the drive circuitry 210 and measurement circuitry 250.
- Drive circuitry 210 generates a drive current 21 1.
- Measurement circuitry 250 comprises a gain 251.
- a safety threshold 213 is shown that corresponds to known safe current requirements, for example AAMI ESl requirements.
- Drive current 21 1 is below a safety threshold 213.
- Drive current 21 1 , safety threshold 213 and gain 21 1 change with frequency.
- a first frequency 215 for example about 1 kHz
- safety threshold 213 corresponds to about 10 ⁇ A.
- Safety threshold 213 corresponds to about 10 ⁇ A for frequencies below 1 kHz. From about 1 kHz to about 100 kHz, threshold 213 increases by about 10 ⁇ A per decade from about 1 kHz to about 100 kHz.
- safety threshold 213 comprises a safe currently limit of about 1000 ⁇ A or 1 mA.
- drive current 21 1 increase from first frequency 21 1 to a second frequency 217, for example 10 kHz
- drive current 213 increases substantially, for example about an order of magnitude, such that the drive current at the second frequency is above the safety threshold at the first frequency.
- gain 251 of the measurement circuitry decreases. In specific embodiments, gain 251 is about 100 at first frequency 215 of about 1 kHz and gain 251 is about 10 at second frequency 217 of about 10 kHz.
- the total system gain of the impedance circuitry can be defined as the product of the drive current times the measurement circuitry.
- the inverse frequency response of the drive circuitry and measurement circuitry is such that the total system gain is substantially uniform, for example to within 25%, over from the first frequency to the second frequency, even though the drive current increase by at least a factor of two, for example by a factor of 10. Therefore, the impedance circuitry provides a substantially uniform total system gain when the drive current at higher frequency exceeds a safety threshold at the lower frequency.
- Figure 3A shows circuitry 300 for measuring patient impedance with an impedance converter, according to embodiments of the present invention.
- the impedance converter circuitry can be configured to determine tissue impedance with a four point measurement technique comprising a grounded unknown impedance and distributed parasitic impedance.
- circuitry 300 comprises an impedance converter 302.
- Impedance converter 302 may comprise a known impedance converter, for example an Analog Devices AD5934 and/or AD5933.
- Circuitry 300 comprises drive circuitry 310, calibration circuitry 304, measurement circuitry 320 and processor circuitry 350.
- measurement circuitry 300 can be used to separate the excitation signal from the measurement signal in the AD5934.
- measurement of the impedance is grounded, such that any distributed parasitic impedance can be factored out.
- Drive circuitry 310 may comprise a master clock signal 312, for example from a known 16 MHz oscillator.
- the oscillator and/or master clock are coupled to a digital data synthesis core, for example DDS core 314.
- DDS core 314 can generate a digital representation of a waveform.
- DDS core 314 is coupled to a digital to analog converter, for example DAC 316.
- An amplifier 318 is coupled to the output of DAC 316 to provide an excitation voltage at an output 319 of impedance converter 302.
- Output 317 can be connected to patient protection circuitry, for example network 317 that limits current to the patient in response to frequency, as described above.
- a parasitic impedance 308 can be distributed among components of circuitry 300 and may comprise capacitance from electrodes coupled to the patient, among other sources.
- Calibration circuitry 304 may comprise a resistor 305. Current from the drive circuitry can pass a current through resistor 305 that can be measured to calibrate the system. Current through calibration circuitry 304 that comprises resistor 305 generates a calibration signal 326.
- Measurement circuitry 320 comprises an amplifier 322, for example instrumentation amplifier, to measure voltage across resistor 305, such that the current through the resistor can be measured.
- Measurement circuitry 320 comprises an amplifier 324, for example an instrumentation amplifier, to measure a tissue impedance signal 328.
- Amplifier 322 and amplifier 324 are coupled to a switch 330.
- Switch 330 can select amplifier 322 or amplifier 324.
- a control signal 331 to switch 330 can select output of amplifier 322 or output of amplifier 324 for further processing with the impedance converter.
- the output of amplifier 322 and the output of amplifier 324 can be measured in parallel, for example with two digital to analog converters on a processor.
- Impedance converter 302 may comprise components of measurement circuitry 320 such as an amplifier 334, a selectable gain 336, a low pass filter 338 and an analog to digital converter, for example ADC 340.
- Amplifier 334 comprises a current follower that converts an input current to a voltage.
- Selectable gain 336 may comprise switches to select a I X or 5X gain from amplifier 334.
- Low pass filter 338 may comprise a known low pass filter to pass low frequencies and inhibit high frequencies.
- ADC 340 may comprise a known ADC with 12 bit resolution.
- Circuitry 300 comprises processor circuitry 350, for example circuitry on an AD 5934 that processes signals from ADC 340.
- Processor circuitry 350 may comprise 1024-point DFT circuitry 356 to compute the discrete Fourier transform of the signal.
- circuitry 300 can be configured to provide 1024 samples for 256 cycles at the selected excitation frequency, such that the data are sampled four times, or quadrature sampled, for each cycle at the measurement frequency.
- a real register 352 comprises memory that stores the real component of the 1024 point DFT from circuitry 356.
- An imaginary register 354 comprises memory that stores the imaginary component of the 1024 point DFT from circuitry 356.
- An interface 358 allows another device, such as microcontroller, to access the real and imaginary components written in memory.
- the real and imaginary components of the DFT can be processed to determine the tissue impedance in response to the DFT of calibration signal 326 and the DFT of the tissue impedance signal 328.
- the real and imaginary components of the DFT of calibration signal 326 may comprise a complex calibration signal
- the real and imaginary components of the DFT of the tissue impedance signal 328 may comprise a complex tissue signal.
- the impedance of the tissue can be determined by computing the complex ratio of the complex tissue signal over the complex calibration signal time and multiplying the complex ratio by the resistance of calibration resistor 305.
- Impedance converter 302 may comprise as an synchronous exciter/voltmeter that drives a series connected combination of calibration resistor 305 and tissue impedance 306 and one or more parasitic impedances 308 with a substantially fixed voltage. To determine the tissue impedance, impedance converter 302 can be commanded to make two measurements, one across the calibration resistor 305, and one across the tissue impedance 306. Instrumentation amplifier inputs and/or outputs can be switched accordingly for each measurement with switch 330. Since substantially the same current flows through both components, the relative phasor voltage across each is proportional to the impedance.
- a current sensing component may comprise calibration resistor 305 so as to give a reference phase angle of zero degrees.
- the complex tissue impedance can be determined.
- the excitation voltage may be replaced with a controlled excitation current such that measurement of voltage across the calibration resistor can be replaced with the constant current.
- This constant current method may use a complex energy efficient bipolar voltage to current converter.
- the constant voltage method and constant drive current can factor out distributed parasitic impedances, since the impedances are in series and current is consistent through all the impedances. In addition to the benefits described above, these methods easily allow one side of the load to be at either DC or AC ground and do not require a finite DC resistance return path.
- FIG. 3B shows an equivalent circuit 390 that may comprise a model for measuring tissue impedance with circuitry 300 that shows components that contribute to the impedance measurements.
- Drive circuitry 310 and network 317 pass the drive current through the calibration circuitry comprising calibration resistor 305.
- Calibration impedance signal 326 corresponds to a voltage across the resistor.
- At least four electrodes that can couple the patient tissue to the circuit include electrode 362, electrode 364, electrode 366 and electrode 368.
- Electrode 362 and electrode 368 may comprise at least two drive electrodes to pass current through the tissue.
- Electrode 364 and electrode 366 may comprise at least two measurement electrodes.
- Tissue impedance signal 328 may correspond to a voltage measured between the at least two measurement electrodes comprising electrode 364 and electrode 366.
- At least four parasitic tissue impedances comprise parasitic impedance 372, parasitic impedance 374, parasitic impedance 376, and parasitic impedance 378.
- a tissue of interest 380 may comprise a tissue below the skin of the patient, for which tissue hydration can be determined based on the impedance.
- the drive current passed through electrode 632 and electrode 368 generates a voltage signal 382 across tissue of interest 380.
- Measurement of the impedance of tissue of interest 380 can be affected by a significant number of uncontrolled series impedances, such as the at least four parasitic impedances.
- patient protection circuit comprising network 317 that limits maximum applied current as a function of frequency introduces a frequency dependent excitation voltage and may also introduce a non-zero equivalent series impedance.
- an assumption about circuit 390 may comprise that V 11 is measured by a very high input impedance amplifier, for example an instrumentation amplifier, so that any sensing channel parasitic series impedance is negligible in comparison.
- Figure 3C shows an equivalent circuit 395 of a model that is similar to the model of Figure 3B and allows for correction of parasitic impedance.
- many of the parasitic impedances of Figure 3B can be lumped into a single value of lumped parasitic impedance 396.
- the tissue impedance signal 328 may more closely correspond to the voltage signal 382 across tissue of interest 380.
- Equivalent circuit 395 shows lumped parasitic impedance 396 connected to ground, although the lumped parasitic impedance can be disposed anywhere in the series circuit as needed during analysis, for example to determine worst case operating conditions. In many embodiments, one can assume that the excitation voltage corresponding to the drive current is whatever voltage is available between ground and the high-side of the calibration resistor.
- the four point, or four electrode, method of measuring voltage across the series connected calibration resistor and series connected tissue impedance produces a maximum analog to digital conversion signal when the unknown impedance is large.
- the largest calibration resistor voltage, V r may occur when the unknown tissue impedance is zero ohms.
- the value of calibration resistor can be chosen during design, so that saturation of the calibration signal and tissue measurement signal does not occur.
- the tissue impedance can be from about 50 to 100 ohms.
- the calibration resistance may be about twice the maximum tissue impedance, for example about 200 ohms.
- the measurable limits of impedance, the impedance resolution limits, the gains of each of the impedance converter and instrumentation amplifier stages and the effects of parasitic impedance on measurement limits can be calculated using known engineering analysis techniques to determine an optimal configuration of the circuitry components for resolution and dynamic range.
- Figure 4 shows a method 400 of measuring patient impedance.
- Method 400 can be implemented with the impedance converter, processor and/or circuits shown above.
- the processor comprises a tangible medium configured to perform method 400.
- a step 405 selects a frequency. The selected frequency is within a range from about DC to about 1 Mhz, and can be from about 100 Hz to about 100 kHz.
- a step 410 selects calibration, for example by configuring switches coupled to the drive circuitry and measurement circuitry, such that the calibration circuitry is measurement with the drive circuitry and measurement circuitry.
- the calibration circuitry can be selected with switches such that on board calibration circuitry located on the measurement device is selected.
- the calibration circuitry may comprise a resistor, such that the selected calibration circuitry substantially comprises a resistance with very little reactance.
- the resistance of the calibration circuitry may comprises a known resistance, for example a DC resistance from a resistor, that is used as a calibration value stored on the processor and/or impedance converter.
- a step 415 generates a source signal. The source signal is generated at the selected frequency.
- the source signal generally comprises a time base that is synchronous with the digitization/detection circuitry to determine both amplitude and phase of the measurement signal.
- a step 420 samples the impedance signal such that the calibration circuitry is measured at the selected frequency.
- the drive electronics, measurement electronics and time delay, for example phase lag, of the system electronics are calibrated with the selected frequency.
- the calibration circuitry substantially comprises a resistance, most of the phase of the measured calibration signal can be attributed to delays in the drive circuitry and the measurement circuitry.
- the impedance signal sampled from the resistance circuitry can be digitized with an A/D converter and may comprise quadrature sampling of about 1024 data points at the selected frequency for about 256 full cycles.
- the cosine and sine transforms of the impedance signal can be calculated to determine the complex impedance of the calibration signal.
- the complex impedance of the calibration signal can then be multiplied and/or divided by the known calibration value, for example known impedance of the calibration resistor, to determine the real and imaginary components of the complex calibration coefficient.
- a step 425 determines the complex calibration coefficients.
- the complex calibration coefficients generally comprise a magnitude that corresponds to the resistance of the calibration circuitry and a phase that corresponds to delays in the drive circuitry and measurement circuitry.
- a step 430 selects tissue, for example by configuring the switches coupled to the drive circuitry and measurement circuitry, such that an outer two of the at least four electrodes are coupled to the drive circuitry to pass current through the tissue and an inner two, or remaining two, of the at least four electrodes are coupled to the measurement circuitry to measure an impedance signal from the tissue.
- a step 440 samples the impedance of the tissue.
- the impedance signal from the sampled tissue can be digitized with an A/D converter and may comprise quadrature sampling of about 1024 data points at the selected frequency for about 256 full cycles.
- the cosine and sine transforms of the impedance signal can be calculated to determine the complex impedance of the tissue signal.
- the complex impedance of the tissue signal can then be multiplied and/or divided by the complex calibration coefficients to determine the impedance of the tissue.
- This use of complex impedance calibration coefficients based on a known resistance in the calibration circuitry, can cause inaccuracies of the gain and phase of the drive and measurement circuitry to drop out of the calculated tissue impedance, such that the determined tissue impedance corresponds to the actual impedance of the tissue.
- a step 445 determines the tissue impedance in response to the complex impedance calibration coefficients and the complex impedance of the tissue signal, for example with complex multiplication. [0120]
- a step 450 determines whether the tissue impedance is within a calibration tolerance.
- the processor may check to determine whether the tissue impedance is within 20% of the calibration circuitry and/or within 20% of a previous tissue measurement.
- a step 455 repeats calibration. Calibration can be repeated with the calibration circuitry, as described above, for example in response to the tissue measurement outside the tolerance range.
- a step 460 repeats the tissue measurement. The tissue measurement may be repeated when the calibration step is repeated.
- a step 465 selects a new frequency, for example a second frequency greater than the first frequency.
- the amount of injected current will increase above a safety threshold of the current injected at the first frequency, and the gain will decrease, for example with an inverse frequency response, such that the signal remains within the range of the A/D converter.
- New calibration and tissue measurements are taken at the new frequency.
- the impedance signal of the calibration circuitry can be measured at the new frequency to determine the complex calibration coefficients, as described above, at the second frequency.
- a resistor will have a substantially fixed resistance at the new frequencies, such that the resistance, for example the real calibration value, of the calibration circuitry may be the same at the second frequency as the first frequency.
- changes in the measured calibration signal can be substantially attributed to changes in the drive current of the drive circuitry and/or gain and time delay measurement circuitry.
- the tissue impedance signal at the new frequency can be determined with the complex calibration coefficient and complex tissue signal. Steps 465 and 470 can be repeated to measure impedance and hydration at many frequencies.
Abstract
A device to measure tissue impedance comprises drive circuitry coupled to calibration circuitry, such that a calibration signal from the calibration circuitry corresponds to the current delivered through the tissue. Measurement circuitry can be coupled to measurement electrodes and the calibration circuitry, such that the tissue impedance can be determined in response to the measured calibration signal from the calibration circuitry and the measured tissue impedance signal from the measurement electrodes. Processor circuitry comprising a tangible medium can be configured to determine a complex tissue impedance in response to the calibration signal and the tissue impedance signal. The processor can be configured to select a frequency for the drive current, and the amount of drive current at increased frequencies may exceed a safety threshold for the drive current at lower frequencies.
Description
METHOD AND APPARATUS TO MEASURE BIOELECTRIC IMPEDANCE OF PATIENT TISSUE
CROSS-REFERENCES TO RELATED APPLICATIONS [0001] The present application claims the benefit under 35 USC 1 19(e) of US Provisional Application No. 61/046,221 filed April 18, 2008; the full disclosure of which is incorporated herein by reference in its entirety.
BACKGROUND OF THE INVENTION
[0002] The present invention relates to patient monitoring. Although embodiments make specific reference to monitoring impedance and electrocardiogram signals with an adherent patch, the system methods and device described herein may be applicable to many applications in which physiological monitoring is used, for example physiological monitoring with implantable devices.
[0003] Patients are often treated for diseases and/or conditions associated with a compromised status of the patient, for example a compromised physiologic status. In some instances, a patient may report symptoms that require diagnosis to determine the underlying cause. For example, a patient may report fainting or dizziness that requires diagnosis, in which long term monitoring of the patient can provide useful information as to the physiologic status of the patient. In some instances a patient may have suffered a heart attack and require care and/or monitoring after release from the hospital. One example of a device to provide long term monitoring of a patient is the Holter monitor, or ambulatory electrocardiography device. In addition to measuring heart signals with electrocardiograms, known physiologic measurements include impedance measurements that can be used to assess the status of the patient.
[0004] Impedance measurements can be used to measure hydration and respiration of a patient. Long term impedance measurements used to determine patient hydration in relation to cardiac status represents one area where impedance measurements may be useful. Although current methodologies have been somewhat successful in measuring hydration, work in relation to embodiments of the present invention suggests that known methods and apparatus for monitoring patient hydration with impedance may be less than ideal. Some current devices may not accurately measure the impedance of the internal tissue of the patient, thereby making accurate hydration measurements more difficult. In some instances, the skin of the patient and/or
coupling of electrodes to the skin may affect the impedance measurements. For example, environmental factors external to the patient may effect the measurements, for example when the patient showers. The electronics used to measure complex impedance signals of the patient may be somewhat larger than ideal and may not provide as much accuracy as would be ideal. Thus, devices that are worn by the patient may be somewhat uncomfortable, which may lead to patients not wearing the devices and not complying with direction from the health care provider, such that data collected may be less than ideal. As a compromise to reduce size and improve patient comfort, some devices to measure impedance may use circuitry that measures part of the tissue impedance without determining the resistance and reactance components of the complex impedance of the tissue.
[0005] Although implantable devices may be used in some instances, many of these devices can be invasive and/or costly, and may suffer at least some of the shortcomings of known wearable devices described above. In addition, implantable devices can be invasive and/or costly such that many patients cannot receive a therapeutic benefit. Although injectable devices may decrease invasiveness, the size requirements of injectable devices can place limitations on the circuitry and may limit the accuracy of such devices.
[0006] Therefore, a need exists for improved patient monitoring with impedance measurements. Ideally, such improved patient monitoring would avoid at least some of the shortcomings of the present methods and devices.
BRIEF SUMMARY OF THE INVENTION
[0007] The present invention relates to patient monitoring. Although embodiments make specific reference to monitoring impedance and electrocardiogram signals with an adherent patch, the system methods and device described herein may be applicable to many applications in which physiological monitoring with impedance measurements are used, for example physiological monitoring with implantable devices.
[0008] In many embodiments of the present invention, tissue impedance is determined in response a calibration signal from calibration circuitry and a tissue impedance signal from the tissue. Because the tissue impedance can be determined from both a tissue impedance signal and a calibration signal, errors can be minimized, for example errors that correspond to fluctuations in drive current, variations in measurement circuitry gain, time delays of the drive circuitry, time delays of the measurement circuitry, and parasitic impedance of the tissue, for example skin. The drive circuitry can be coupled to the calibration circuitry and at least two drive electrodes so
as to drive current through the tissue and the calibration circuitry. Thus, a calibration signal from the calibration circuitry can be measured when the electrodes are connected to the patient, such that the calibration signal substantially corresponds to the current actually delivered through the tissue. Measurement circuitry can be connected to at least two measurement electrodes so as to measure a tissue impedance signal in response to the impedance of the tissue and the current through the tissue. The measurement circuitry can also be coupled to the calibration circuitry to measure the calibration signal, such that the tissue impedance can be determined in response to the measured calibration signal and the measured tissue impedance signal. Processor circuitry comprising a tangible medium can be configured to determine a complex tissue impedance in response to the calibration signal and the tissue impedance signal, such errors are minimized which correspond to fluctuations in drive current, variations in measurement circuitry gain, time delays of the drive circuitry, time delays of the measurement circuitry, and parasitic impedance of the tissue. As the calibration resistor can be provided with the drive circuitry and measurement circuitry, the system can be self calibrating, thereby eliminating a time consuming step at manufacture and minimizing memory resources of the controlling computer and/or processor. In many embodiments, the processor can be configured to select a frequency for the drive current, and the drive circuitry can be configured to increase the amount of drive current with increasing frequency, such that the signal to noise ratio can be improved. The amount of drive current at a selected increased frequency may even exceed a safety threshold for the amount of drive current at a lower frequency. The measurement circuitry can be configured to decrease the gain of the impedance signal with increasing frequency, such that the increased amount of current does not saturated the measurement circuitry and/or digitization electronics such as an analog to digital converter.
[0009] In a first aspect, embodiments of the present invention provide a device for measuring an impedance of a tissue of a patient. The calibration circuitry comprises an impedance. At least four electrodes are configured to couple to the tissue of the patient. The at least four electrodes may comprise at least two measurement electrodes and at least two drive electrodes. Drive circuitry is coupled to the at least two drive electrodes and the calibration circuitry to pass a current through the at least two drive electrodes and the calibration circuitry. Measurement circuitry is configured to couple to the at least two measurement electrodes and the calibration circuitry, such that the measurement circuitry can be configured to measure a calibration signal from the calibration circuitry and a tissue impedance signal from the at least two measurement electrodes. Processor circuitry comprising a tangible medium is configured to determine the impedance of the tissue in response to the calibration signal and the tissue impedance signal.
[0010] In many embodiments, the processor circuitry comprises as least one of an impedance converter or a microcontroller. The processor circuitry can be configured to determine the impedance of the tissue with a discrete Fourier transform of at least one of measurement signal or the current signal. [0011] In many embodiments, the calibration circuitry can be connected in series between the drive circuitry and the at least two measurement electrodes to calibrate the tissue impedance measurement when the at least two electrodes are connected to the patient. The drive circuitry can be configured to pass the current through the tissue and the calibration circuitry to generate the tissue measurement signal and the calibration signal when the at least four electrodes are connected to the tissue. The calibration circuitry may comprise a calibration resistor, and the measurement circuitry can be configured to measure the calibration signal in response to the current through the calibration resistor and the tissue. The measurement circuitry can be configured to measure the tissue measurement signal in response to the current through the tissue and the calibration resistor. The processor can be configured to determine the tissue impedance from the calibration signal and the tissue measurement signal.
[0012] In many embodiments, at least one switch is coupled to the drive circuitry, the measurement circuitry, the calibration circuitry and the at least four electrodes. The at least one switch comprises a first configuration and a second configuration, In the first configuration the at least one switch couples the measurement circuitry to the calibration circuitry to measure the calibration signal. In the second configuration the at least one switch couples the measurement circuitry to the at least two measurement electrodes to measure the tissue impedance signal. The processor circuitry can be coupled to the at least one switch to select the first configuration or the second configuration.
[0013] In many embodiments, the measurement circuitry comprises a first measurement circuit configured to measure the calibration signal and a second measurement circuit configured to measure the tissue impedance signal.
[0014] In many embodiments, the calibration circuitry comprises at least one resistor connected in series to the drive circuitry and the at least two drive electrodes, such that a resistance of the resistor corresponds to at least 90% the impedance of the calibration circuitry. The calibration circuitry may comprise a resistance, and the calibration signal may comprise a complex calibration signal. The tissue impedance signal may comprise a complex tissue
impedance signal, and the processor can be configured to determine a complex impedance of the tissue in response to the complex calibration signal and the complex tissue impedance signal.
[0015] In many embodiments, the processor is configured to store a calibration value comprising a resistance of the calibration circuitry that corresponds to a real number, and the calibration signal corresponds to the resistance of the calibration circuitry, delays of the drive circuitry and delays of the measurement circuitry. The processor can be configured to determine a complex calibration coefficient in response to the calibration value and the calibration signal. The tissue impedance may comprise a complex tissue impedance and processor can be configured to determine the complex tissue impedance in response to the complex calibration coefficient and the tissue impedance signal. For example, the processor can be configured to determine a complex tissue parameter from the tissue impedance signal, and the processor can be configured to determine the complex tissue impedance with at least one of a complex multiplication or a complex division of the complex calibration coefficient and the complex tissue parameter. The processor can be configured to determine the complex tissue parameter with a discrete Fourier transform of the tissue impedance signal and determine the complex calibration coefficient with a discrete Fourier transform of the calibration signal. The delays of the drive circuitry and the measurement circuitry can correspond to a phase angle of the calibration signal of at least about 90 degrees.
[0016] In many embodiments, the processor is configured to select a first frequency and a second frequency to measure impedance signals of the calibration circuitry at each of the first frequency and the second frequency, and the processor is configured to measure impedance signals of the tissue at each of the first frequency and the second frequency. The processor can be configured to determine an impedance of the tissue at the each of the first frequency and the second frequency in response to the impedance signals of the calibration circuitry measured at each of the first frequency and the second frequency and the impedance signals of the tissue measured at each of the first frequency and the second frequency.
[0017] In many embodiments, the processor is configured to store a tolerance range and measure the calibration circuitry in response to the impedance signal of the tissue and the tolerance range. The tolerance range may comprise plus or minus twenty percent of a baseline tissue impedance measurement, and the processor can be configured to measure the calibration circuitry in response to the tissue impedance outside the tolerance range.
[0018] In another aspect, embodiments of the present invention provide a device for measuring an impedance of a tissue of a patient. The device comprises at least four electrodes configured to couple to the tissue of the patient. The at least four electrodes comprising at least two drive electrodes, and at least two measurement electrodes. Drive circuitry is coupled to the at least two drive electrodes to pass a variable current through the tissue to generate a tissue measurement signal. The drive circuitry is configured to increase the current from a first current amount at a first frequency to a second current amount at a second frequency, in which the second frequency greater than the first frequency. Measurement circuitry is coupled to the at least two measurement electrodes to determine the impedance of the tissue in response to the tissue measurement signal. The measurement circuitry comprises a variable gain of the measurement signal, and the variable gain is configured to decrease from a first gain at the first frequency to a second gain at the second frequency.
[0019] In many embodiments, the variable current of the drive circuitry comprises a drive current frequency response, and the variable gain of the measurement circuitry comprises variable gain frequency response, in which the variable gain frequency response comprises an inverse of the drive current frequency response.
[0020] In many embodiments, the drive circuitry is configured to increase the second current amount to at least four times the first current amount, and the measurement circuitry is configured to decrease the second gain to no more than about one half of the first gain. In specific embodiments, the drive circuitry is configured to increase the second current amount to at least ten times the first current amount, and the measurement circuitry is configured to decrease the second gain to no more than about one third of the first gain.
[0021] In many embodiments, the second frequency is at least 1 kHz, and the second current amount is at least 10 μA and no more than 1000 μA. The first frequency corresponds to a first safety threshold of the first current, and the second frequency corresponds to a second safety threshold of the second current. The drive circuitry can be configured to exceed the first safety threshold with the second current amount and not to exceed the second safety threshold with the second current amount. The drive circuitry can be configured to exceed the first safety threshold with the second current by at least a factor of two. The safety threshold of the first current may correspond to 10 μA or a product of the first current in μA times the first frequency in kHz, whichever is greater.
[0022] In another aspect, embodiments of the present invention provide a method of measuring patient impedance. The method comprises providing at least four electrodes comprising at least two drive electrodes and at least two measurement electrodes. The at least two drive electrodes can be connected in series to a calibration resistor. Measurement circuitry is provided to measure a tissue impedance signal from the measurement electrodes. A drive current is passed through the at least two drive electrodes and the calibration resistor with drive circuitry. A current signal is measured from the calibration resistor in response to the current through the calibration resistor. The tissue impedance signal is measured from the measurement electrodes. The tissue impedance is determined in response to the current signal and the tissue impedance signal.
[0023] In many embodiments, the current signal from the calibration resistor is measured with the measurement circuitry.
[0024] In many embodiments, the tissue impedance can be determined with an impedance converter. The current signal from the calibration resistor may comprise a first voltage that is converted into a first current and the first current can be fed into the impedance converter. The tissue impedance signal from the measurement electrodes may comprise a second voltage that can be converted to a second current and the second current fed into the impedance converter.
[0025] In many embodiments, the drive circuitry may comprise a network to limit the drive current through the patient, such that the network increases the drive current through the patient as a frequency of the drive current increases. The measurement circuitry may comprise a variable gain that decreases when the frequency is increases and the drive current increases.
BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure IA shows a patient and a monitoring system comprising an adherent device, according to embodiments of the present invention;
[0027] Figure I B shows a bottom view of the adherent device as in Figure IA comprising an adherent patch;
[0028] Figure 1C shows a top view of the adherent patch, as in Figure 1 B;
[0029] Figure I D shows a printed circuit boards and electronic components over the adherent patch, as in Figure 1 C;
[0030] Figure I Dl shows an equivalent circuit that can be used to determine optimal frequencies for determining patient hydration, according to embodiments of the present invention;
[0031] Figure IE shows batteries positioned over the printed circuit board and electronic components as in Figure ID;
[0032] Figure IF shows a top view of an electronics housing and a breathable cover over the batteries, electronic components and printed circuit board as in Figure I E;
[0033] Figure IG shows a side view of the adherent device as in Figures IA to I F;
[0034] Figure 1 H shown a bottom isometric view of the adherent device as in Figures IA to I G;
[0035] Figures 11 and IJ show a side cross-sectional view and an exploded view, respectively, of the adherent device as in Figures IA to IH;
[0036] Figure 1 K shows at least one electrode configured to electrically couple to a skin of the patient through a breathable tape, according to embodiments of the present invention; [0037] Figure 2A shows a simplified schematic illustration of a circuit diagram for measuring patient impedance, according to embodiments of the present invention;
[0038] Figure 2B shows an inverse frequency response of the drive circuitry and measurement circuitry, according to embodiments of the present invention;
[0039] Figure 3A shows circuitry for measuring patient impedance with an impedance converter, according to embodiments of the present invention;
[0040] Figure 3B shows a model for measuring patient impedance with circuitry as in Figure
3A;
[0041] Figure 3C shows a model equivalent to the model of Figure 3B that allows for correction of parasitic impedance, according to embodiments of the present invention; and [0042] Figure 4 shows a method of measuring patient impedance, according to embodiments of the present invention.
DETAILED DESCRIPTION OF THE INVENTION
[0043] Embodiments of the present invention relate to patient monitoring. Although embodiments make specific reference to monitoring impedance and electrocardiogram signals with an adherent patch, the system methods and device described herein may be applicable to many application in which physiological monitoring is used, for example physiological monitoring with implantable devices.
[0044] In many embodiments, the adherent devices described herein may be used for 90 day monitoring, or more, and may comprise completely disposable components and/or reusable components, and can provide reliable data acquisition and transfer. In many embodiments, the patch is configured for patient comfort, such that the patch can be worn and/or tolerated by the patient for extended periods, for example 90 days or more. In many embodiments, the adherent patch comprises a tape, which comprises a material, preferably breathable, with an adhesive, such that trauma to the patient skin can be minimized while the patch is worn for the extended period. In many embodiments, the printed circuit board comprises a flex printed circuit board that can flex with the patient to provide improved patient comfort.
[0045] Figure IA shows a patient P and a monitoring system 10. Patient P comprises a midline M, a first side Sl , for example a right side, and a second side S2, for example a left side. Monitoring system 10 comprises an adherent device 100. Adherent device 100 can be adhered to a patient P at many locations, for example thorax T of patient P. In many embodiments, the adherent device may adhere to one side of the patient, from which side data can be collected. Work in relation with embodiments of the present invention suggests that location on a side of the patient can provide comfort for the patient while the device is adhered to the patient.
[0046] Monitoring system 10 includes components to transmit data to a remote center 106. Adherent device 100 can communicate wirelessly to an intermediate device 102, for example with a single wireless hop from the adherent device on the patient to the intermediate device. Intermediate device 102 can communicate with remote center 106 in many ways, for example with an internet connection. In many embodiments, monitoring system 10 comprises a distributed processing system with at least one processor on device 100, at least one processor on intermediate device 102, and at least one process at remote center 106, each of which processors is in electronic communication with the other processors. Remote center 106 can be in communication with a health care provider 108A with a communication system 107A, such as the Internet, an intranet, phone lines, wireless and/or satellite phone. Health care provider 108A, for example a family member, can be in communication with patient P with a communication,
for example with a two way communication system, as indicated by arrow 109A, for example by cell phone, email, landline. Remote center 106 can be in communication with a health care professional, for example a physician 108B, with a communication system 107B, such as the Internet, an intranet, phone lines, wireless and/or satellite phone. Physician 108B can be in communication with patient P with a communication, for example with a two way communication system, as indicated by arrow 109B, for example by cell phone, email, landline. Remote center 106 can be in communication with an emergency responder 108C, for example a 91 1 operator and/or paramedic, with a communication system 107C, such as the Internet, an intranet, phone lines, wireless and/or satellite phone. Emergency responder 108C can travel to the patient as indicated by arrow 109C. Thus, in many embodiments, monitoring system 10 comprises a closed loop system in which patient care can be monitored and implemented from the remote center in response to signals from the adherent device.
[0047] In many embodiments, the adherent device may continuously monitor physiological parameters, communicate wirelessly with a remote center, and provide alerts when necessary. The system may comprise an adherent patch, which attaches to the patient's thorax and contains sensing electrodes, battery, memory, logic, and wireless communication capabilities. In some embodiments, the patch can communicates with the remote center, via the intermediate device in the patient's home. In the many embodiments, the remote center receives the data and applies the prediction algorithm. When a flag is raised, the center may communicate with the patient, hospital, nurse, and/or physician to allow for therapeutic intervention to prevent decompensation.
[0048] The adherent device may be affixed and/or adhered to the body in many ways. For example, with at least one of the following an adhesive tape, a constant-force spring, suspenders around shoulders, a screw-in microneedle electrode, a pre-shaped electronics module to shape fabric to a thorax, a pinch onto roll of skin, or transcutaneous anchoring. Patch and/or device replacement may occur with a keyed patch (e.g. two-part patch), an outline or anatomical mark, a low-adhesive guide (place guide | remove old patch | place new patch | remove guide), or a keyed attachment for chatter reduction. The patch and/or device may comprise an adhesiveless embodiment (e.g. chest strap), and/or a low-irritation adhesive model for sensitive skin. The adherent patch and/or device can comprise many shapes, for example at least one of a dogbone, an hourglass, an oblong, a circular or an oval shape.
[0049] In many embodiments, the adherent device may comprise a reusable electronics module with replaceable patches (the module collects cumulative data for approximately 90 days) and/or the entire adherent component (electronics + patch) may be disposable. In a completely
disposable embodiment, a "baton" mechanism may be used for data transfer and retention, for example baton transfer may include baseline information. In some embodiments, the device may have a rechargeable module, and may use dual battery and/or electronics modules, wherein one module 101 A can be recharged using a charging station 103 while the other module 101 B is placed on the adherent device. In some embodiments, the intermediate device 102 may comprise the charging module, data transfer, storage and/or transmission, such that one of the electronics modules can be placed in the intermediate device for charging and/or data transfer while the other electronics module is worn by the patient.
[0050] In many embodiments, the system can perform the following functions: initiation, programming, measuring, storing, analyzing, communicating, predicting, and displaying. The adherent device may contain a subset of the following physiological sensors: bioimpedance, respiration, respiration rate variability, heart rate (ave, min, max), heart rhythm, HRV, HRT, heart sounds (e.g. S3), respiratory sounds, blood pressure, activity, posture, wake/sleep, orthopnea, temperature/heat flux, and weight. The activity sensor may be one of the following: ball switch, accelerometer, minute ventilation, HR, bioimpedance noise, skin temperature/heat flux, BP, muscle noise, posture.
[0051] In many embodiments, the patch wirelessly communicates with a remote center. In some embodiments, the communication may occur directly (via a cellular or Wi-Fi network), or indirectly through intermediate device 102. Intermediate device 102 may consist of multiple devices which communicate wired or wirelessly to relay data to remote center 106.
[0052] In many embodiments, instructions are transmitted from a remote site to a processor supported with the patient, and the processor supported with the patient can receive updated instructions for the patient treatment and/or monitoring, for example while worn by the patient.
[0053] Figure I B shows a bottom view of adherent device 100 as in Figure IA comprising an adherent patch 1 10. Adherent patch 1 10 comprises a first side, or a lower side 1 1 OA, that is oriented toward the skin of the patient when placed on the patient. In many embodiments, adherent patch 1 10 comprises a tape 1 1 OT which is a material, preferably breathable, with an adhesive 1 16A. Patient side 1 1OA comprises adhesive 1 16A to adhere the patch 1 10 and adherent device 100 to patient P. Electrodes 1 12A, 1 12B, 1 12C and 1 12D are affixed to adherent patch 1 10. In many embodiments, at least four electrodes are attached to the patch, for example six electrodes. In some embodiments the patch comprises two electrodes, for example two electrodes to measure the electrocardiogram (ECG) of the patient. Gel 1 14A, gel 1 14B, gel
1 14C and gel 1 14D can each be positioned over electrodes 1 12A, 1 12B, 1 12C and 1 12D, respectively, to provide electrical conductivity between the electrodes and the skin of the patient. In many embodiments, the electrodes can be affixed to the patch 1 10, for example with known methods and structures such as rivets, adhesive, stitches, etc. In many embodiments, patch 1 10 comprises a breathable material to permit air and/or vapor to flow to and from the surface of the skin.
[0054] Figure 1 C shows a top view of the adherent patch 100, as in Figure I B. Adherent patch 100 comprises a second side, or upper side 1 1 OB. In many embodiments, electrodes 1 1 OA, 1 1 OB, 1 1 OC and 1 1 OD extend from lower side 1 1 OA through the adherent patch to upper side 1 1 OB. In some embodiments, an adhesive 1 16B can be applied to upper side 1 1 OB to adhere structures, for example electronic structures, to the patch such that the patch can support the electronics and other structures when the patch is adhered to the patient. The PCB comprise completely flex PCB, rigid PCB combined flex PCB and/or rigid PCB boards connected by cable. [0055] Figure 1 D shows a printed circuit boards and electronic components over adherent patch 1 10, as in Figure 1 C. In some embodiments, a printed circuit board (PCB), for example flex PCB 120, may be connected to upper side I OOB of patch 1 10 with connectors 122 A, 122B, 122C and 122D. Flex PCB 120 can include traces 123 A, 123B, 123C and 123 D that extend to connectors 122A, 122B, 122C and 122D, respectively, on the flex PCB. Connectors 122A, 122B, 122C and 122D can be positioned on flex PCB 120 in alignment with electrodes 1 12A, 1 12B, 1 12C and 1 12D so as to electrically couple the flex PCB with the electrodes. In some embodiments, connectors 122A, 122B, 122C and 122D may comprise insulated wires that provide strain relief between the PCB and the electrodes. In some embodiments, additional PCB's, for example rigid PCB's 120A, 120B, 120C and 120D, can be connected to flex PCB 120. Electronic components 130 can be connected to flex PCB 120 and/or mounted thereon. In some embodiments, electronic components 130 can be mounted on the additional PCB's.
[0056] Electronic components 130 comprise components to take physiologic measurements, transmit data to remote center 106 and receive commands from remote center 106. In many embodiments, electronics components 130 may comprise known low power circuitry, for example complementary metal oxide semiconductor (CMOS) circuitry components. Electronics components 130 comprise an activity sensor and activity circuitry 134, impedance circuitry 136 and electrocardiogram circuitry, for example ECG circuitry 136. In some embodiments, electronics circuitry 130 may comprise a microphone and microphone circuitry 142 to detect an
audio signal from within the patient, and the audio signal may comprise a heart sound and/or a respiratory sound, for example an S3 heart sound and a respiratory sound with rales and/or crackles. Electronics circuitry 130 may comprise a temperature sensor, for example a thermistor, and temperature sensor circuitry 144 to measure a temperature of the patient, for example a temperature of a skin of the patient.
[0057] Work in relation to embodiments of the present invention suggests that skin temperature may effect impedance and/or hydration measurements, and that skin temperature measurements may be used to correct impedance and/or hydration measurements. In some embodiments, increase in skin temperature or heat flux can be associated with increased vaso- dilation near the skin surface, such that measured impedance measurement decreased, even through the hydration of the patient in deeper tissues under the skin remains substantially unchanged. Thus, use of the temperature sensor can allow for correction of the hydration signals to more accurately assess the hydration, for example extra cellular hydration, of deeper tissues of the patient, for example deeper tissues in the thorax. [0058] Electronics circuitry 130 may comprise a processor 146. Processor 146 comprises a tangible medium, for example read only memory (ROM), electrically erasable programmable read only memory (EEPROM) and/or random access memory (RAM). Electronic circuitry 130 may comprise real time clock and frequency generator circuitry 148. In some embodiments, processor 136 may comprise the frequency generator and real time clock. The processor can be configured to control a collection and transmission of data from the impedance circuitry electrocardiogram circuitry and the accelerometer. In many embodiments, device 100 comprise a distributed processor system, for example with multiple processors on device 100.
[0059] In many embodiments, electronics components 130 comprise wireless communications circuitry 132 to communicate with remote center 106. The wireless communication circuitry can be coupled to the impedance circuitry, the electrocardiogram circuitry and the accelerometer to transmit to a remote center with a communication protocol at least one of the hydration signal, the electrocardiogram signal or the inclination signal. In specific embodiments, wireless communication circuitry is configured to transmit the hydration signal, the electrocardiogram signal and the inclination signal to the remote center with a single wireless hop, for example from wireless communication circuitry 132 to intermediate device 102. The communication protocol comprises at least one of Bluetooth, Zigbee, WiFi, WiMax, IR, amplitude modulation or frequency modulation. In many embodiments, the communications protocol comprises a two
way protocol such that the remote center is capable of issuing commands to control data collection.
[0060] In some embodiments, intermediate device 102 comprises a data collection system to collect and store data from the wireless transmitter. The data collection system can be configured to communicate periodically with the remote center. In many embodiments, the data collection system can transmit data in response to commands from remote center 106 and/or in response to commands from the adherent device.
[0061] Activity sensor and activity circuitry 134 can comprise many known activity sensors and circuitry. In many embodiments, the accelerometer comprises at least one of a piezoelectric accelerometer, capacitive accelerometer or electromechanical accelerometer. The accelerometer may comprises a 3-axis accelerometer to measure at least one of an inclination, a position, an orientation or acceleration of the patient in three dimensions. Work in relation to embodiments of the present invention suggests that three dimensional orientation of the patient and associated positions, for example sitting, standing, lying down, can be very useful when combined with data from other sensors, for example ECG data and/or hydration data.
[0062] Impedance circuitry 136 can generate both hydration data and respiration data. In many embodiments, impedance circuitry 136 is electrically connected to electrodes 1 12A, 1 12B, 1 12C and 1 12D such that electrodes 1 12A and 1 12D comprise outer electrodes that are driven with a current, or force electrodes. The current delivered between electrodes 1 12A and 1 12D generates a measurable voltage between electrodes 1 12B and 1 12C, such that electrodes 1 12B and 1 12C comprise inner electrodes, or measurement electrodes that measure the voltage in response to the current from the force electrodes. The voltage measured by the measurement electrodes can be used to determine the hydration of the patient.
[0063] Figure I Dl shows an equivalent circuit 152 that can be used to determine optimal frequencies for measuring patient hydration. Work in relation to embodiments of the present invention indicates that the frequency of the current and/or voltage at the force electrodes can be selected so as to provide impedance signals related to the extracellular and/or intracellular hydration of the patient tissue. Equivalent circuit 152 comprises an intracellular resistance 156, or R(ICW) in series with a capacitor 154, and an extracellular resistance 158, or R(ECW). Extracellular resistance 158 is in parallel with intracellular resistance 156 and capacitor 154 related to capacitance of cell membranes. In many embodiments, impedances can be measured and provide useful information over a wide range of frequencies, for example from about 0.5
kHz to about 200 KHz. Work in relation to embodiments of the present invention suggests that extracellular resistance 158 can be significantly related extracellular fluid and to cardiac decompensation, and that extracellular resistance 158 and extracellular fluid can be effectively measured with frequencies in a range from about 0.5 kHz to about 20 kHz, for example from about 1 kHz to about 10 kHz. In some embodiments, a single frequency can be used to determine the extracellular resistance and/or fluid. As sample frequencies increase from about 10 kHz to about 20 kHz, capacitance related to cell membranes decrease the impedance, such that the intracellular fluid contributes to the impedance and/or hydration measurements. Thus, many embodiments of the present invention employ measure hydration with frequencies from about 0.5 kHz to about 20 kHz to determine patient hydration.
[0064] In many embodiments, impedance circuitry 136 can be configured to determine respiration of the patient. In specific embodiments, the impedance circuitry can measure the hydration at 25 Hz intervals, for example at 25 Hz intervals using impedance measurements with a frequency from about 0.5 kHz to about 20 kHz. [0065] ECG circuitry 138 can generate electrocardiogram signals and data from electrodes 1 12A, 1 12B, 1 12C and 1 12D. In some embodiments, ECG circuitry 138 is connected to inner electrodes 1 12B and 122C, which may comprise measurement electrodes of the impedance circuitry as described above. In some embodiments, the inner electrodes may be positioned near the outer electrodes to increase the voltage of the ECG signal measured by ECG circuitry 138. In some embodiments, the ECG circuitry can share components with the impedance circuitry.
[0066] Figure 1 E shows batteries 150 positioned over the flex printed circuit board and electronic components as in Figure I D. Batteries 150 may comprise rechargeable batteries that can be removed and/or recharged. In some embodiments, batteries 150 can be removed from the adherent patch and recharged and/or replaced. [0067] Figure IF shows a top view of a cover 162 over the batteries, electronic components and flex printed circuit board as in Figure I E. In many embodiments, an electronics housing 160 may be disposed under cover 162 to protect the electronic components, and in some embodiments electronics housing 160 may comprise an encapsulant over the electronic components and PCB. In some embodiments, cover 162 can be adhered to adhesive patch with an adhesive 164 on an underside of cover 162. In some embodiments, electronics housing 160 can be adhered to cover 162 with an adhesive 166 where cover 162 contacts electronics housing 160. In many embodiments, electronics housing 160 may comprise a water proof material, for
example a sealant adhesive such as epoxy or silicone coated over the electronics components and/or PCB. In some embodiments, electronics housing 160 may comprise metal and/or plastic. Metal or plastic may be potted with a material such as epoxy or silicone.
[0068] Cover 162 may comprise many known biocompatible cover, casing and/or housing materials, such as elastomers, for example silicone. The elastomer may be fenestrated to improve breathability. In some embodiments, cover 162 may comprise many known breathable materials, for example polyester, polyamide, and/or elastane (Spandex). The breathable fabric may be coated to make it water resistant, waterproof, and/or to aid in wicking moisture away from the patch. [0069] Figure I G shows a side view of adherent device 100 as in Figures IA to I F. Adherent device 100 comprises a maximum dimension, for example a length 170 from about 4 to 10 inches (from about 100 mm to about 250mm), for example from about 6 to 8 inches (from about 150 mm to about 200 mm). In some embodiments, length 170 may be no more than about 6 inches (no more than about 150 mm). Adherent device 100 comprises a thickness 172. Thickness 172 may comprise a maximum thickness along a profile of the device. Thickness 172 can be from about 0.2 inches to about 0.4 inches (from about 5 mm to about 10 mm), for example about 0.3 inches (about 7.5 mm) .
[0070] Figure I H shown a bottom isometric view of adherent device 100 as in Figures IA to I G. Adherent device 100 comprises a width 174, for example a maximum width along a width profile of adherent device 100. Width 174 can be from about 2 to about 4 inches (from about 50 mm to 100 mm), for example about 3 inches (about 75 mm).
[0071] Figures 1 1 and U show a side cross-sectional view and an exploded view, respectively, of adherent device 100 as in Figures IA to I H. Device 100 comprises several layers. Gel 1 14A, or gel layer, is positioned on electrode 1 12A to provide electrical conductivity between the electrode and the skin. Electrode 1 12A may comprise an electrode layer. Adhesive patch 1 10 may comprise a layer of breathable tape 1 1 OT, for example a known breathable tape, such as tricot-knit polyester fabric. An adhesive 1 16A, for example a layer of aery late pressure sensitive adhesive, can be disposed on underside 1 1 OA of patch 1 10. A gel cover 180, or gel cover layer, for example a polyurethane non-woven tape, can be positioned over patch 1 10 comprising the breathable tape. A PCB layer, for example flex PCB 120, or flex PCB layer, can be positioned over gel cover 180 with electronic components 130 connected and/or mounted to flex PCB 120, for example mounted on flex PCB so as to comprise an electronics layer disposed on the flex
PCB. In many embodiments, the adherent device may comprise a segmented inner component, for example the PCB, for limited flexibility. In many embodiments, the electronics layer may be encapsulated in electronics housing 160 which may comprise a waterproof material, for example silicone or epoxy. In many embodiments, the electrodes are connected to the PCB with a flex connection, for example trace 123 A of flex PCB 120, so as to provide strain relive between the electrodes 1 12A, 1 12B, 1 12C and 1 12D and the PCB. Gel cover 180 can inhibit flow of gel 1 14A and liquid. In many embodiments, gel cover 180 can inhibit gel 1 14A from seeping through breathable tape 1 1OT to maintain gel integrity over time. Gel cover 180 can also keep external moisture from penetrating into gel 1 14A. In many embodiments, cover 162 can encase the flex PCB and/or electronics and can be adhered to at least one of the electronics, the flex
PCB or the adherent patch, so as to protect the device. In some embodiments, cover 162 attaches to adhesive patch 1 10 with adhesive 1 16B, and cover 162 is adhered to the PCB module with an adhesive 161 on the upper surface of the electronics housing. Cover 162 can comprise many known biocompatible cover, housing and/or casing materials, for example silicone. In many embodiments, cover 162 comprises an outer polymer cover to provide smooth contour without limiting flexibility. In some embodiments, cover 162 may comprise a breathable fabric. Cover 162 may comprise many known breathable fabrics, for example breathable fabrics as described above. In some embodiments, the breathable fabric may comprise polyester, polyamide, and/or elastane (Spandex) to allow the breathable fabric to stretch with body movement. In some embodiments, the breathable tape may contain and elute a pharmaceutical agent, such as an antibiotic, anti-inflammatory or antifungal agent, when the adherent device is placed on the patient.
[0072] In many embodiments, the breathable tape of adhesive patch 1 10 comprises a first mesh with a first porosity and gel cover 180 comprises a breathable tape with a second mesh porosity, in which the second porosity is less than the first porosity to inhibit flow of the gel through the breathable tape.
[0073] In many embodiments, a gap 169 extends from adherent patch 1 10 to the electronics module and/or PCB, such that breathable tape 1 1 OT can breath to provide patient comfort.
[0074] In many embodiments, the adherent device comprises a patch component and at least one electronics module. The patch component may comprise adhesive patch 1 10 comprising the breathable tape with adhesive coating 1 16A, at least one electrode 1 14A and gel 1 14, for example a gel coating. The at least one electronics module can be is separable from the patch component. In many embodiments, the at least one electronics module comprises the flex
printed circuit board 120, electronic component 130, electronics housing 160 and waterproof cover 162, such that the flex printed circuit board, electronic components electronics housing and water proof cover are reusable and/or removable for recharging and data transfer, for example as described above. In many embodiments, adhesive 1 16B is coated on upper side 1 1 OA of adhesive patch 1 1 OB, such that the electronics module, or electronics layers, can be adhered to and/or separated from the adhesive component, or adhesive layers. In specific embodiments, the electronic module can be adhered to the patch component with a releasable connection, for example with Velcro™, a known hook and loop connection, and/or snap directly to the electrodes. In some embodiments, two electronics modules can be provided, such that one electronics module can be worn by the patient while the other is charged as described above.
[0075] In many embodiments, at least one electrode 1 12A extends through at least one aperture in the breathable tape 1 10.
[0076] In some embodiments, the adhesive patch may comprise a medicated patch that releases a medicament, such as antibiotic, beta-blocker, ACE inhibitor, diuretic, or steroid to reduce skin irritation. In some embodiments, the adhesive patch may comprise a thin, flexible, breathable patch with a polymer grid for stiffening. This grid may be anisotropic, may use electronic components to act as a stiffener, may use electronics-enhanced adhesive elution, and may use an alternating elution of adhesive and steroid.
[0077] Figure I K shows at least one electrode 190 configured to electrically couple to a skin of the patient through a breathable tape 192. In many embodiments, at least one electrode 190 and breathable tape 192 comprise electrodes and materials similar to those described above. Electrode 190 and breathable tape 192 can be incorporated into adherent devices as described above, so as to provide electrical coupling between the skin an electrode through the breathable tape, for example with the gel. [0078] Figure 2A shows a simplified schematic illustration of circuitry 200 for measuring patient signals, such as impedance signals to measure hydration, ECG signals. Circuitry 200 comprises drive circuitry 210 to drive a current through the patient tissue, and measurement circuitry 250 to measure an impedance signal from the patient tissue. Circuitry 200 may comprise at least four electrodes 240 to couple drive circuitry 210 and measurement circuitry 250 to the patient tissue. Circuitry 200 comprises calibration circuitry 220 to calibrate the drive circuitry and measurement circuitry. Circuitry 200 may comprise a processor system 260 that comprises at least one processor, for example a processor 262 on the adherent device as
described above. Circuitry 200 may comprise at least one switch 230 that can be used to select for measurement either on board calibration circuitry 220 or electrodes 240 that are coupled to the skin of the patient. Circuitry 200 may comprise ECG circuitry 270 to measure electrocardiogram signals from the patient, accelerometer 280 to measure patient position and/or activity, and wireless circuitry 290 to transmit the data.
[0079] Drive circuitry 210 may comprise a drive module 212. Drive module 212 can be used to generate a drive current at a selected frequency. For example, drive module 212 may comprise direct digital synthesis (DDS) and digital to analog conversion (DAC) and amplifiers to generate the drive current at the selected frequency. The amplifiers to generate the drive current may comprise a gain, and in some embodiments the gain of the drive current amplifiers increases with increasing frequency. In some embodiments, drive module 212 may comprise analog electronics, for example a frequency generator to generate the drive current at the selected frequency. The drive current may comprise an AC component at the selected frequency and a DC component. Drive circuitry 210 comprises circuitry to adjust the current delivered to the patient in response to the selected frequency. In many embodiments, drive circuitry 210 can increase the current delivered to the patient as the drive frequency increases, such that the amount of current complies with safe current requirements, for example known AAMI ESl requirements. The drive current is generally below a safety threshold that corresponds to 10 μA for frequencies below 1 kHz, increases by 10 μA per decade kHz from 1 kHz to 100 kHz, and remains at 1 mA for frequencies above 100 kHz, for example from 100 kHz to 1 MHz. In many embodiments, drive circuitry 210 comprises an attenuation network that decreases current from the drive module to the tissue. In many embodiments, the attenuation of drive current from the drive module decreases with increasing frequency, such that the amount of current delivered to the patient increases with increasing frequency. In specific embodiments, attenuation circuitry 212 may comprise a high pass RC circuit network such that the current delivered to tissue increases from about 200 Hz to about 1 kHz, for example with a corner frequency, fc, within a range from about 200 Hz to about 1 kHz. Alternatively or in combination, drive circuitry 210 may comprise a high pass amplifier that increases the gain of current delivered to the patient as the selected frequency increases. [0080] Calibration circuitry 220 can comprise components of known impedance to calibrate circuitry 200. Calibration circuitry 220 can be connected to drive circuitry 210 and measurement circuitry 250 to calibrate the electronics of circuitry 200, for example drive circuitry 210 and measurement circuitry 250. In specific embodiments, calibration circuitry 220 comprises a
resistor of known resistance that can be used to calibrate drive circuitry 210 and measurement circuitry 250. Calibration circuitry 220 may comprise a substantial resistance with very little reactance, for example resistance may comprise at least 90% of the magnitude of the impedance of calibration circuitry 220. The use of calibration circuitry that comprises substantial resistance can facilitate calibration, as phase delay and amplitude changes in the measured calibration signal may be attributed to changes in drive circuitry 210 and measurement circuitry 250. In many embodiments, the resistor of calibration circuitry 220 comprises a known resistance that is close to the impedance of tissue measured such that the calibration circuitry comprises an impedance with a magnitude within the range of physiologic tissue impedances likely to be measured with the electrodes, for example from about 10 Ohms to about 200 Ohms. In some embodiments, calibration circuitry 220 may comprises a plurality of selectable resistors to select a resistance that is close to the measured tissue impedance.
[0081] At least one electrode 240 comprises at least two drive electrodes, for example V+ electrode 244 and V- electrode 248. The at least two drive electrodes can be coupled to drive circuitry 210 to pass a current through the tissue of the patient. At least one electrode 240 comprises at least two measurement electrodes, for example 1+ electrode 244 and I- electrode 246. The at least two measurement electrodes can be coupled to measurement circuitry 250 to measure an impedance signal from the tissue, for example a voltage drop across the tissue from the current passed through the tissue. [0082] Circuitry 200 may comprise at least one switch 230. At least one switch 230 may comprise a first package of high performance switches SWl , a second package of high performance switches SW2 and a third package of high performance switches SW3. At least one switch 230 can be configured in many ways. In specific embodiments, a first configuration of at least one switch 230 couples drive circuitry 210 and measurement circuitry 250 to calibration circuitry 230 to measure an impedance signal from calibration circuitry 230 to calibrate the circuitry. A second configuration of at least one switch 230 couples drive circuitry 210 to the at least two drive electrodes and measurement circuitry 250 to the at least two measurement electrodes to measure the impedance of the tissue of the patient.
[0083] Although at least one switch 230 is shown, in some embodiments calibration can be performed without switches, for example with substantially parallel drive and measurement circuits. In specific embodiments, drive circuitry 210 may comprise substantially similar parallel drive circuits with one of the parallel drive circuits coupled to the resistance circuitry and the other of the parallel drive circuits coupled to the tissue with the drive electrodes. Measurement
circuitry 250 may comprise substantially similar measurement circuits with one of the substantially similar measurement circuits coupled to the resistance circuitry and the other of the substantially similar measurement circuits coupled to the tissue with the measurement electrodes. Thus, in at least some embodiments, calibration based on the resistance circuitry can be performed without the at least one switch.
[0084] Measurement circuitry 250 may comprise a differential amplifier, for example an instrumentation amplifier 252 with high input impedance. Instrumentation amplifier 252 may comprise known instrumentation amplifier circuits. Measurement circuitry can be configured with a variable gain that decreases as the current to the tissue increases. Measurement circuitry 250 may comprise a pre-emphasis before analog to digital converter 256, for example de- emphasis network that decreases the gain of the measurement circuitry as the frequency increases. In specific embodiments, an RC network can be used to provide a decrease in gain of the measurement circuitry with an increase in drive frequency and drive current. Measurement circuitry 250 may comprise an analog to digital converter 256 (A/D) to convert the analog measurement signal to a digital measurement signal the analog to digital converter communicates the digitized measurement signal to the processor system.
[0085] Circuitry 200 may comprise ECG circuitry 270. ECG circuitry 270 can be connected to the drive electrodes of at least one electrode 240 and may be connected to the measurement electrodes of at least one electrode 240 to measure the ECG signal from the patient. ECG circuitry may comprise known ECG circuitry with variable gain, for example known instrumentation amplifiers and known bandpass filters to select the frequencies of the ECG signal with variable gain. ECG circuitry 270 can be connected to processor 262 to process the ECG signals.
[0086] Circuitry 200 may comprise an accelerometer 280 to measure patient orientation, acceleration and/or activity of the patient. Accelerometer 280 may comprise many known accelerometers. Accelerometer 280 may be connected to processor 262 to process signals from accelerometer 280.
[0087] Circuitry 200 may comprise wireless circuitry 290. Wireless circuitry 290 may comprise known wireless circuitry for wireless communication from the device. Wireless communications circuitry 290 can communicate with remote center as described above. The wireless communication circuitry can be coupled to the impedance circuitry, the electrocardiogram circuitry and the accelerometer to transmit to a remote center with a
communication protocol at least one of the hydration signal, the electrocardiogram signal or the inclination signal from the accelerometer. In specific embodiments, wireless communication circuitry is configured to transmit the hydration signal, the electrocardiogram signal and the inclination signal to the remote center with a single wireless hop, for example from wireless communication circuitry 290 to the intermediate device as described above. The communication protocol may comprise at least one of Bluetooth, Zigbee, WiFi, WiMax, IR, amplitude modulation or frequency modulation. In many embodiments, the communications protocol comprises a two way protocol such that the remote center is capable of issuing commands to control data collection. [0088] Processor system 260 may comprise processors in addition to processor 262, for example a remote processor as described above. Processor 262 comprises a tangible medium that can be configured with instructions, for example known processor memory. Processor 262 may comprise a known single chip processor with random access memory (RAM), read only memory (ROM), erasable read only memory (EPROM) and a central processing unit. Processor system 260 may also comprise an onboard impedance converter 264, for example AD5934 commercially available from Analog Devices of Norwood, MA, USA. Impedance converter 264 and/or processor 262 can be configured to synthesize a drive signal with drive circuitry 212 comprising direct digital synthesis (DDS) and digital to analog conversion (DAC). Impedance converter 262 and/or processor 262 can also be configured to measure the impedance signal with analog to digital conversion (ADC) and a digital Fourier transform (DFT). In many embodiments, processor 262 is connected to a precision oscillator, for example a know quartz 16 MHz oscillator, so as to provide an accurate and synchronous time base. The synchronous time base is provided for the drive signal and analog to digital conversion, such that time and/or phase delay of the circuitry and tissue impedance measurement can be accurately determined. Thus, the measured phase angle of a signal may correspond to the time delay from digitization of the drive signal at the DAC to measurement of the signal at the ADC. Work in relation to embodiments of the present invention suggests that time delays of the drive circuitry and time delays of the measurement circuitry can correspond to a phase angle of 270 degrees at some measurement frequencies, such that calibration that includes delays of the drive circuitry and measurement circuitry can provide improved accuracy of the determined complex tissue impedance.
[0089] The four wire, for four electrode, impedance determination uses that property that current through a series circuit will create a voltage drop across each component that is proportional to
their respective impedances. The general form of this, realizing that each variable is a complex number, is:
[0090] Zuπkowπ / Rc3I = V11 / V1. [0091] which becomes [0092] Zunkown = (Vu / Vr)*Rcal
[0093] where Zuπkπown comprises the unkown impedance, or tissue impedance, Rcai comprises the resistance of the calibration circuitry, Vu comprises the voltage signal across the unknown impedance, and V1-, comprises the voltage across the calibration resistor.
[0094] Processor system 260 can be configured to make complex calibration and tissue impedance measurements at many frequencies as described above. In specific embodiments, processor system 262 can store a known value of the resistance of calibration circuitry in memory of the processor. For example, the calibration circuitry may comprise a known resistance, Rcaι, that can be measured with an ohm meter and stored in processor memory as a real number. The processor system can select calibration circuitry 220 in a first configuration of at least one switch 230, as described above. A drive current is passed through calibration circuitry 220 and an impedance signal measured with measurement circuitry 250. The impedance signal is digitized with the analog to digital converter 256, for example with quadrature sampling for about 256 cycles corresponding to 1024 samples of the measurement calibration signal. Processor system 260, for example processor 262 and/or impedance converter 262, calculates a digital transform of the signal, for example at least one of a discrete Fourier transform (DFT), a cosine transform or a sine transform of the measurement signal. In a specific embodiment, processor 262 calculates a cosine transform of the measurement signal and a sine transform of the measurement signal at the tissue excitation frequency with the current. The cosine transform comprises a known transform and calculating the cosine transform of the measurement signal may comprise multiplying the measurement signal by the cosine of the phase of the drive signal at each sampled data point and summing the values. The sine transform comprises a known transform and calculating the sine transform of the measurement signal may comprise multiplying the measurement signal by the sine of the phase of the drive signal at each sampled data point and summing the values. The cosine transform of the measured impedance calibration signal, C0, corresponds to the real component, or resistance, of the measured impedance calibration signal, and the sine transform of the measured impedance calibration
signal, Cs, corresponds to the imaginary component, or reactance, of the measured impedance calibration signal.
[0095] The measured complex impedance calibration signal can be expressed as
[0096] The complex calibration coefficient, Zcoef, can be expressed as [0097] Zcoefr = Rcal / Zcal = Rcal / (Cc + JCs)
[0098] As noted above, although the calibration circuit comprises a substantial resistance, often without a substantial reactance component, the complex calibration coefficient may include a substantial reactance component due to the phase and/or time delay of the drive circuitry, time delay of the measurement circuitry, and/or additional parasitic impedances such as the electrode to tissue coupling. The complex calibration coefficient can be used to calculate the tissue impedance, such that the phase and/or time delays can be calibrated out of the tissue impedance measurement along with the parasitic impedances such as the electrode to tissue coupling. Work in relation to embodiments of the present invention suggests that the phase delay due to the drive circuitry and/or measurement circuitry can be 90 degrees or more, for example 270 degrees, such that a much more accurate determination impedance can be made using the calibration circuitry and complex calibration coefficient.
[0099] The tissue can be selected for measurement with the at least one switch in the second configuration, as described above. A drive current can be passed through measurement electrodes with measurement circuitry 210 and a tissue impedance signal measured from the measurement electrodes with measurement circuitry 250. The tissue impedance signal is digitized and the cosine and sine transforms of the measured tissue impedance signal calculated. The cosine transform of the tissue measured tissue impedance signal, Tc, corresponds to the real component, or resistance, of the measured tissue impedance signal and the sine transform of the measured tissue impedance signal, Ts, corresponds to the imaginary component, or reactance, of the measured tissue impedance signal. The complex tissue impedance signal, Zts, can be expressed as
[0100] Zts = Tc +jTs
[0101] The complex impedance of the tissue, ZtiSSue, can be determined and/or calculated in response to the complex impedance calibration signal and the complex tissue impedance signal. In specific embodiments, the complex impedance of the tissue can be calculated in response to
the measured complex calibration coefficient and the measured complex tissue impedance signal by multiplying the measured complex calibration coefficient and the measured complex tissue impedance signal, expressed as
[0102] Ztissue = Zcal*Zts = Zcal*(T, +JT2) = [(T1 +JT2) / (Cc + JQ)] * Rcai [0103] Therefore, the complex impedance of the tissue can be calculated in response to the measured calibration impedance signal and the measured tissue impedance signal, such that phase and/or time delays of the drive circuitry, measurement circuitry and/or parasitic impedance of tissue are corrected. In some embodiments, the complex impedance of the tissue can be determined from the complex ratio of the complex tissue impedance signal over the complex calibration impedance signal times the resistance of the calibration resistor. The changes in the current applied to the tissue with the drive circuitry and changes in the gain of the measurement circuitry can be corrected by repeating the above measurements and calculations at additional frequencies. As the impedance of the calibration circuitry, for example the calibration resistor, remains substantially constant at different measurement frequencies these additional measurements can provide very accurate measurements of tissue impedance at many frequencies.
[0104] Although the complex calibration impedance measurements and complex tissue impedance measurements are explained with reference to digital transforms, similar results can be obtained with known methods using lock-in detection and/or synchronous demodulation. In some embodiments, lock-in detection with first and second lock-in amplifiers can be driven at the measurement frequency, in which the first and second lock-in amplifiers are phase shifted by ninety degrees to obtain the real and imaginary components, respectively, of the measured impedance signal. A switch, as described above, can select the calibration circuitry or the tissue electrodes for measurement with the phase shifted lock-in amplifiers.
[0105] Figure 2B shows an inverse frequency response of the drive circuitry 210 and measurement circuitry 250. Drive circuitry 210 generates a drive current 21 1. Measurement circuitry 250 comprises a gain 251. A safety threshold 213 is shown that corresponds to known safe current requirements, for example AAMI ESl requirements. Drive current 21 1 is below a safety threshold 213. Drive current 21 1 , safety threshold 213 and gain 21 1 change with frequency. At a first frequency 215, for example about 1 kHz, safety threshold 213 corresponds to about 10 μA. Safety threshold 213 corresponds to about 10 μA for frequencies below 1 kHz. From about 1 kHz to about 100 kHz, threshold 213 increases by about 10 μA per decade from about 1 kHz to about 100 kHz. At frequencies above about 100 kHz, for example from 100 kHz
to 1 MHz, safety threshold 213 comprises a safe currently limit of about 1000 μA or 1 mA. As drive current 21 1 increase from first frequency 21 1 to a second frequency 217, for example 10 kHz, drive current 213 increases substantially, for example about an order of magnitude, such that the drive current at the second frequency is above the safety threshold at the first frequency. As drive frequency 21 1 increases above 1 kHz, gain 251 of the measurement circuitry decreases. In specific embodiments, gain 251 is about 100 at first frequency 215 of about 1 kHz and gain 251 is about 10 at second frequency 217 of about 10 kHz. The total system gain of the impedance circuitry can be defined as the product of the drive current times the measurement circuitry. The inverse frequency response of the drive circuitry and measurement circuitry is such that the total system gain is substantially uniform, for example to within 25%, over from the first frequency to the second frequency, even though the drive current increase by at least a factor of two, for example by a factor of 10. Therefore, the impedance circuitry provides a substantially uniform total system gain when the drive current at higher frequency exceeds a safety threshold at the lower frequency. [0106] Figure 3A shows circuitry 300 for measuring patient impedance with an impedance converter, according to embodiments of the present invention. The impedance converter circuitry can be configured to determine tissue impedance with a four point measurement technique comprising a grounded unknown impedance and distributed parasitic impedance. In many embodiments, circuitry 300 comprises an impedance converter 302. Impedance converter 302 may comprise a known impedance converter, for example an Analog Devices AD5934 and/or AD5933. Circuitry 300 comprises drive circuitry 310, calibration circuitry 304, measurement circuitry 320 and processor circuitry 350. In many embodiments, measurement circuitry 300 can be used to separate the excitation signal from the measurement signal in the AD5934. In many embodiments, measurement of the impedance is grounded, such that any distributed parasitic impedance can be factored out.
[0107] Drive circuitry 310 may comprise a master clock signal 312, for example from a known 16 MHz oscillator. The oscillator and/or master clock are coupled to a digital data synthesis core, for example DDS core 314. DDS core 314 can generate a digital representation of a waveform. DDS core 314 is coupled to a digital to analog converter, for example DAC 316. An amplifier 318 is coupled to the output of DAC 316 to provide an excitation voltage at an output 319 of impedance converter 302. Output 317 can be connected to patient protection circuitry, for example network 317 that limits current to the patient in response to frequency, as described
above. A parasitic impedance 308 can be distributed among components of circuitry 300 and may comprise capacitance from electrodes coupled to the patient, among other sources.
[0108] Calibration circuitry 304 may comprise a resistor 305. Current from the drive circuitry can pass a current through resistor 305 that can be measured to calibrate the system. Current through calibration circuitry 304 that comprises resistor 305 generates a calibration signal 326.
[0109] Measurement circuitry 320 comprises an amplifier 322, for example instrumentation amplifier, to measure voltage across resistor 305, such that the current through the resistor can be measured. Measurement circuitry 320 comprises an amplifier 324, for example an instrumentation amplifier, to measure a tissue impedance signal 328. Amplifier 322 and amplifier 324 are coupled to a switch 330. Switch 330 can select amplifier 322 or amplifier 324. A control signal 331 to switch 330 can select output of amplifier 322 or output of amplifier 324 for further processing with the impedance converter. In some embodiments, the output of amplifier 322 and the output of amplifier 324 can be measured in parallel, for example with two digital to analog converters on a processor. The output of switch 330 is coupled to a resistor 332 to convert the output voltage from the selected amplifier, either amplifier 322 or amplifier 324, to current that is measured with components of impedance converter 302. Impedance converter 302 may comprise components of measurement circuitry 320 such as an amplifier 334, a selectable gain 336, a low pass filter 338 and an analog to digital converter, for example ADC 340. Amplifier 334 comprises a current follower that converts an input current to a voltage. Selectable gain 336 may comprise switches to select a I X or 5X gain from amplifier 334. Low pass filter 338 may comprise a known low pass filter to pass low frequencies and inhibit high frequencies. ADC 340 may comprise a known ADC with 12 bit resolution.
[0110] Circuitry 300 comprises processor circuitry 350, for example circuitry on an AD 5934 that processes signals from ADC 340. Processor circuitry 350 may comprise 1024-point DFT circuitry 356 to compute the discrete Fourier transform of the signal. In some embodiments, circuitry 300 can be configured to provide 1024 samples for 256 cycles at the selected excitation frequency, such that the data are sampled four times, or quadrature sampled, for each cycle at the measurement frequency. A real register 352 comprises memory that stores the real component of the 1024 point DFT from circuitry 356. An imaginary register 354 comprises memory that stores the imaginary component of the 1024 point DFT from circuitry 356. An interface 358 allows another device, such as microcontroller, to access the real and imaginary components written in memory. The real and imaginary components of the DFT can be processed to determine the tissue impedance in response to the DFT of calibration signal 326 and the DFT of
the tissue impedance signal 328. The real and imaginary components of the DFT of calibration signal 326 may comprise a complex calibration signal, and the real and imaginary components of the DFT of the tissue impedance signal 328 may comprise a complex tissue signal. The impedance of the tissue can be determined by computing the complex ratio of the complex tissue signal over the complex calibration signal time and multiplying the complex ratio by the resistance of calibration resistor 305.
[0111] Impedance converter 302 may comprise as an synchronous exciter/voltmeter that drives a series connected combination of calibration resistor 305 and tissue impedance 306 and one or more parasitic impedances 308 with a substantially fixed voltage. To determine the tissue impedance, impedance converter 302 can be commanded to make two measurements, one across the calibration resistor 305, and one across the tissue impedance 306. Instrumentation amplifier inputs and/or outputs can be switched accordingly for each measurement with switch 330. Since substantially the same current flows through both components, the relative phasor voltage across each is proportional to the impedance. A current sensing component may comprise calibration resistor 305 so as to give a reference phase angle of zero degrees. By simply computing the complex ratio of the real and imaginary components of complex tissue signal over the real and imaginary components of the complex calibration signal, and multiplying by the resistance value of resistor 305, the complex tissue impedance can be determined. In some embodiments, the excitation voltage may be replaced with a controlled excitation current such that measurement of voltage across the calibration resistor can be replaced with the constant current. This constant current method may use a complex energy efficient bipolar voltage to current converter. The constant voltage method and constant drive current can factor out distributed parasitic impedances, since the impedances are in series and current is consistent through all the impedances. In addition to the benefits described above, these methods easily allow one side of the load to be at either DC or AC ground and do not require a finite DC resistance return path.
[0112] Figure 3B shows an equivalent circuit 390 that may comprise a model for measuring tissue impedance with circuitry 300 that shows components that contribute to the impedance measurements. Drive circuitry 310 and network 317 pass the drive current through the calibration circuitry comprising calibration resistor 305. Calibration impedance signal 326 corresponds to a voltage across the resistor. At least four electrodes that can couple the patient tissue to the circuit include electrode 362, electrode 364, electrode 366 and electrode 368. Electrode 362 and electrode 368 may comprise at least two drive electrodes to pass current through the tissue. Electrode 364 and electrode 366 may comprise at least two measurement
electrodes. Tissue impedance signal 328 may correspond to a voltage measured between the at least two measurement electrodes comprising electrode 364 and electrode 366. At least four parasitic tissue impedances comprise parasitic impedance 372, parasitic impedance 374, parasitic impedance 376, and parasitic impedance 378. A tissue of interest 380 may comprise a tissue below the skin of the patient, for which tissue hydration can be determined based on the impedance. The drive current passed through electrode 632 and electrode 368 generates a voltage signal 382 across tissue of interest 380.
[0113] Measurement of the impedance of tissue of interest 380 can be affected by a significant number of uncontrolled series impedances, such as the at least four parasitic impedances. In addition, patient protection circuit comprising network 317 that limits maximum applied current as a function of frequency introduces a frequency dependent excitation voltage and may also introduce a non-zero equivalent series impedance. In many embodiments, an assumption about circuit 390 may comprise that V11 is measured by a very high input impedance amplifier, for example an instrumentation amplifier, so that any sensing channel parasitic series impedance is negligible in comparison.
[0114] Figure 3C shows an equivalent circuit 395 of a model that is similar to the model of Figure 3B and allows for correction of parasitic impedance. For analysis simplification, many of the parasitic impedances of Figure 3B can be lumped into a single value of lumped parasitic impedance 396. With this method, the tissue impedance signal 328 may more closely correspond to the voltage signal 382 across tissue of interest 380. Equivalent circuit 395 shows lumped parasitic impedance 396 connected to ground, although the lumped parasitic impedance can be disposed anywhere in the series circuit as needed during analysis, for example to determine worst case operating conditions. In many embodiments, one can assume that the excitation voltage corresponding to the drive current is whatever voltage is available between ground and the high-side of the calibration resistor.
[0115] When making Vr and V14 differential voltage measurements with the instrumentation amplifiers, a significant common mode component of the excitation signal may be present at the instrumentation amplifier input. Known instrumentation amplifiers with high common mode rejection ratios, and appropriate known models can be used to select the instrumentation amplifiers in the measurement circuitry.
[0116] The four point, or four electrode, method of measuring voltage across the series connected calibration resistor and series connected tissue impedance produces a maximum
analog to digital conversion signal when the unknown impedance is large. The largest calibration resistor voltage, Vr, may occur when the unknown tissue impedance is zero ohms. The value of calibration resistor can be chosen during design, so that saturation of the calibration signal and tissue measurement signal does not occur. The tissue impedance can be from about 50 to 100 ohms. The calibration resistance may be about twice the maximum tissue impedance, for example about 200 ohms. The measurable limits of impedance, the impedance resolution limits, the gains of each of the impedance converter and instrumentation amplifier stages and the effects of parasitic impedance on measurement limits can be calculated using known engineering analysis techniques to determine an optimal configuration of the circuitry components for resolution and dynamic range.
[0117] Figure 4 shows a method 400 of measuring patient impedance. Method 400 can be implemented with the impedance converter, processor and/or circuits shown above. In specific embodiments, the processor comprises a tangible medium configured to perform method 400. A step 405 selects a frequency. The selected frequency is within a range from about DC to about 1 Mhz, and can be from about 100 Hz to about 100 kHz.
[0118] A step 410 selects calibration, for example by configuring switches coupled to the drive circuitry and measurement circuitry, such that the calibration circuitry is measurement with the drive circuitry and measurement circuitry. The calibration circuitry can be selected with switches such that on board calibration circuitry located on the measurement device is selected. The calibration circuitry may comprise a resistor, such that the selected calibration circuitry substantially comprises a resistance with very little reactance. The resistance of the calibration circuitry may comprises a known resistance, for example a DC resistance from a resistor, that is used as a calibration value stored on the processor and/or impedance converter. A step 415 generates a source signal. The source signal is generated at the selected frequency. The source signal generally comprises a time base that is synchronous with the digitization/detection circuitry to determine both amplitude and phase of the measurement signal. A step 420 samples the impedance signal such that the calibration circuitry is measured at the selected frequency. The drive electronics, measurement electronics and time delay, for example phase lag, of the system electronics are calibrated with the selected frequency. As the calibration circuitry substantially comprises a resistance, most of the phase of the measured calibration signal can be attributed to delays in the drive circuitry and the measurement circuitry. The impedance signal sampled from the resistance circuitry can be digitized with an A/D converter and may comprise quadrature sampling of about 1024 data points at the selected frequency for about 256 full
cycles. The cosine and sine transforms of the impedance signal can be calculated to determine the complex impedance of the calibration signal. The complex impedance of the calibration signal can then be multiplied and/or divided by the known calibration value, for example known impedance of the calibration resistor, to determine the real and imaginary components of the complex calibration coefficient. A step 425 determines the complex calibration coefficients. The complex calibration coefficients generally comprise a magnitude that corresponds to the resistance of the calibration circuitry and a phase that corresponds to delays in the drive circuitry and measurement circuitry.
[0119] A step 430 selects tissue, for example by configuring the switches coupled to the drive circuitry and measurement circuitry, such that an outer two of the at least four electrodes are coupled to the drive circuitry to pass current through the tissue and an inner two, or remaining two, of the at least four electrodes are coupled to the measurement circuitry to measure an impedance signal from the tissue. A step 440 samples the impedance of the tissue. The impedance signal from the sampled tissue can be digitized with an A/D converter and may comprise quadrature sampling of about 1024 data points at the selected frequency for about 256 full cycles. The cosine and sine transforms of the impedance signal can be calculated to determine the complex impedance of the tissue signal. The complex impedance of the tissue signal can then be multiplied and/or divided by the complex calibration coefficients to determine the impedance of the tissue. This use of complex impedance calibration coefficients, based on a known resistance in the calibration circuitry, can cause inaccuracies of the gain and phase of the drive and measurement circuitry to drop out of the calculated tissue impedance, such that the determined tissue impedance corresponds to the actual impedance of the tissue. A step 445 determines the tissue impedance in response to the complex impedance calibration coefficients and the complex impedance of the tissue signal, for example with complex multiplication. [0120] A step 450 determines whether the tissue impedance is within a calibration tolerance. For example, the processor may check to determine whether the tissue impedance is within 20% of the calibration circuitry and/or within 20% of a previous tissue measurement. A step 455 repeats calibration. Calibration can be repeated with the calibration circuitry, as described above, for example in response to the tissue measurement outside the tolerance range. A step 460 repeats the tissue measurement. The tissue measurement may be repeated when the calibration step is repeated.
[0121] A step 465 selects a new frequency, for example a second frequency greater than the first frequency. In many embodiments, the amount of injected current will increase above a
safety threshold of the current injected at the first frequency, and the gain will decrease, for example with an inverse frequency response, such that the signal remains within the range of the A/D converter. New calibration and tissue measurements are taken at the new frequency. The impedance signal of the calibration circuitry can be measured at the new frequency to determine the complex calibration coefficients, as described above, at the second frequency. One will appreciate that a resistor will have a substantially fixed resistance at the new frequencies, such that the resistance, for example the real calibration value, of the calibration circuitry may be the same at the second frequency as the first frequency. Therefore, changes in the measured calibration signal can be substantially attributed to changes in the drive current of the drive circuitry and/or gain and time delay measurement circuitry. The tissue impedance signal at the new frequency can be determined with the complex calibration coefficient and complex tissue signal. Steps 465 and 470 can be repeated to measure impedance and hydration at many frequencies.
[0122] It should be appreciated that the specific steps illustrated in Figure 4 provide a particular method of measuring impedance of a patient, according to an embodiment of the present invention. Other sequences of steps may also be performed according to alternative embodiments. For example, alternative embodiments of the present invention may perform the steps outlined above in a different order. Moreover, the individual steps illustrated in Figure 4 may include multiple sub-steps that may be performed in various sequences as appropriate to the individual step. Furthermore, additional steps may be added or removed depending on the particular applications. One of ordinary skill in the art would recognize many variations, modifications, and alternatives. For example, although the processor system and circuitry, as described above, can perform the method 400, additional analog circuits may be used, for example lock-in detection and synchronous demodulation circuits. [0123] While the exemplary embodiments have been described in some detail, by way of example and for clarity of understanding, those of skill in the art will recognize that a variety of modifications, adaptations, and changes may be employed. Hence, the scope of the present invention should be limited solely by the appended claims.
Claims
1. A device for measuring an impedance of a tissue of a patient, the device comprising: calibration circuitry comprising an impedance; at least four electrodes configured to couple to the tissue of the patient, the at least four electrodes comprising at least two measurement electrodes and at least two drive electrodes; drive circuitry coupled to the at least two drive electrodes and the calibration circuitry to pass a current through the at least two drive electrodes and the calibration circuitry; measurement circuitry configured to couple to the at least two measurement electrodes and the calibration circuitry, the measurement circuitry configured to measure a calibration signal from the calibration circuitry and a tissue impedance signal from the at least two measurement electrodes; and processor circuitry comprising a tangible medium configured to determine the impedance of the tissue in response to the calibration signal and the tissue impedance signal.
2. The device of claim 1 wherein the processor circuitry comprises as least one of an impedance converter or a microcontroller.
3. The device of claim 1 wherein the processor circuitry is configured to determine the impedance of the tissue with a discrete Fourier transform of at least one of measurement signal or the current signal.
4. The device of claim 1 wherein the calibration circuitry is connected in series between the drive circuitry and the at least two measurement electrodes to calibrate the tissue impedance measurement when the at least two electrodes are connected to the patient.
5. The device of claim 1 wherein the drive circuitry is configured to pass the current through the tissue and the calibration circuitry to generate the tissue measurement signal and the calibration signal when the at least four electrodes are connected to the tissue.
6. The device of claim 5 wherein the calibration circuitry comprises a calibration resistor, and the measurement circuitry is configured to measure the calibration signal in response to the current through the calibration resistor and the tissue.
7. The device of claim 6 wherein the measurement circuitry is configured to measure the tissue measurement signal in response to the current through the tissue and the calibration resistor.
8. The device of claim 7 wherein the processor is configured to determine the tissue impedance in response to the calibration signal and the tissue measurement signal.
9. The device of claim 1 further comprising at least one switch coupled to the drive circuitry, the measurement circuitry, the calibration circuitry and the at least four electrodes, the at least one switch comprising a first configuration and a second configuration, wherein in the first configuration the at least one switch couples the measurement circuitry to the calibration circuitry to measure the calibration signal and wherein in the second configuration the at least one switch couples the measurement circuitry to the at least two measurement electrodes to measure the tissue impedance signal.
10. The device of claim 1 , wherein the processor circuitry is coupled to the at least one switch to select the first configuration or the second configuration.
1 1. The device of claim 1 , wherein the measurement circuitry comprises a first measurement circuit configured to measure the calibration signal and a second measurement circuit configured to measure the tissue impedance signal.
12. The device of claim 1, wherein the calibration circuitry comprises at least one resistor connected in series to the drive circuitry and the at least two drive electrodes, such that a resistance of the resistor corresponds to at least 90% the impedance of the calibration circuitry.
13. The device of claim 1 , wherein the calibration circuitry comprises a resistance, wherein the calibration signal comprises a complex calibration signal, wherein the tissue impedance signal comprises a complex tissue impedance signal, and wherein the processor is configured to determine a complex impedance of the tissue in response to the complex calibration signal and the complex tissue impedance signal.
14. The device of claim 1 , wherein the processor is configured to store a calibration value comprising a resistance of the calibration circuitry that corresponds to a real number, and wherein the calibration signal corresponds to the resistance of the calibration circuitry, delays of the drive circuitry and delays of the measurement circuitry.
15. The device of claim 14, wherein the processor is configured to determine a complex calibration coefficient in response to the calibration value and the calibration signal.
16. The device of claim 15, wherein the tissue impedance comprises a complex tissue impedance and processor is configured to determine the complex tissue impedance in response to the complex calibration coefficient and the tissue impedance signal.
17. The device of claim 16, wherein the processor is configured to determine a complex tissue parameter from the tissue impedance signal and wherein the processor is configured to determine the complex tissue impedance with at least one of a complex multiplication or a complex division of the complex calibration coefficient and the complex tissue parameter.
18. The device of claim 17, wherein the processor is configured to determine the complex tissue parameter with a discrete Fourier transform of the tissue impedance signal and determine the complex calibration coefficient with a discrete Fourier transform of the calibration signal.
19. The device of claim 14, wherein the delays of the drive circuitry and the measurement circuitry correspond to a phase angle of the calibration signal of at least about 90 degrees.
20. The device of claim 1 , wherein the processor is configured to select a first frequency and a second frequency to measure impedance signals of the calibration circuitry at each of the first frequency and the second frequency, and configured to measure impedance signals of the tissue at each of the first frequency and the second frequency.
21. The device of claim 20, wherein the processor is configured to determine impedance of the tissue at the each of the first frequency and the second frequency in response to impedance signals of the calibration circuitry measured at each of the first frequency and the second frequency and impedance signals of the tissue measured at each of the first frequency and the second frequency.
22. The device of claim 1 , wherein the processor is configured to store a tolerance range and measure the calibration circuitry in response to the impedance signal of the tissue and the tolerance range.
23. The device of claim 22, wherein the tolerance range comprises plus or minus twenty percent of a baseline tissue impedance measurement and the processor is configured to measure the calibration circuitry in response to the tissue impedance outside the tolerance range.
24. A device for measuring an impedance of a tissue of a patient, the device comprising: at least four electrodes configured to couple to the tissue of the patient, the at least four electrodes comprising at least two drive electrodes and at least two measurement electrodes; drive circuitry coupled to the at least two drive electrodes to pass a variable current through the tissue to generate a tissue measurement signal, the drive circuitry configured to increase the current from a first current amount at a first frequency to a second current amount at a second frequency, the second frequency greater than the first frequency; and measurement circuitry coupled to the at least two measurement electrodes to determine the impedance of the tissue in response to the tissue measurement signal, the measurement circuitry comprising a variable gain of the measurement signal configured to decrease from a first gain at the first frequency to a second gain at the second frequency.
25. The device of claim 24, wherein the variable current of the drive circuitry comprises a drive current frequency response and the variable gain of the measurement circuitry comprises variable gain frequency response and wherein the variable gain frequency response comprises an inverse of the drive current frequency response.
26. The device of claim 24, wherein the drive circuitry is configured to increase the second current amount to at least four times the first current amount and wherein the measurement circuitry is configured to decrease the second gain to no more than about one half of the first gain..
27. The device of claim 24, wherein the drive circuitry is configured to increase the second current amount to at least ten times the first current amount and wherein the measurement circuitry is configured to decrease the second gain to no more than about one third of the first gain.
28. The device of claim 24, wherein the second frequency is at least 1 kHz and the second current amount is at least 10 μA and no more than 1000 μ A and wherein the first frequency corresponds to a first safety threshold of the first current and the second frequency corresponds to a second safety threshold of the second current and wherein the drive circuitry is configured to exceed the first safety threshold with the second current amount and not to exceed the second safety threshold with the second current amount.
29. The device of claim 28 wherein the drive circuitry is configured to exceed the first safety threshold with the second current by at least a factor of two.
30. The device of claim 28 wherein the safety threshold of the first current corresponds to 10 μA or a product of the first current in μA times the first frequency in kHz, whichever is greater.
31. A method of measuring patient impedance, the method comprising: providing at least four electrodes comprising at least two drive electrodes and at least two measurement electrodes, the at least two drive electrodes connected in series to a calibration resistor; providing measurement circuitry to measure a tissue impedance signal from the measurement electrodes; passing a drive current through the at least two drive electrodes and the calibration resistor with drive circuitry, measuring a current signal from the calibration resistor in response to the current through the calibration resistor; measuring the tissue impedance signal from the measurement electrodes; and determining the tissue impedance in response to the current signal and the tissue impedance signal.
32. The method of claim 31 wherein the current signal from the calibration resistor is measured with the measurement circuitry.
33. The method of claim 31 wherein the tissue impedance is determined with an impedance converter.
34. The method of claim 33 wherein the current signal from the calibration resistor comprises a first voltage that is converted into a first current and the first current is fed into the impedance converter and wherein the tissue impedance signal from the measurement electrodes comprises a second voltage that is converted to a second current and the second current fed into the impedance converter.
35. The method of claim 33 wherein the drive circuitry comprising a network to limit the drive current through the patient, such that the network increases the drive current through the patient as a frequency of the drive current increases.
36. The method of claim 35 wherein the measurement circuitry comprises a variable gain that decreases when the frequency is increases and the drive current increases.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4622108P | 2008-04-18 | 2008-04-18 | |
US61/046,221 | 2008-04-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009146214A1 true WO2009146214A1 (en) | 2009-12-03 |
Family
ID=41201715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/041143 WO2009146214A1 (en) | 2008-04-18 | 2009-04-20 | Method and apparatus to measure bioelectric impedance of patient tissue |
Country Status (2)
Country | Link |
---|---|
US (3) | US8412317B2 (en) |
WO (1) | WO2009146214A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014201522A1 (en) * | 2013-06-19 | 2014-12-24 | Ti2 Pty Ltd | Methods and apparatuses for characterisation of body tissue |
Families Citing this family (209)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080306325A1 (en) | 2006-10-02 | 2008-12-11 | Emkinetics | Method and apparatus for magnetic induction therapy |
WO2011053607A1 (en) | 2009-10-26 | 2011-05-05 | Emkinetics, Inc. | Method and apparatus for electromagnetic stimulation of nerve, muscle, and body tissues |
US9339641B2 (en) | 2006-01-17 | 2016-05-17 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
US9610459B2 (en) | 2009-07-24 | 2017-04-04 | Emkinetics, Inc. | Cooling systems and methods for conductive coils |
US9005102B2 (en) | 2006-10-02 | 2015-04-14 | Emkinetics, Inc. | Method and apparatus for electrical stimulation therapy |
US11224742B2 (en) | 2006-10-02 | 2022-01-18 | Emkinetics, Inc. | Methods and devices for performing electrical stimulation to treat various conditions |
US10786669B2 (en) | 2006-10-02 | 2020-09-29 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
US8369944B2 (en) | 2007-06-06 | 2013-02-05 | Zoll Medical Corporation | Wearable defibrillator with audio input/output |
US8271082B2 (en) | 2007-06-07 | 2012-09-18 | Zoll Medical Corporation | Medical device configured to test for user responsiveness |
US8140154B2 (en) | 2007-06-13 | 2012-03-20 | Zoll Medical Corporation | Wearable medical treatment device |
US7974689B2 (en) | 2007-06-13 | 2011-07-05 | Zoll Medical Corporation | Wearable medical treatment device with motion/position detection |
US8460189B2 (en) | 2007-09-14 | 2013-06-11 | Corventis, Inc. | Adherent cardiac monitor with advanced sensing capabilities |
EP2200499B1 (en) | 2007-09-14 | 2019-05-01 | Medtronic Monitoring, Inc. | Multi-sensor patient monitor to detect impending cardiac decompensation |
EP2257216B1 (en) | 2008-03-12 | 2021-04-28 | Medtronic Monitoring, Inc. | Heart failure decompensation prediction based on cardiac rhythm |
WO2009146214A1 (en) * | 2008-04-18 | 2009-12-03 | Corventis, Inc. | Method and apparatus to measure bioelectric impedance of patient tissue |
US20150201858A1 (en) * | 2008-08-15 | 2015-07-23 | Global Cardiac Monitors, Inc. | Diagnostic device for remote sensing and transmitting biophysiological signals |
WO2010030225A1 (en) * | 2008-09-09 | 2010-03-18 | Fernando Seoane Martinez | Method and apparatus for brain damage detection |
US9219956B2 (en) | 2008-12-23 | 2015-12-22 | Keyssa, Inc. | Contactless audio adapter, and methods |
US9191263B2 (en) | 2008-12-23 | 2015-11-17 | Keyssa, Inc. | Contactless replacement for cabled standards-based interfaces |
US20100234755A1 (en) * | 2009-03-11 | 2010-09-16 | Latman Neal S | Electrode holder for use on hairy animals such as horses, camels, and the like |
WO2011020216A1 (en) * | 2009-08-18 | 2011-02-24 | Yang Changming | Product, method and system for monitoring physiological function and posture |
US8790259B2 (en) | 2009-10-22 | 2014-07-29 | Corventis, Inc. | Method and apparatus for remote detection and monitoring of functional chronotropic incompetence |
US9451897B2 (en) | 2009-12-14 | 2016-09-27 | Medtronic Monitoring, Inc. | Body adherent patch with electronics for physiologic monitoring |
US8874186B2 (en) * | 2009-12-30 | 2014-10-28 | Avery Dennison Corporation | Apparatus and method for monitoring physiological parameters using electrical measurements |
EP2547252B1 (en) * | 2010-03-17 | 2021-06-02 | Web Biotechnology Pte Ltd | Electrocardiographic monitoring system |
US20130131551A1 (en) * | 2010-03-24 | 2013-05-23 | Shriram Raghunathan | Methods and devices for diagnosing and treating vocal cord dysfunction |
US8965498B2 (en) | 2010-04-05 | 2015-02-24 | Corventis, Inc. | Method and apparatus for personalized physiologic parameters |
US9228785B2 (en) | 2010-05-04 | 2016-01-05 | Alexander Poltorak | Fractal heat transfer device |
EP3165161B1 (en) | 2010-05-12 | 2020-05-06 | Irhythm Technologies, Inc. | Device features and design elements for long-term adhesion |
EP2571572B1 (en) | 2010-05-18 | 2016-11-23 | Zoll Medical Corporation | Wearable therapeutic device |
BR112012029240A2 (en) | 2010-05-18 | 2017-05-30 | Zoll Medical Corp | ambulatory medical detection device with multiple detection electrodes |
WO2011146708A2 (en) | 2010-05-21 | 2011-11-24 | Medicomp, Inc. | Retractable multi-use cardiac monitor |
US9585584B2 (en) | 2010-05-21 | 2017-03-07 | Medicomp, Inc. | Physiological signal monitor with retractable wires |
US8588884B2 (en) | 2010-05-28 | 2013-11-19 | Emkinetics, Inc. | Microneedle electrode |
MX2013001557A (en) * | 2010-08-13 | 2013-06-28 | Respiratory Motion Inc | Devices and methods for respiratory variation monitoring by measurement of respiratory volumes, motion and variability. |
US9937355B2 (en) | 2010-11-08 | 2018-04-10 | Zoll Medical Corporation | Remote medical device alarm |
EP2648609B1 (en) | 2010-12-09 | 2018-05-30 | Zoll Medical Corporation | Electrode with redundant impedance reduction |
BR112013014219A2 (en) | 2010-12-10 | 2016-09-13 | Zoll Medical Corp | therapeutic device |
US9427564B2 (en) | 2010-12-16 | 2016-08-30 | Zoll Medical Corporation | Water resistant wearable medical device |
US9684767B2 (en) | 2011-03-25 | 2017-06-20 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US8600486B2 (en) | 2011-03-25 | 2013-12-03 | Zoll Medical Corporation | Method of detecting signal clipping in a wearable ambulatory medical device |
WO2012135062A1 (en) | 2011-03-25 | 2012-10-04 | Zoll Medical Corporation | Selection of optimal channel for rate determination |
US9135398B2 (en) | 2011-03-25 | 2015-09-15 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US9861293B2 (en) | 2011-04-28 | 2018-01-09 | Myolex Inc. | Sensors, including disposable sensors, for measuring tissue |
EP2701591A2 (en) * | 2011-04-28 | 2014-03-05 | Skulpt, Inc. | Devices and methods for evaluating tissue |
EP2704625A4 (en) | 2011-05-02 | 2014-10-01 | Zoll Medical Corp | Patient-worn energy delivery apparatus and techniques for sizing same |
MX365902B (en) | 2011-07-20 | 2019-06-19 | Respiratory Motion Inc | Impedance measuring devices and methods for emergency cardiovascular care. |
BR112014003953A2 (en) | 2011-09-01 | 2017-06-13 | Zoll Medical Corporation | dressing treatment and monitoring device |
US20130071807A1 (en) | 2011-09-20 | 2013-03-21 | Alexander Franz Doll | Iontophoretic oral care devices with automatic oral care implement detection and mode selection |
EP2578147B1 (en) * | 2011-10-07 | 2016-04-20 | Fresenius Medical Care Deutschland GmbH | Method and arrangement for determining an overhydration parameter or a body composition parameter |
US9339691B2 (en) | 2012-01-05 | 2016-05-17 | Icon Health & Fitness, Inc. | System and method for controlling an exercise device |
JP2015510780A (en) | 2012-03-02 | 2015-04-13 | ゾール メディカル コーポレイションZOLL Medical Corporation | System and method for configuring a wearable medical monitoring and / or treatment device |
US9427165B2 (en) | 2012-03-02 | 2016-08-30 | Medtronic Monitoring, Inc. | Heuristic management of physiological data |
US20130310742A1 (en) * | 2012-03-12 | 2013-11-21 | Gary P. Warren | Dressing for an Insertion Site of an Intravascular Infusate |
US11026632B2 (en) * | 2012-04-20 | 2021-06-08 | Vital Connect, Inc. | Determining respiratory rate via impedance pneumography |
US10328266B2 (en) | 2012-05-31 | 2019-06-25 | Zoll Medical Corporation | External pacing device with discomfort management |
EP4082602A1 (en) | 2012-05-31 | 2022-11-02 | Zoll Medical Corporation | Medical monitoring and treatment device with external pacing |
JP2015523877A (en) | 2012-05-31 | 2015-08-20 | ゾール メディカル コーポレイションZOLL Medical Corporation | System and method for detecting health disorders |
US11097107B2 (en) | 2012-05-31 | 2021-08-24 | Zoll Medical Corporation | External pacing device with discomfort management |
US10314492B2 (en) | 2013-05-23 | 2019-06-11 | Medibotics Llc | Wearable spectroscopic sensor to measure food consumption based on interaction between light and the human body |
US9582035B2 (en) | 2014-02-25 | 2017-02-28 | Medibotics Llc | Wearable computing devices and methods for the wrist and/or forearm |
US20180279903A1 (en) * | 2012-09-07 | 2018-10-04 | Respiratory Motion, Inc. | Spacing of electrodes for bioimpedance measurements |
AU2013312218C1 (en) | 2012-09-07 | 2019-01-31 | Respiratory Motion, Inc. | Electrode padset |
US20140084949A1 (en) * | 2012-09-24 | 2014-03-27 | Access Business Group International Llc | Surface impedance systems and methods |
US9782082B2 (en) | 2012-11-01 | 2017-10-10 | Blue Spark Technologies, Inc. | Body temperature logging patch |
AU2014209376B2 (en) | 2013-01-24 | 2017-03-16 | Irhythm Technologies, Inc. | Physiological monitoring device |
US9999393B2 (en) | 2013-01-29 | 2018-06-19 | Zoll Medical Corporation | Delivery of electrode gel using CPR puck |
US20140316297A1 (en) * | 2013-02-22 | 2014-10-23 | Noninvasive Medical Technologies, Inc. | Impedance monitors, electrode arrays and methods of use |
US8880196B2 (en) | 2013-03-04 | 2014-11-04 | Zoll Medical Corporation | Flexible therapy electrode |
EP2969058B1 (en) | 2013-03-14 | 2020-05-13 | Icon Health & Fitness, Inc. | Strength training apparatus with flywheel and related methods |
EP2983593B1 (en) | 2013-04-08 | 2021-11-10 | Irhythm Technologies, Inc. | Skin abrader |
CN105492070A (en) | 2013-06-28 | 2016-04-13 | 卓尔医疗公司 | Systems and methods of delivering therapy using an ambulatory medical device |
EP3016583A4 (en) * | 2013-07-01 | 2017-03-22 | Impedimed Limited | Apparatuses for home use in determining tissue wetness |
DE102013011141A1 (en) * | 2013-07-03 | 2015-01-08 | Dräger Medical GmbH | Measuring device for measuring a body function and method for operating such a measuring device |
US10624551B2 (en) | 2013-09-25 | 2020-04-21 | Bardy Diagnostics, Inc. | Insertable cardiac monitor for use in performing long term electrocardiographic monitoring |
US11723575B2 (en) | 2013-09-25 | 2023-08-15 | Bardy Diagnostics, Inc. | Electrocardiography patch |
US9655538B2 (en) | 2013-09-25 | 2017-05-23 | Bardy Diagnostics, Inc. | Self-authenticating electrocardiography monitoring circuit |
US10806360B2 (en) | 2013-09-25 | 2020-10-20 | Bardy Diagnostics, Inc. | Extended wear ambulatory electrocardiography and physiological sensor monitor |
US9504423B1 (en) | 2015-10-05 | 2016-11-29 | Bardy Diagnostics, Inc. | Method for addressing medical conditions through a wearable health monitor with the aid of a digital computer |
US9433367B2 (en) | 2013-09-25 | 2016-09-06 | Bardy Diagnostics, Inc. | Remote interfacing of extended wear electrocardiography and physiological sensor monitor |
US9775536B2 (en) | 2013-09-25 | 2017-10-03 | Bardy Diagnostics, Inc. | Method for constructing a stress-pliant physiological electrode assembly |
US10165946B2 (en) | 2013-09-25 | 2019-01-01 | Bardy Diagnostics, Inc. | Computer-implemented system and method for providing a personal mobile device-triggered medical intervention |
US9408545B2 (en) | 2013-09-25 | 2016-08-09 | Bardy Diagnostics, Inc. | Method for efficiently encoding and compressing ECG data optimized for use in an ambulatory ECG monitor |
US10736531B2 (en) | 2013-09-25 | 2020-08-11 | Bardy Diagnostics, Inc. | Subcutaneous insertable cardiac monitor optimized for long term, low amplitude electrocardiographic data collection |
US10888239B2 (en) | 2013-09-25 | 2021-01-12 | Bardy Diagnostics, Inc. | Remote interfacing electrocardiography patch |
US9700227B2 (en) | 2013-09-25 | 2017-07-11 | Bardy Diagnostics, Inc. | Ambulatory electrocardiography monitoring patch optimized for capturing low amplitude cardiac action potential propagation |
US10251576B2 (en) | 2013-09-25 | 2019-04-09 | Bardy Diagnostics, Inc. | System and method for ECG data classification for use in facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer |
US9364155B2 (en) | 2013-09-25 | 2016-06-14 | Bardy Diagnostics, Inc. | Self-contained personal air flow sensing monitor |
US10799137B2 (en) | 2013-09-25 | 2020-10-13 | Bardy Diagnostics, Inc. | System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer |
US9433380B1 (en) | 2013-09-25 | 2016-09-06 | Bardy Diagnostics, Inc. | Extended wear electrocardiography patch |
US10463269B2 (en) | 2013-09-25 | 2019-11-05 | Bardy Diagnostics, Inc. | System and method for machine-learning-based atrial fibrillation detection |
US9655537B2 (en) | 2013-09-25 | 2017-05-23 | Bardy Diagnostics, Inc. | Wearable electrocardiography and physiology monitoring ensemble |
WO2015048323A2 (en) * | 2013-09-25 | 2015-04-02 | Bardy Diagnostics, Inc. | Extended wear electrocardiography patch using interlaced wire electrodes |
WO2015048194A1 (en) | 2013-09-25 | 2015-04-02 | Bardy Diagnostics, Inc. | Self-contained personal air flow sensing monitor |
US9717432B2 (en) | 2013-09-25 | 2017-08-01 | Bardy Diagnostics, Inc. | Extended wear electrocardiography patch using interlaced wire electrodes |
US10736529B2 (en) | 2013-09-25 | 2020-08-11 | Bardy Diagnostics, Inc. | Subcutaneous insertable electrocardiography monitor |
US10820801B2 (en) | 2013-09-25 | 2020-11-03 | Bardy Diagnostics, Inc. | Electrocardiography monitor configured for self-optimizing ECG data compression |
US9615763B2 (en) | 2013-09-25 | 2017-04-11 | Bardy Diagnostics, Inc. | Ambulatory electrocardiography monitor recorder optimized for capturing low amplitude cardiac action potential propagation |
US9737224B2 (en) | 2013-09-25 | 2017-08-22 | Bardy Diagnostics, Inc. | Event alerting through actigraphy embedded within electrocardiographic data |
US11213237B2 (en) | 2013-09-25 | 2022-01-04 | Bardy Diagnostics, Inc. | System and method for secure cloud-based physiological data processing and delivery |
US9619660B1 (en) | 2013-09-25 | 2017-04-11 | Bardy Diagnostics, Inc. | Computer-implemented system for secure physiological data collection and processing |
US9730593B2 (en) | 2013-09-25 | 2017-08-15 | Bardy Diagnostics, Inc. | Extended wear ambulatory electrocardiography and physiological sensor monitor |
US9345414B1 (en) | 2013-09-25 | 2016-05-24 | Bardy Diagnostics, Inc. | Method for providing dynamic gain over electrocardiographic data with the aid of a digital computer |
US10667711B1 (en) | 2013-09-25 | 2020-06-02 | Bardy Diagnostics, Inc. | Contact-activated extended wear electrocardiography and physiological sensor monitor recorder |
US9408551B2 (en) | 2013-11-14 | 2016-08-09 | Bardy Diagnostics, Inc. | System and method for facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer |
US10433748B2 (en) | 2013-09-25 | 2019-10-08 | Bardy Diagnostics, Inc. | Extended wear electrocardiography and physiological sensor monitor |
US9717433B2 (en) | 2013-09-25 | 2017-08-01 | Bardy Diagnostics, Inc. | Ambulatory electrocardiography monitoring patch optimized for capturing low amplitude cardiac action potential propagation |
US20190167139A1 (en) | 2017-12-05 | 2019-06-06 | Gust H. Bardy | Subcutaneous P-Wave Centric Insertable Cardiac Monitor For Long Term Electrocardiographic Monitoring |
US10433751B2 (en) | 2013-09-25 | 2019-10-08 | Bardy Diagnostics, Inc. | System and method for facilitating a cardiac rhythm disorder diagnosis based on subcutaneous cardiac monitoring data |
US10055549B2 (en) * | 2013-10-10 | 2018-08-21 | Wireless Medical Monitoring, Inc. | Method and apparatus for wireless health monitoring and emergent condition prediction |
WO2015061459A1 (en) * | 2013-10-23 | 2015-04-30 | Lgch, Inc. | Detecting seizures including loose electrode monitoring |
USD831833S1 (en) | 2013-11-07 | 2018-10-23 | Bardy Diagnostics, Inc. | Extended wear electrode patch |
USD744659S1 (en) | 2013-11-07 | 2015-12-01 | Bardy Diagnostics, Inc. | Extended wear electrode patch |
USD793566S1 (en) | 2015-09-10 | 2017-08-01 | Bardy Diagnostics, Inc. | Extended wear electrode patch |
USD892340S1 (en) | 2013-11-07 | 2020-08-04 | Bardy Diagnostics, Inc. | Extended wear electrode patch |
USD717955S1 (en) | 2013-11-07 | 2014-11-18 | Bardy Diagnostics, Inc. | Electrocardiography monitor |
USD801528S1 (en) | 2013-11-07 | 2017-10-31 | Bardy Diagnostics, Inc. | Electrocardiography monitor |
EP3623020A1 (en) | 2013-12-26 | 2020-03-18 | Icon Health & Fitness, Inc. | Magnetic resistance mechanism in a cable machine |
WO2015123198A1 (en) | 2014-02-12 | 2015-08-20 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US10429888B2 (en) | 2014-02-25 | 2019-10-01 | Medibotics Llc | Wearable computer display devices for the forearm, wrist, and/or hand |
CN106415695B (en) | 2014-03-06 | 2020-06-09 | 呼吸运动公司 | Method and apparatus for displaying trends and variability in physiological data sets |
WO2015138339A1 (en) | 2014-03-10 | 2015-09-17 | Icon Health & Fitness, Inc. | Pressure sensor to quantify work |
US11055980B2 (en) | 2014-04-16 | 2021-07-06 | Murata Vios, Inc. | Patient care and health information management systems and methods |
USD734191S1 (en) | 2014-05-22 | 2015-07-14 | Samsung Electronics Co., Ltd. | Sensor module |
USD730219S1 (en) | 2014-05-22 | 2015-05-26 | Samsung Electronics Co., Ltd. | Sensor module |
USD734192S1 (en) | 2014-05-22 | 2015-07-14 | Samsung Electronics Co., Ltd. | Sensor module |
USD734682S1 (en) | 2014-05-22 | 2015-07-21 | Samsung Electronics Co., Ltd. | Sensor module |
US10426989B2 (en) | 2014-06-09 | 2019-10-01 | Icon Health & Fitness, Inc. | Cable system incorporated into a treadmill |
WO2015195965A1 (en) | 2014-06-20 | 2015-12-23 | Icon Health & Fitness, Inc. | Post workout massage device |
US9968301B2 (en) | 2014-07-09 | 2018-05-15 | The Board Of Regents, The University Of Texas System | Body-driven pseudorandom signal injection for biomedical acquisition channel calibration |
CN104146709B (en) * | 2014-07-29 | 2016-05-11 | 中国科学院合肥物质科学研究院 | A kind of multifrequency point bio-electrical impedance fast acquiring method |
US10180485B2 (en) | 2014-09-05 | 2019-01-15 | Leonid Matsiev | Performance and versatility of single-frequency DFT detectors |
JP2018504148A (en) | 2014-10-31 | 2018-02-15 | アイリズム・テクノロジーズ・インコーポレイテッドiRhythm Technologies,Inc. | Wireless biological monitoring device and system |
US10004408B2 (en) | 2014-12-03 | 2018-06-26 | Rethink Medical, Inc. | Methods and systems for detecting physiology for monitoring cardiac health |
WO2016100906A1 (en) | 2014-12-18 | 2016-06-23 | Zoll Medical Corporation | Pacing device with acoustic sensor |
US9693689B2 (en) | 2014-12-31 | 2017-07-04 | Blue Spark Technologies, Inc. | Body temperature logging patch |
US10391361B2 (en) | 2015-02-27 | 2019-08-27 | Icon Health & Fitness, Inc. | Simulating real-world terrain on an exercise device |
WO2016149583A1 (en) | 2015-03-18 | 2016-09-22 | Zoll Medical Corporation | Medical device with acoustic sensor |
US10272010B2 (en) | 2015-03-20 | 2019-04-30 | Zoll Medical Corporation | Systems and methods for testing a medical device |
US10835449B2 (en) | 2015-03-30 | 2020-11-17 | Zoll Medical Corporation | Modular components for medical devices |
US11471107B2 (en) * | 2015-04-16 | 2022-10-18 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Systems and methods for performing an electrocardiogram |
EP3282938A4 (en) | 2015-04-16 | 2019-03-20 | Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | Systems and methods for performing an electrocardiogram |
KR20160132750A (en) * | 2015-05-11 | 2016-11-21 | 삼성전자주식회사 | Electrode structure of biosenor and biosnesor comprising that |
WO2016182315A1 (en) * | 2015-05-11 | 2016-11-17 | Samsung Electronics Co., Ltd. | Biosensor electrode structure and biosensor including the same |
US11471109B2 (en) | 2015-07-09 | 2022-10-18 | Capsuletech, Inc. | Methods and devices for recovering data from an amplitude-modulated signal |
GB2540986A (en) * | 2015-08-03 | 2017-02-08 | Hassan Ahmed Rahma | A hygiene monitoring device |
CN105054906B (en) * | 2015-08-31 | 2017-08-25 | 电子科技大学 | A kind of microminiature body temperature and bio-electrical impedance measuring apparatus |
US10252070B2 (en) | 2015-09-08 | 2019-04-09 | Zoll Medical Corporation | Secure limited components for use with medical devices |
USD766447S1 (en) | 2015-09-10 | 2016-09-13 | Bardy Diagnostics, Inc. | Extended wear electrode patch |
CN108290044B (en) | 2015-10-02 | 2021-08-27 | 心脏起搏器股份公司 | Prediction of worsening heart failure |
CN105266795A (en) * | 2015-11-05 | 2016-01-27 | 北京众云在线科技有限公司 | Dynamic electrocardiosignal acquisition device |
CN111407249B (en) | 2015-11-23 | 2024-02-27 | Zoll医疗公司 | Wearable medical device |
KR20170061752A (en) * | 2015-11-26 | 2017-06-07 | 삼성전자주식회사 | Electronic device analyzing bio-electrical impedance by means of calribrated current |
US11709747B2 (en) | 2016-01-08 | 2023-07-25 | Zoll Medical Corporation | Patient assurance system and method |
WO2017136746A1 (en) | 2016-02-03 | 2017-08-10 | Cormetrics Llc | Modular sensing guidewire |
US10350423B2 (en) | 2016-02-04 | 2019-07-16 | Cardiac Pacemakers, Inc. | Delivery system with force sensor for leadless cardiac device |
EP3416549A4 (en) * | 2016-02-16 | 2019-09-18 | Impedimed Limited | Heart failure indicator |
US11617538B2 (en) | 2016-03-14 | 2023-04-04 | Zoll Medical Corporation | Proximity based processing systems and methods |
US10272317B2 (en) | 2016-03-18 | 2019-04-30 | Icon Health & Fitness, Inc. | Lighted pace feature in a treadmill |
US10625137B2 (en) | 2016-03-18 | 2020-04-21 | Icon Health & Fitness, Inc. | Coordinated displays in an exercise device |
US10493349B2 (en) | 2016-03-18 | 2019-12-03 | Icon Health & Fitness, Inc. | Display on exercise device |
US10739433B2 (en) * | 2016-03-21 | 2020-08-11 | Texas Instruments Incorporated | Calibrating body impedance measurement systems |
CN109414208A (en) * | 2016-03-22 | 2019-03-01 | 生命信号公司 | The system and method collected for physiological signal |
US10674911B2 (en) | 2016-03-30 | 2020-06-09 | Zoll Medical Corporation | Systems and methods of integrating ambulatory medical devices |
US10426342B2 (en) | 2016-03-31 | 2019-10-01 | Zoll Medical Corporation | Remote access for ambulatory medical device |
USD775361S1 (en) * | 2016-04-01 | 2016-12-27 | Michael J. Vosch | Electrode patch array |
US11154246B2 (en) * | 2016-06-24 | 2021-10-26 | Georgia Tech Research Corporation | Systems and methods of IV infiltration detection |
WO2018013668A1 (en) | 2016-07-12 | 2018-01-18 | Alexander Poltorak | System and method for maintaining efficiency of a heat sink |
US11224354B2 (en) * | 2016-08-08 | 2022-01-18 | Analog Devices International Unlimited Company | Systems and methods of monitoring electrodermal activity (EDA) using an AC signal and discrete fourier transform (DFT) analysis |
US10912481B2 (en) * | 2016-08-10 | 2021-02-09 | Koninklijke Philips N.V. | Bioimpedance measurement system calibration |
CN107811630A (en) * | 2016-09-13 | 2018-03-20 | 深圳市岩尚科技有限公司 | A kind of SMD electrocardiogram acquisition equipment |
CN206333895U (en) * | 2016-09-26 | 2017-07-18 | 深圳市岩尚科技有限公司 | A kind of non-disposable dry electrode |
US10671705B2 (en) | 2016-09-28 | 2020-06-02 | Icon Health & Fitness, Inc. | Customizing recipe recommendations |
US20180103915A1 (en) * | 2016-10-18 | 2018-04-19 | Alcare Co., Ltd. | Operation processing aparatus calculating numerical value representing skin barrier function, equipument, computer readable medium, and method for evaluating skin barrier function |
TWI598073B (en) | 2016-12-15 | 2017-09-11 | 財團法人工業技術研究院 | Physiological signal measuring method and physiological signal measuring device |
EP3363354A1 (en) * | 2017-02-21 | 2018-08-22 | Koninklijke Philips N.V. | An apparatus and method for measuring electrode impedance during electrophysiological measurements |
US11213691B2 (en) | 2017-02-27 | 2022-01-04 | Zoll Medical Corporation | Ambulatory medical device interaction |
US11009870B2 (en) | 2017-06-06 | 2021-05-18 | Zoll Medical Corporation | Vehicle compatible ambulatory defibrillator |
US10702184B2 (en) * | 2017-06-07 | 2020-07-07 | Analog Devices International Unlimited Company | Low power measurement of skin electrical properties |
WO2018226967A1 (en) * | 2017-06-07 | 2018-12-13 | Respiratory Motion, Inc. | Spacing of electrodes for bioimpedance measurements |
US10849501B2 (en) | 2017-08-09 | 2020-12-01 | Blue Spark Technologies, Inc. | Body temperature logging patch |
EP3485801A1 (en) * | 2017-11-19 | 2019-05-22 | Indigo Diabetes N.V. | Implantable integrated sensor device |
US10646707B2 (en) | 2017-11-30 | 2020-05-12 | Zoll Medical Corporation | Medical devices with rapid sensor recovery |
US10960213B2 (en) | 2018-03-12 | 2021-03-30 | Zoll Medical Corporation | Verification of cardiac arrhythmia prior to therapeutic stimulation |
US10602945B2 (en) | 2018-03-13 | 2020-03-31 | Zoll Medical Corporation | Telemetry of wearable medical device information to secondary medical device or system |
JP2021516080A (en) | 2018-03-16 | 2021-07-01 | ゾール メディカル コーポレイションZOLL Medical Corporation | Physiological condition monitoring based on biovibration and radio frequency data analysis |
WO2019246086A1 (en) | 2018-06-18 | 2019-12-26 | Zoll Medical Corporation | Medical device for estimating risk of patient deterioration |
US11623102B2 (en) | 2018-07-31 | 2023-04-11 | Medtronic, Inc. | Wearable defibrillation apparatus configured to apply a machine learning algorithm |
US11568984B2 (en) | 2018-09-28 | 2023-01-31 | Zoll Medical Corporation | Systems and methods for device inventory management and tracking |
US10918877B2 (en) | 2018-09-28 | 2021-02-16 | Zoll Medical Corporation | Battery lock for ambulatory medical device |
US11890461B2 (en) | 2018-09-28 | 2024-02-06 | Zoll Medical Corporation | Adhesively coupled wearable medical device |
WO2020078962A1 (en) | 2018-10-16 | 2020-04-23 | Koninklijke Philips N.V. | On-body sensor system |
CN109394214B (en) * | 2018-11-20 | 2022-04-19 | 中山大学 | Bio-impedance measuring device and method based on isolation excitation current phase-locking method |
WO2020139880A1 (en) | 2018-12-28 | 2020-07-02 | Zoll Medical Corporation | Wearable medical device response mechanisms and methods of use |
KR20210118431A (en) * | 2019-01-24 | 2021-09-30 | 오츠카 세이야쿠 가부시키가이샤 | Elastic wearable sensor |
US11488361B1 (en) * | 2019-02-15 | 2022-11-01 | Meta Platforms Technologies, Llc | Systems and methods for calibrating wearables based on impedance levels of users' skin surfaces |
KR20200128924A (en) | 2019-05-07 | 2020-11-17 | 삼성전자주식회사 | Method and device to measure signal |
CN110151204A (en) * | 2019-06-23 | 2019-08-23 | 复旦大学 | Wearable non-intrusion type bladder capacity monitoring alarm |
US11116451B2 (en) | 2019-07-03 | 2021-09-14 | Bardy Diagnostics, Inc. | Subcutaneous P-wave centric insertable cardiac monitor with energy harvesting capabilities |
US11696681B2 (en) | 2019-07-03 | 2023-07-11 | Bardy Diagnostics Inc. | Configurable hardware platform for physiological monitoring of a living body |
US11096579B2 (en) | 2019-07-03 | 2021-08-24 | Bardy Diagnostics, Inc. | System and method for remote ECG data streaming in real-time |
CN112642061A (en) | 2019-10-09 | 2021-04-13 | Zoll医疗公司 | Modular electrotherapy device |
CA3171482C (en) | 2020-02-12 | 2024-03-26 | Irhythm Technologies, Inc | Non-invasive cardiac monitor and methods of using recorded cardiac data to infer a physiological characteristic of a patient |
WO2021216887A1 (en) * | 2020-04-22 | 2021-10-28 | Biotags, LLC | Temperature sensor patch and system |
CA3188325A1 (en) | 2020-08-06 | 2022-02-10 | Jeff ABERCROMBIE | Adhesive physiological monitoring device |
EP4192335A1 (en) | 2020-08-06 | 2023-06-14 | Irhythm Technologies, Inc. | Electrical components for physiological monitoring device |
US20220233230A1 (en) * | 2021-01-27 | 2022-07-28 | NovaScan, Inc. | Impedance-calibrated diagnostic medical devices |
GB2604110B (en) | 2021-02-22 | 2023-03-01 | Zelemiq Ltd | Methods and apparatus for transdermal measurement of impedance |
US20230263407A1 (en) * | 2022-02-18 | 2023-08-24 | SR-Medizinelektronik | Mobile cardiac monitoring device and methods of using same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5454377A (en) * | 1993-10-08 | 1995-10-03 | The Ohio State University | Method for measuring the myocardial electrical impedance spectrum |
US5642734A (en) * | 1990-10-04 | 1997-07-01 | Microcor, Inc. | Method and apparatus for noninvasively determining hematocrit |
US20060085049A1 (en) * | 2004-10-20 | 2006-04-20 | Nervonix, Inc. | Active electrode, bio-impedance based, tissue discrimination system and methods of use |
Family Cites Families (663)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US834261A (en) | 1906-04-04 | 1906-10-30 | Clarence S Chambers | Vaccine-injector. |
US2087124A (en) | 1936-10-08 | 1937-07-13 | Clarence O Smith | Wire cable cutter |
US2184511A (en) | 1937-10-28 | 1939-12-26 | Samuel M Bagno | Method and apparatus for measuring impedance |
US3170459A (en) * | 1962-03-20 | 1965-02-23 | Clifford G Phipps | Bio-medical instrumentation electrode |
US3232291A (en) * | 1962-11-23 | 1966-02-01 | San Francisco Res Corp | Surgical adhesive tape and bandage |
US3370459A (en) * | 1964-04-16 | 1968-02-27 | Cescati Arturo | Device for detecting pressure existing in pneumatic tires |
USRE30101E (en) | 1964-08-19 | 1979-09-25 | Regents Of The University Of Minnesota | Impedance plethysmograph |
US3517999A (en) | 1966-01-07 | 1970-06-30 | Itt | Optical strain gauge |
US3620216A (en) | 1969-06-25 | 1971-11-16 | Abbott Lab | Implant trocar |
US3677260A (en) | 1970-09-04 | 1972-07-18 | Statham Instrument Inc | Arrhythmia detector |
US3805769A (en) | 1971-08-27 | 1974-04-23 | R Sessions | Disposable electrode |
US3845757A (en) | 1972-07-12 | 1974-11-05 | Minnesota Mining & Mfg | Biomedical monitoring electrode |
US3882853A (en) | 1973-02-15 | 1975-05-13 | Cardiodynamics | Biomedical electrode |
US3874368A (en) | 1973-04-19 | 1975-04-01 | Manfred Asrican | Impedance plethysmograph having blocking system |
US4121573A (en) | 1973-10-04 | 1978-10-24 | Goebel Fixture Co. | Wireless cardiac monitoring system and electrode-transmitter therefor |
US3942517A (en) | 1973-12-03 | 1976-03-09 | Dracard Limited | Electrodes |
US3972329A (en) | 1974-11-25 | 1976-08-03 | Kaufman John George | Body electrode for electro-medical use |
US4008712A (en) * | 1975-11-14 | 1977-02-22 | J. M. Richards Laboratories | Method for monitoring body characteristics |
US4024312A (en) | 1976-06-23 | 1977-05-17 | Johnson & Johnson | Pressure-sensitive adhesive tape having extensible and elastic backing composed of a block copolymer |
US4077406A (en) | 1976-06-24 | 1978-03-07 | American Cyanamid Company | Pellet implanter for animal treatment |
GB1596298A (en) * | 1977-04-07 | 1981-08-26 | Morgan Ltd P K | Method of and apparatus for detecting or measuring changes in the cross-sectional area of a non-magnetic object |
US4185621A (en) * | 1977-10-28 | 1980-01-29 | Triad, Inc. | Body parameter display incorporating a battery charger |
US4141366A (en) * | 1977-11-18 | 1979-02-27 | Medtronic, Inc. | Lead connector for tape electrode |
US4216462A (en) | 1978-03-06 | 1980-08-05 | General Electric Company | Patient monitoring and data processing system |
US4674511A (en) | 1979-04-30 | 1987-06-23 | American Hospital Supply Corporation | Medical electrode |
US4838273A (en) | 1979-04-30 | 1989-06-13 | Baxter International Inc. | Medical electrode |
US4300575A (en) | 1979-06-25 | 1981-11-17 | Staodynamics, Inc. | Air-permeable disposable electrode |
US4522211A (en) | 1979-12-06 | 1985-06-11 | C. R. Bard, Inc. | Medical electrode construction |
US4358678A (en) | 1980-11-19 | 1982-11-09 | Hersey Products, Inc. | Fiber optic transducer and method |
US5862802A (en) * | 1981-04-03 | 1999-01-26 | Forrest M. Bird | Ventilator having an oscillatory inspiratory phase and method |
FI62422C (en) * | 1981-06-24 | 1982-12-10 | Kone Oy | TESTING PROCEDURES FOR FASTS ADJUSTMENT AV EN ECG ELECTRODES |
US4409983A (en) | 1981-08-20 | 1983-10-18 | Albert David E | Pulse measuring device |
US4699146A (en) | 1982-02-25 | 1987-10-13 | Valleylab, Inc. | Hydrophilic, elastomeric, pressure-sensitive adhesive |
US4451254A (en) | 1982-03-15 | 1984-05-29 | Eli Lilly And Company | Implant system |
SE455043B (en) | 1982-04-22 | 1988-06-20 | Karolinska Inst | DEVICE FOR MONITORING THE LIQUID BALANCE OF THE HUMAN BODY BY MEASURING THE IMPEDANCE OF THE BODY |
US4450527A (en) | 1982-06-29 | 1984-05-22 | Bomed Medical Mfg. Ltd. | Noninvasive continuous cardiac output monitor |
US4478223A (en) | 1982-12-06 | 1984-10-23 | Allor Douglas R | Three dimensional electrocardiograph |
US4981139A (en) * | 1983-08-11 | 1991-01-01 | Pfohl Robert L | Vital signs monitoring and communication system |
US4692685A (en) | 1984-03-14 | 1987-09-08 | Blaze Kevin L | Electrical measuring apparatus, and methods for determining the condition or identity of biological material |
JPS60261431A (en) | 1984-06-11 | 1985-12-24 | 浅井 利夫 | Water-proof electrode with transmitter for recording cardiograph |
DE3428975A1 (en) * | 1984-08-06 | 1986-02-13 | Michael S. 8113 Kochel Lampadius | BREATH-CONTROLLED HEART PACEMAKER |
DE3513400A1 (en) | 1985-04-15 | 1986-10-16 | Philips Patentverwaltung Gmbh, 2000 Hamburg | OPTICAL MOTION SENSOR |
NZ216003A (en) | 1985-05-06 | 1987-10-30 | Phillips Pty Ltd N J | Pellet-implanting injector with indexing mechanism |
US4781200A (en) | 1985-10-04 | 1988-11-01 | Baker Donald A | Ambulatory non-invasive automatic fetal monitoring system |
US4669480A (en) | 1985-10-16 | 1987-06-02 | Murray Electronics Associates Limited Partnership | Temperature indicating electrotherapy electrode/coil and method of use |
US4661103A (en) | 1986-03-03 | 1987-04-28 | Engineering Development Associates, Ltd. | Multiple implant injector |
US4733107A (en) | 1986-07-10 | 1988-03-22 | Western Digital Corporation | Low current high precision CMOS schmitt trigger circuit |
US4730611A (en) | 1986-09-02 | 1988-03-15 | Absorbent Cotton Company | Medical dressing device |
FR2604890A1 (en) | 1986-10-14 | 1988-04-15 | Thomson Csf | OPTICAL DEVICE FOR THE SIMULTANEOUS DETECTION OF HEART MOVEMENT AND BREATHING AND ITS USE IN THE SYNCHRONIZATION OF NUCLEAR MAGNETIC RESONANCE ACQUISITION IMAGING DEVICES |
US4838279A (en) | 1987-05-12 | 1989-06-13 | Fore Don C | Respiration monitor |
US4850370A (en) | 1987-07-22 | 1989-07-25 | Dower Gordon E | Method and apparatus for sensing and analyzing electrical activity of the human heart |
US4911175A (en) | 1987-09-17 | 1990-03-27 | Diana Twyman | Method for measuring total body cell mass and total extracellular mass by bioelectrical resistance and reactance |
JPH01126535A (en) | 1987-11-12 | 1989-05-18 | Kao Corp | Method and apparatus for measuring content of skin moisture |
US4895163A (en) * | 1988-05-24 | 1990-01-23 | Bio Analogics, Inc. | System for body impedance data acquisition |
US4880004A (en) | 1988-06-07 | 1989-11-14 | Intermedics, Inc. | Implantable cardiac stimulator with automatic gain control and bandpass filtering in feedback loop |
US4988335A (en) * | 1988-08-16 | 1991-01-29 | Ideal Instruments, Inc. | Pellet implanter apparatus |
US4955381A (en) | 1988-08-26 | 1990-09-11 | Cardiotronics, Inc. | Multi-pad, multi-function electrode |
US5080099A (en) * | 1988-08-26 | 1992-01-14 | Cardiotronics, Inc. | Multi-pad, multi-function electrode |
US5012810A (en) | 1988-09-22 | 1991-05-07 | Minnesota Mining And Manufacturing Company | Biomedical electrode construction |
US5133355A (en) | 1988-09-22 | 1992-07-28 | Minnesota Mining And Manufacturing Company | Biomedical electrode construction |
US5001632A (en) | 1989-12-22 | 1991-03-19 | Hall Tipping Justin | Video game difficulty level adjuster dependent upon player's aerobic activity level during exercise |
US5511553A (en) | 1989-02-15 | 1996-04-30 | Segalowitz; Jacob | Device-system and method for monitoring multiple physiological parameters (MMPP) continuously and simultaneously |
US5168874A (en) | 1989-02-15 | 1992-12-08 | Jacob Segalowitz | Wireless electrode structure for use in patient monitoring system |
JPH0315502U (en) | 1989-06-28 | 1991-02-15 | ||
US5769793A (en) | 1989-09-08 | 1998-06-23 | Steven M. Pincus | System to determine a relative amount of patternness |
US5050612A (en) | 1989-09-12 | 1991-09-24 | Matsumura Kenneth N | Device for computer-assisted monitoring of the body |
US5086781A (en) * | 1989-11-14 | 1992-02-11 | Bookspan Mark A | Bioelectric apparatus for monitoring body fluid compartments |
US5027824A (en) | 1989-12-01 | 1991-07-02 | Edmond Dougherty | Method and apparatus for detecting, analyzing and recording cardiac rhythm disturbances |
US5140985A (en) | 1989-12-11 | 1992-08-25 | Schroeder Jon M | Noninvasive blood glucose measuring device |
US5083563A (en) * | 1990-02-16 | 1992-01-28 | Telectronics Pacing Systems, Inc. | Implantable automatic and haemodynamically responsive cardioverting/defibrillating pacemaker |
US5125412A (en) | 1990-07-23 | 1992-06-30 | Thornton William E | Musculoskeletal activity monitor |
US5113869A (en) | 1990-08-21 | 1992-05-19 | Telectronics Pacing Systems, Inc. | Implantable ambulatory electrocardiogram monitor |
ATE175068T1 (en) | 1990-08-31 | 1999-01-15 | Gen Hospital Corp | SYSTEM FOR MANAGING MULTIPLE DEVICES, FOR EXAMPLE PORTABLE PATIENT MONITORING DEVICES IN A NETWORK |
US5063937A (en) | 1990-09-12 | 1991-11-12 | Wright State University | Multiple frequency bio-impedance measurement system |
US5271411A (en) | 1990-09-21 | 1993-12-21 | Colin Electronics Co., Ltd. | Method and apparatus for ECG signal analysis and cardiac arrhythmia detection |
US5150708A (en) | 1990-12-03 | 1992-09-29 | Spacelabs, Inc. | Tabbed defibrillator electrode pad |
US5437285A (en) | 1991-02-20 | 1995-08-01 | Georgetown University | Method and apparatus for prediction of sudden cardiac death by simultaneous assessment of autonomic function and cardiac electrical stability |
EP0574509B1 (en) | 1991-03-07 | 1999-09-15 | Masimo Corporation | Signal processing apparatus and method |
MX9702434A (en) | 1991-03-07 | 1998-05-31 | Masimo Corp | Signal processing apparatus. |
US5632272A (en) | 1991-03-07 | 1997-05-27 | Masimo Corporation | Signal processing apparatus |
US5226417A (en) | 1991-03-11 | 1993-07-13 | Nellcor, Inc. | Apparatus for the detection of motion transients |
WO1992017240A1 (en) | 1991-04-05 | 1992-10-15 | Medtronic, Inc. | Subcutaneous multi-electrode sensing system |
ATE199820T1 (en) | 1991-06-12 | 2001-04-15 | Univ Florida Atlantic | DETECTION OF ATHEROSCLEROSIS IN HUMAN BEINGS |
NL9101489A (en) | 1991-09-03 | 1993-04-01 | Texas Instruments Holland | INJECTOR FOR IMMEDIATELY IMPLANTING AN OBJECT IN A LIVING BEING. |
US5309917A (en) | 1991-09-12 | 1994-05-10 | Drexel University | System and method of impedance cardiography and heartbeat determination |
US5335664A (en) | 1991-09-17 | 1994-08-09 | Casio Computer Co., Ltd. | Monitor system and biological signal transmitter therefor |
US5257627A (en) | 1991-11-14 | 1993-11-02 | Telmed, Inc. | Portable non-invasive testing apparatus |
US5353793A (en) | 1991-11-25 | 1994-10-11 | Oishi-Kogyo Company | Sensor apparatus |
US5291013A (en) | 1991-12-06 | 1994-03-01 | Alamed Corporation | Fiber optical monitor for detecting normal breathing and heartbeat motion based on changes in speckle patterns |
DE69215204T2 (en) | 1992-01-29 | 1997-03-13 | Hewlett Packard Gmbh | Process and system for monitoring vital functions |
US5301677A (en) | 1992-02-06 | 1994-04-12 | Cardiac Pacemakers, Inc. | Arrhythmia detector using delta modulated turning point morphology of the ECG wave |
US5282840A (en) * | 1992-03-26 | 1994-02-01 | Medtronic, Inc. | Multiple frequency impedance measurement system |
DE69329710T2 (en) | 1992-04-03 | 2001-08-02 | Micromedical Ind Ltd | ARRANGEMENT FOR MONITORING PHYSIOLOGICAL PARAMETERS |
US5241300B1 (en) | 1992-04-24 | 1995-10-31 | Johannes Buschmann | Sids detection apparatus and methods |
IL102300A (en) * | 1992-06-24 | 1996-07-23 | N I Medical Ltd | Non-invasive system for determining of the main cardiorespiratory parameters of the human body |
US5984102A (en) | 1992-09-24 | 1999-11-16 | Survivalink Corporation | Medical electrode packaging technology |
US5411530A (en) | 1992-11-13 | 1995-05-02 | Akhtar; Masood | Sensing algorithm for anti-tachycardia devices using dual chamber sensing |
US5362069A (en) | 1992-12-03 | 1994-11-08 | Heartbeat Corporation | Combination exercise device/video game |
US5375604A (en) | 1992-12-11 | 1994-12-27 | Siemens Medical Electronics, Inc. | Transportable modular patient monitor |
US5450845A (en) | 1993-01-11 | 1995-09-19 | Axelgaard; Jens | Medical electrode system |
US5797960A (en) * | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
US5558638A (en) | 1993-04-30 | 1996-09-24 | Healthdyne, Inc. | Patient monitor and support system |
US5406945A (en) | 1993-05-24 | 1995-04-18 | Ndm Acquisition Corp. | Biomedical electrode having a secured one-piece conductive terminal |
US5628777A (en) | 1993-07-14 | 1997-05-13 | Pacesetter, Inc. | Implantable leads incorporating cardiac wall acceleration sensors and method of fabrication |
US5607454A (en) | 1993-08-06 | 1997-03-04 | Heartstream, Inc. | Electrotherapy method and apparatus |
DE4329898A1 (en) | 1993-09-04 | 1995-04-06 | Marcus Dr Besson | Wireless medical diagnostic and monitoring device |
US5464012A (en) | 1993-09-13 | 1995-11-07 | Hewlett-Packard Company | Patient alarm detection using target mode |
US5724025A (en) | 1993-10-21 | 1998-03-03 | Tavori; Itzchak | Portable vital signs monitor |
US5523742A (en) | 1993-11-18 | 1996-06-04 | The United States Of America As Represented By The Secretary Of The Army | Motion sensor |
US5544661A (en) | 1994-01-13 | 1996-08-13 | Charles L. Davis | Real time ambulatory patient monitor |
US5964703A (en) | 1994-01-14 | 1999-10-12 | E-Z-Em, Inc. | Extravasation detection electrode patch |
US5447529A (en) | 1994-01-28 | 1995-09-05 | Philadelphia Heart Institute | Method of using endocardial impedance for determining electrode-tissue contact, appropriate sites for arrhythmia ablation and tissue heating during ablation |
US6067467A (en) | 1994-02-07 | 2000-05-23 | New York University | EEG operative and post-operative patient monitoring method |
US5598848A (en) | 1994-03-31 | 1997-02-04 | Ep Technologies, Inc. | Systems and methods for positioning multiple electrode structures in electrical contact with the myocardium |
US5575284A (en) | 1994-04-01 | 1996-11-19 | University Of South Florida | Portable pulse oximeter |
US5566671A (en) | 1994-05-23 | 1996-10-22 | Lyons; Chad | Medical acoustic sensor receptacle |
AU2554795A (en) | 1994-06-07 | 1996-01-04 | Agrizap, Inc. | A portable pest electrocution device with resistive switch sensor |
US5518001A (en) | 1994-06-17 | 1996-05-21 | Pacesetter, Inc. | Cardiac device with patient-triggered storage of physiological sensor data |
NO180024C (en) | 1994-10-11 | 1997-01-29 | Oerjan G Martinsen | Measurement of moisture in the skin |
US5560368A (en) | 1994-11-15 | 1996-10-01 | Berger; Ronald D. | Methodology for automated QT variability measurement |
AUPM964094A0 (en) | 1994-11-24 | 1994-12-15 | Sullivan, C.E. | Biophysical foetal monitor |
US5778882A (en) | 1995-02-24 | 1998-07-14 | Brigham And Women's Hospital | Health monitoring system |
US5564434A (en) | 1995-02-27 | 1996-10-15 | Medtronic, Inc. | Implantable capacitive absolute pressure and temperature sensor |
US5503157A (en) | 1995-03-17 | 1996-04-02 | Sramek; Bohumir | System for detection of electrical bioimpedance signals |
US5788682A (en) | 1995-04-28 | 1998-08-04 | Maget; Henri J.R. | Apparatus and method for controlling oxygen concentration in the vicinity of a wound |
US6327487B1 (en) | 1995-05-04 | 2001-12-04 | Robert A. Stratbucker | Bioelectric interface |
NL1001282C2 (en) * | 1995-09-26 | 1997-03-28 | A J Van Liebergen Holding B V | Stroke volume determination device for a human heart. |
US5772508A (en) | 1995-09-28 | 1998-06-30 | Amtex Co., Ltd. | Game or play facilities controlled by physiological information |
US5807272A (en) | 1995-10-31 | 1998-09-15 | Worcester Polytechnic Institute | Impedance spectroscopy system for ischemia monitoring and detection |
US5678562A (en) | 1995-11-09 | 1997-10-21 | Burdick, Inc. | Ambulatory physiological monitor with removable disk cartridge and wireless modem |
US5944659A (en) | 1995-11-13 | 1999-08-31 | Vitalcom Inc. | Architecture for TDMA medical telemetry system |
US5748103A (en) | 1995-11-13 | 1998-05-05 | Vitalcom, Inc. | Two-way TDMA telemetry system with power conservation features |
US5803915A (en) | 1995-12-07 | 1998-09-08 | Ohmeda Inc. | System for detection of probe dislodgement |
US6035233A (en) | 1995-12-11 | 2000-03-07 | Intermedics Inc. | Implantable medical device responsive to heart rate variability analysis |
US5710376A (en) * | 1995-12-22 | 1998-01-20 | International Business Machines Corporation | Charged mass thin film condenser accelerometer |
US5860860A (en) * | 1996-01-31 | 1999-01-19 | Federal Patent Corporation | Integral video game and cardio-waveform display |
US6463328B1 (en) | 1996-02-02 | 2002-10-08 | Michael Sasha John | Adaptive brain stimulation method and system |
FI960636A (en) | 1996-02-12 | 1997-08-13 | Nokia Mobile Phones Ltd | A procedure for monitoring the health of a patient |
US5833603A (en) | 1996-03-13 | 1998-11-10 | Lipomatrix, Inc. | Implantable biosensing transponder |
US6496715B1 (en) | 1996-07-11 | 2002-12-17 | Medtronic, Inc. | System and method for non-invasive determination of optimal orientation of an implantable sensing device |
JP2000514682A (en) | 1996-07-11 | 2000-11-07 | メドトロニック・インコーポレーテッド | Minimal invasive implantable device for monitoring physiological events |
US5687717A (en) | 1996-08-06 | 1997-11-18 | Tremont Medical, Inc. | Patient monitoring system with chassis mounted or remotely operable modules and portable computer |
US6141575A (en) | 1996-08-16 | 2000-10-31 | Price; Michael A. | Electrode assemblies |
DE19638585A1 (en) | 1996-09-20 | 1998-03-26 | Biotronik Mess & Therapieg | Device for rejection diagnosis after organ transplantation |
US6112224A (en) | 1996-09-20 | 2000-08-29 | Georgia Tech Research Corporation | Patient monitoring station using a single interrupt resource to support multiple measurement devices |
US5718234A (en) * | 1996-09-30 | 1998-02-17 | Northrop Grumman Corporation | Physiological data communication system |
US5814079A (en) | 1996-10-04 | 1998-09-29 | Medtronic, Inc. | Cardiac arrhythmia management by application of adnodal stimulation for hyperpolarization of myocardial cells |
US6198394B1 (en) | 1996-12-05 | 2001-03-06 | Stephen C. Jacobsen | System for remote monitoring of personnel |
US5876353A (en) | 1997-01-31 | 1999-03-02 | Medtronic, Inc. | Impedance monitor for discerning edema through evaluation of respiratory rate |
US5957861A (en) | 1997-01-31 | 1999-09-28 | Medtronic, Inc. | Impedance monitor for discerning edema through evaluation of respiratory rate |
US6102856A (en) | 1997-02-12 | 2000-08-15 | Groff; Clarence P | Wearable vital sign monitoring system |
EP1011792B1 (en) * | 1997-02-26 | 2005-12-07 | Alfred E. Mann Foundation for Scientific Research | Battery-powered patient implantable device |
US6208894B1 (en) | 1997-02-26 | 2001-03-27 | Alfred E. Mann Foundation For Scientific Research And Advanced Bionics | System of implantable devices for monitoring and/or affecting body parameters |
US6164284A (en) | 1997-02-26 | 2000-12-26 | Schulman; Joseph H. | System of implantable devices for monitoring and/or affecting body parameters |
US5865733A (en) * | 1997-02-28 | 1999-02-02 | Spacelabs Medical, Inc. | Wireless optical patient monitoring apparatus |
US5959529A (en) | 1997-03-07 | 1999-09-28 | Kail, Iv; Karl A. | Reprogrammable remote sensor monitoring system |
US6148233A (en) | 1997-03-07 | 2000-11-14 | Cardiac Science, Inc. | Defibrillation system having segmented electrodes |
DE69841846D1 (en) | 1997-03-17 | 2010-09-30 | Adidas Ag | INFORMATION RECONDITIONING SYSTEM FOR PHYSIOLOGICAL SIGNALS |
AUPO616697A0 (en) | 1997-04-11 | 1997-05-08 | Heartlink Pty Ltd | Method for diagnosing psychiatric disorders |
US7941534B2 (en) | 1997-04-14 | 2011-05-10 | Carlos De La Huerga | System and method to authenticate users to computer systems |
US5788643A (en) | 1997-04-22 | 1998-08-04 | Zymed Medical Instrumentation, Inc. | Process for monitoring patients with chronic congestive heart failure |
US6050267A (en) | 1997-04-28 | 2000-04-18 | American Cardiac Ablation Co. Inc. | Catheter positioning system |
FR2766376B1 (en) | 1997-07-25 | 1999-10-22 | Lhd Lab Hygiene Dietetique | WOUND THERAPEUTIC TREATMENT DEVICE |
US6190313B1 (en) * | 1998-04-20 | 2001-02-20 | Allen J. Hinkle | Interactive health care system and method |
AU767312B2 (en) | 1997-08-19 | 2003-11-06 | Philipp Lang | Measurement of capillary related interstitial fluid using ultrasound methods and devices |
US6259939B1 (en) | 1997-08-20 | 2001-07-10 | R. Z. Comparative Diagnostics Ltd. | Electrocardiography electrodes holder including electrocardiograph electronics |
US6090056A (en) | 1997-08-27 | 2000-07-18 | Emergency Medical Systems, Inc. | Resuscitation and alert system |
US6007532A (en) | 1997-08-29 | 1999-12-28 | 3M Innovative Properties Company | Method and apparatus for detecting loss of contact of biomedical electrodes with patient skin |
US5836990A (en) | 1997-09-19 | 1998-11-17 | Medtronic, Inc. | Method and apparatus for determining electrode/tissue contact |
US6027523A (en) * | 1997-10-06 | 2000-02-22 | Arthrex, Inc. | Suture anchor with attached disk |
US6409674B1 (en) | 1998-09-24 | 2002-06-25 | Data Sciences International, Inc. | Implantable sensor with wireless communication |
US6080106A (en) | 1997-10-28 | 2000-06-27 | Alere Incorporated | Patient interface system with a scale |
US6050951A (en) | 1997-11-10 | 2000-04-18 | Critikon Company, L.L.C. | NIBP trigger in response to detected heart rate variability |
US20020180605A1 (en) | 1997-11-11 | 2002-12-05 | Ozguz Volkan H. | Wearable biomonitor with flexible thinned integrated circuit |
US20050096513A1 (en) | 1997-11-11 | 2005-05-05 | Irvine Sensors Corporation | Wearable biomonitor with flexible thinned integrated circuit |
US6129744A (en) | 1997-12-04 | 2000-10-10 | Vitatron Medical, B.V. | Cardiac treatment system and method for sensing and responding to heart failure |
US6047259A (en) | 1997-12-30 | 2000-04-04 | Medical Management International, Inc. | Interactive method and system for managing physical exams, diagnosis and treatment protocols in a health care practice |
US6125297A (en) | 1998-02-06 | 2000-09-26 | The United States Of America As Represented By The United States National Aeronautics And Space Administration | Body fluids monitor |
US6038464A (en) | 1998-02-09 | 2000-03-14 | Axelgaard Manufacturing Co., Ltd. | Medical electrode |
US5904708A (en) | 1998-03-19 | 1999-05-18 | Medtronic, Inc. | System and method for deriving relative physiologic signals |
US6579231B1 (en) | 1998-03-27 | 2003-06-17 | Mci Communications Corporation | Personal medical monitoring unit and system |
US5941831A (en) | 1998-04-03 | 1999-08-24 | Pacesetter, Inc. | Method for diagnosing cardiac arrhythmias using interval irregularity |
US5967995A (en) | 1998-04-28 | 1999-10-19 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | System for prediction of life-threatening cardiac arrhythmias |
PT1053043E (en) * | 1998-05-13 | 2002-11-29 | Cygnus Therapeutic Systems | COLLECTION ASSEMBLIES FOR TRANSDERMIC SAMPLING SYSTEMS |
US6045513A (en) | 1998-05-13 | 2000-04-04 | Medtronic, Inc. | Implantable medical device for tracking patient functional status |
IL124964A (en) | 1998-06-17 | 2002-02-10 | Nimeda Ltd | Method for disclosing a physiological indication and a non-invasive diagnostic physiological monitoring system for use therewith |
US6095991A (en) | 1998-07-23 | 2000-08-01 | Individual Monitoring Systems, Inc. | Ambulatory body position monitor |
JP2002522103A (en) | 1998-08-07 | 2002-07-23 | インフィニット バイオメディカル テクノロジーズ インコーポレイテッド | Method for detecting, indicating and operating implantable myocardial ischemia |
US6052615A (en) | 1998-08-17 | 2000-04-18 | Zymed Medical Instrumentation, Inc. | Method and apparatus for sensing and analyzing electrical activity of the human heart using a four electrode arrangement |
US6267730B1 (en) | 1998-08-25 | 2001-07-31 | Kenneth M. Pacunas | Apnea detecting system |
US6330464B1 (en) | 1998-08-26 | 2001-12-11 | Sensors For Medicine & Science | Optical-based sensing devices |
US6104949A (en) | 1998-09-09 | 2000-08-15 | Vitatron Medical, B.V. | Medical device |
US6343140B1 (en) * | 1998-09-11 | 2002-01-29 | Quid Technologies Llc | Method and apparatus for shooting using biometric recognition |
AU1198100A (en) | 1998-09-23 | 2000-04-10 | Keith Bridger | Physiological sensing device |
US6402689B1 (en) | 1998-09-30 | 2002-06-11 | Sicel Technologies, Inc. | Methods, systems, and associated implantable devices for dynamic monitoring of physiological and biological properties of tumors |
US6306088B1 (en) | 1998-10-03 | 2001-10-23 | Individual Monitoring Systems, Inc. | Ambulatory distributed recorders system for diagnosing medical disorders |
US6519487B1 (en) * | 1998-10-15 | 2003-02-11 | Sensidyne, Inc. | Reusable pulse oximeter probe and disposable bandage apparatus |
KR100649380B1 (en) * | 1998-11-02 | 2006-11-24 | 알자 코포레이션 | Electrotransport device including a compatible antimicrobial agent |
US6358208B1 (en) | 1998-11-21 | 2002-03-19 | Philipp Lang | Assessment of cardiovascular performance using ultrasound methods and devices that interrogate interstitial fluid |
US6398727B1 (en) | 1998-12-23 | 2002-06-04 | Baxter International Inc. | Method and apparatus for providing patient care |
US6049730A (en) | 1998-12-28 | 2000-04-11 | Flaga Hf | Method and apparatus for improving the accuracy of interpretation of ECG-signals |
US6206831B1 (en) | 1999-01-06 | 2001-03-27 | Scimed Life Systems, Inc. | Ultrasound-guided ablation catheter and methods of use |
US6295466B1 (en) | 1999-01-06 | 2001-09-25 | Ball Semiconductor, Inc. | Wireless EKG |
US6117077A (en) | 1999-01-22 | 2000-09-12 | Del Mar Medical Systems, Llc | Long-term, ambulatory physiological recorder |
US6473640B1 (en) | 1999-01-25 | 2002-10-29 | Jay Erlebacher | Implantable device and method for long-term detection and monitoring of congestive heart failure |
WO2000044580A1 (en) | 1999-01-27 | 2000-08-03 | Compumedics Sleep Pty. Ltd. | Vigilance monitoring system |
US6305943B1 (en) | 1999-01-29 | 2001-10-23 | Biomed Usa, Inc. | Respiratory sinus arrhythmia training system |
US6212427B1 (en) | 1999-02-02 | 2001-04-03 | J&J Engineering | Heart rate variability feedback monitor system |
US6266554B1 (en) | 1999-02-12 | 2001-07-24 | Cardiac Pacemakers, Inc. | System and method for classifying cardiac complexes |
US6821249B2 (en) | 1999-03-08 | 2004-11-23 | Board Of Regents, The University Of Texas | Temperature monitoring of congestive heart failure patients as an indicator of worsening condition |
US6454707B1 (en) | 1999-03-08 | 2002-09-24 | Samuel W. Casscells, III | Method and apparatus for predicting mortality in congestive heart failure patients |
US6223078B1 (en) * | 1999-03-12 | 2001-04-24 | Cardiac Pacemakers, Inc. | Discrimination of supraventricular tachycardia and ventricular tachycardia events |
US6751498B1 (en) | 1999-03-15 | 2004-06-15 | The Johns Hopkins University | Apparatus and method for non-invasive, passive fetal heart monitoring |
GB2348707B (en) | 1999-04-07 | 2003-07-09 | Healthcare Technology Ltd | Heart activity detection apparatus |
US6416471B1 (en) | 1999-04-15 | 2002-07-09 | Nexan Limited | Portable remote patient telemonitoring system |
US6450953B1 (en) | 1999-04-15 | 2002-09-17 | Nexan Limited | Portable signal transfer unit |
US6454708B1 (en) | 1999-04-15 | 2002-09-24 | Nexan Limited | Portable remote patient telemonitoring system using a memory card or smart card |
US6494829B1 (en) | 1999-04-15 | 2002-12-17 | Nexan Limited | Physiological sensor array |
US6385473B1 (en) | 1999-04-15 | 2002-05-07 | Nexan Limited | Physiological sensor device |
US7577475B2 (en) | 1999-04-16 | 2009-08-18 | Cardiocom | System, method, and apparatus for combining information from an implanted device with information from a patient monitoring apparatus |
US6290646B1 (en) | 1999-04-16 | 2001-09-18 | Cardiocom | Apparatus and method for monitoring and communicating wellness parameters of ambulatory patients |
US6190324B1 (en) * | 1999-04-28 | 2001-02-20 | Medtronic, Inc. | Implantable medical device for tracking patient cardiac status |
AUPQ047899A0 (en) | 1999-05-21 | 1999-06-10 | Cooke, Michael | A device for use with computer games |
US6312378B1 (en) | 1999-06-03 | 2001-11-06 | Cardiac Intelligence Corporation | System and method for automated collection and analysis of patient information retrieved from an implantable medical device for remote patient care |
AUPQ113799A0 (en) | 1999-06-22 | 1999-07-15 | University Of Queensland, The | A method and device for measuring lymphoedema |
US7454359B2 (en) | 1999-06-23 | 2008-11-18 | Visicu, Inc. | System and method for displaying a health status of hospitalized patients |
US6287252B1 (en) | 1999-06-30 | 2001-09-11 | Monitrak | Patient monitor |
US7149773B2 (en) | 1999-07-07 | 2006-12-12 | Medtronic, Inc. | System and method of automated invoicing for communications between an implantable medical device and a remote computer system or health care provider |
WO2001004864A1 (en) | 1999-07-09 | 2001-01-18 | The Government Of The United States As Represented By The Administrator Of The National Aeronautics And Space Administration (Nasa) | Method and apparatus for encouraging physiological self-regulation through modulation of an operators control input to a video game or training simulator |
US6512949B1 (en) * | 1999-07-12 | 2003-01-28 | Medtronic, Inc. | Implantable medical device for measuring time varying physiologic conditions especially edema and for responding thereto |
US6347245B1 (en) * | 1999-07-14 | 2002-02-12 | Medtronic, Inc. | Medical device ECG marker for use in compressed data system |
US6221011B1 (en) | 1999-07-26 | 2001-04-24 | Cardiac Intelligence Corporation | System and method for determining a reference baseline of individual patient status for use in an automated collection and analysis patient care system |
CA2314517A1 (en) | 1999-07-26 | 2001-01-26 | Gust H. Bardy | System and method for determining a reference baseline of individual patient status for use in an automated collection and analysis patient care system |
JP2001052930A (en) | 1999-08-06 | 2001-02-23 | Tdk Corp | Laminated inductor and manufacture thereof |
US6442422B1 (en) | 1999-08-11 | 2002-08-27 | Ge Medical Systems Information Technologies, Inc. | Compliance monitoring apparatus and method |
US6721594B2 (en) | 1999-08-24 | 2004-04-13 | Cardiac Pacemakers, Inc. | Arrythmia display |
EP1217942A1 (en) | 1999-09-24 | 2002-07-03 | Healthetech, Inc. | Physiological monitor and associated computation, display and communication unit |
US6272377B1 (en) | 1999-10-01 | 2001-08-07 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system with arrhythmia prediction and prevention |
US6527711B1 (en) | 1999-10-18 | 2003-03-04 | Bodymedia, Inc. | Wearable human physiological data sensors and reporting system therefor |
US6520967B1 (en) * | 1999-10-20 | 2003-02-18 | Cauthen Research Group, Inc. | Spinal implant insertion instrument for spinal interbody prostheses |
US6350237B1 (en) | 1999-11-05 | 2002-02-26 | General Electric Company | Method and apparatus for monitoring fetal status data |
US6600949B1 (en) | 1999-11-10 | 2003-07-29 | Pacesetter, Inc. | Method for monitoring heart failure via respiratory patterns |
US6942622B1 (en) | 1999-11-10 | 2005-09-13 | Pacesetter, Inc. | Method for monitoring autonomic tone |
US6527729B1 (en) | 1999-11-10 | 2003-03-04 | Pacesetter, Inc. | Method for monitoring patient using acoustic sensor |
US6480733B1 (en) | 1999-11-10 | 2002-11-12 | Pacesetter, Inc. | Method for monitoring heart failure |
US6368284B1 (en) | 1999-11-16 | 2002-04-09 | Cardiac Intelligence Corporation | Automated collection and analysis patient care system and method for diagnosing and monitoring myocardial ischemia and outcomes thereof |
US6336903B1 (en) * | 1999-11-16 | 2002-01-08 | Cardiac Intelligence Corp. | Automated collection and analysis patient care system and method for diagnosing and monitoring congestive heart failure and outcomes thereof |
US6277078B1 (en) | 1999-11-19 | 2001-08-21 | Remon Medical Technologies, Ltd. | System and method for monitoring a parameter associated with the performance of a heart |
US6602191B2 (en) * | 1999-12-17 | 2003-08-05 | Q-Tec Systems Llp | Method and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity |
US7127370B2 (en) | 2000-01-07 | 2006-10-24 | Nocwatch International Inc. | Attitude indicator and activity monitoring device |
US6611783B2 (en) | 2000-01-07 | 2003-08-26 | Nocwatch, Inc. | Attitude indicator and activity monitoring device |
US6970742B2 (en) | 2000-01-11 | 2005-11-29 | Savacor, Inc. | Method for detecting, diagnosing, and treating cardiovascular disease |
JP2001198098A (en) | 2000-01-21 | 2001-07-24 | Tanita Corp | Dropsy measurement method and dropsy measurement device |
US6551251B2 (en) | 2000-02-14 | 2003-04-22 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Passive fetal heart monitoring system |
US6699200B2 (en) | 2000-03-01 | 2004-03-02 | Medtronic, Inc. | Implantable medical device with multi-vector sensing electrodes |
US6893396B2 (en) | 2000-03-01 | 2005-05-17 | I-Medik, Inc. | Wireless internet bio-telemetry monitoring system and interface |
GB0005247D0 (en) | 2000-03-03 | 2000-04-26 | Btg Int Ltd | Electrical impedance method for differentiating tissue types |
JP3846844B2 (en) * | 2000-03-14 | 2006-11-15 | 株式会社東芝 | Body-mounted life support device |
US6584343B1 (en) | 2000-03-15 | 2003-06-24 | Resolution Medical, Inc. | Multi-electrode panel system for sensing electrical activity of the heart |
US6871211B2 (en) | 2000-03-28 | 2005-03-22 | Ge Medical Systems Information Technologies, Inc. | Intranet-based medical data distribution system |
US6485461B1 (en) | 2000-04-04 | 2002-11-26 | Insulet, Inc. | Disposable infusion device |
CA2405848C (en) | 2000-04-17 | 2010-11-09 | Vivometrics, Inc. | Systems and methods for ambulatory monitoring of physiological signs |
US6496705B1 (en) * | 2000-04-18 | 2002-12-17 | Motorola Inc. | Programmable wireless electrode system for medical monitoring |
EP1290652A2 (en) | 2000-05-05 | 2003-03-12 | Hill-Rom Services, Inc. | Hospital monitoring and control system and method |
FR2808609B1 (en) | 2000-05-05 | 2006-02-10 | Univ Rennes | DEVICE AND METHOD FOR DETECTING ABNORMAL SITUATIONS |
US6478800B1 (en) | 2000-05-08 | 2002-11-12 | Depuy Acromed, Inc. | Medical installation tool |
US6572557B2 (en) | 2000-05-09 | 2003-06-03 | Pacesetter, Inc. | System and method for monitoring progression of cardiac disease state using physiologic sensors |
US6988989B2 (en) * | 2000-05-19 | 2006-01-24 | Welch Allyn Protocol, Inc. | Patient monitoring system |
CA2312194A1 (en) | 2000-06-13 | 2001-12-13 | Mario Boucher | Fluorinated, bromo-sulfonated curable elastomers, with a low gt, derived from vinylidene fluoride and containing neither tetrafluoroethylene nor a siloxane group |
US20040049132A1 (en) | 2000-06-15 | 2004-03-11 | The Procter & Gamble Company | Device for body activity detection and processing |
US6605038B1 (en) | 2000-06-16 | 2003-08-12 | Bodymedia, Inc. | System for monitoring health, wellness and fitness |
US7261690B2 (en) * | 2000-06-16 | 2007-08-28 | Bodymedia, Inc. | Apparatus for monitoring health, wellness and fitness |
US20060122474A1 (en) | 2000-06-16 | 2006-06-08 | Bodymedia, Inc. | Apparatus for monitoring health, wellness and fitness |
US7689437B1 (en) | 2000-06-16 | 2010-03-30 | Bodymedia, Inc. | System for monitoring health, wellness and fitness |
ES2260245T3 (en) | 2000-06-23 | 2006-11-01 | Bodymedia, Inc. | SYSTEM TO CONTROL HEALTH, WELFARE AND EXERCISE. |
WO2002000096A2 (en) * | 2000-06-23 | 2002-01-03 | Physiometrix, Inc. | Frontal electrode array for patient eeg signal acquisition |
US6480734B1 (en) | 2000-06-30 | 2002-11-12 | Cardiac Science Inc. | Cardiac arrhythmia detector using ECG waveform-factor and its irregularity |
US6569160B1 (en) | 2000-07-07 | 2003-05-27 | Biosense, Inc. | System and method for detecting electrode-tissue contact |
US7149576B1 (en) | 2000-07-10 | 2006-12-12 | Cardiodynamics International Corporation | Apparatus and method for defibrillation of a living subject |
US6602201B1 (en) | 2000-07-10 | 2003-08-05 | Cardiodynamics International Corporation | Apparatus and method for determining cardiac output in a living subject |
US6636754B1 (en) | 2000-07-10 | 2003-10-21 | Cardiodynamics International Corporation | Apparatus and method for determining cardiac output in a living subject |
US6659947B1 (en) | 2000-07-13 | 2003-12-09 | Ge Medical Systems Information Technologies, Inc. | Wireless LAN architecture for integrated time-critical and non-time-critical services within medical facilities |
WO2002006826A1 (en) | 2000-07-17 | 2002-01-24 | Opt-E-Scrip, Inc. | Single-patient drug trials used with accumulated database |
CA2414309C (en) | 2000-07-18 | 2006-10-31 | Motorola, Inc. | Wireless electrocardiograph system and method |
JP3977983B2 (en) | 2000-07-31 | 2007-09-19 | 株式会社タニタ | Dehydration state determination device by bioimpedance measurement |
WO2002019897A2 (en) * | 2000-09-08 | 2002-03-14 | Wireless Medical, Inc. | Cardiopulmonary monitoring |
US20020099277A1 (en) | 2000-09-12 | 2002-07-25 | Nexan Limited | Disposable vital signs monitoring sensor band with removable alignment sheet |
DE10046075A1 (en) | 2000-09-15 | 2002-04-04 | Friendly Sensors Ag | Device and method for generating measurement data |
US6572636B1 (en) | 2000-09-19 | 2003-06-03 | Robert Sean Hagen | Pulse sensing patch and associated methods |
US6490478B1 (en) | 2000-09-25 | 2002-12-03 | Cardiac Science Inc. | System and method for complexity analysis-based cardiac tachyarrhythmia detection |
US6752151B2 (en) | 2000-09-25 | 2004-06-22 | Respironics, Inc. | Method and apparatus for providing variable positive airway pressure |
US7499742B2 (en) | 2001-09-26 | 2009-03-03 | Cvrx, Inc. | Electrode structures and methods for their use in cardiovascular reflex control |
US6665559B2 (en) | 2000-10-06 | 2003-12-16 | Ge Medical Systems Information Technologies, Inc. | Method and apparatus for perioperative assessment of cardiovascular risk |
CA2425224A1 (en) | 2000-10-10 | 2002-04-18 | Alan Remy Magill | Health monitoring |
US20020045836A1 (en) | 2000-10-16 | 2002-04-18 | Dima Alkawwas | Operation of wireless biopotential monitoring system |
FI119716B (en) | 2000-10-18 | 2009-02-27 | Polar Electro Oy | Electrode structure and heart rate measurement arrangement |
US6738671B2 (en) | 2000-10-26 | 2004-05-18 | Medtronic, Inc. | Externally worn transceiver for use with an implantable medical device |
US6978177B1 (en) | 2000-11-14 | 2005-12-20 | Cardiac Pacemakers, Inc. | Method and apparatus for using atrial discrimination algorithms to determine optimal pacing therapy and therapy timing |
US6658300B2 (en) | 2000-12-18 | 2003-12-02 | Biosense, Inc. | Telemetric reader/charger device for medical sensor |
WO2002052480A1 (en) | 2000-12-22 | 2002-07-04 | Trac Medical Solutions, Inc. | Dynamic electronic chain-of-trust document with audit trail |
WO2002065901A2 (en) * | 2000-12-29 | 2002-08-29 | Ares Medical, Inc. | Sleep apnea risk evaluation |
JP3927495B2 (en) | 2001-02-08 | 2007-06-06 | ミニ−ミッター カンパニー,インコーポレイテッド | Skin patch with built-in temperature sensor |
US6749566B2 (en) | 2001-02-14 | 2004-06-15 | Draeger Medical Systems, Inc. | Patient monitoring area network |
ITBO20010110A1 (en) | 2001-03-01 | 2002-09-01 | Tre Esse Progettazione Biomedi | PROCEDURE AND IMPLANTABLE DEVICE FOR THE INTRA-PULMONARY MEASUREMENT OF PHYSICAL PROPERTIES OF THE PULMONARY FABRIC DEPENDENT ON ITS DENSIT |
US6595929B2 (en) | 2001-03-30 | 2003-07-22 | Bodymedia, Inc. | System for monitoring health, wellness and fitness having a method and apparatus for improved measurement of heat flow |
EP1379167A1 (en) | 2001-04-06 | 2004-01-14 | Medic4all Inc. | A physiological monitoring system for a computational device of a human subject |
US20050283197A1 (en) | 2001-04-10 | 2005-12-22 | Daum Douglas R | Systems and methods for hypotension |
EP1249691A1 (en) | 2001-04-11 | 2002-10-16 | Omron Corporation | Electronic clinical thermometer |
US6453186B1 (en) | 2001-04-13 | 2002-09-17 | Ge Medical Systems Information Technologies, Inc. | Electrocardiogram electrode patch |
US6665385B2 (en) | 2001-04-23 | 2003-12-16 | Cardionet, Inc. | Medical monitoring system having multipath communications capability |
US6641542B2 (en) | 2001-04-30 | 2003-11-04 | Medtronic, Inc. | Method and apparatus to detect and treat sleep respiratory events |
US7702394B2 (en) | 2001-05-01 | 2010-04-20 | Intrapace, Inc. | Responsive gastric stimulator |
US6894204B2 (en) | 2001-05-02 | 2005-05-17 | 3M Innovative Properties Company | Tapered stretch removable adhesive articles and methods |
US20060161073A1 (en) | 2001-05-03 | 2006-07-20 | Singer Michael G | In vitro and in vivo assessment of organs and tissue and use, transplant, freshness and tissue conditions |
US6587715B2 (en) | 2001-05-03 | 2003-07-01 | The Nutrition Solutions Corporation | Assessment of organs for transplant, xenotransplant, and predicting time of death |
KR20030092120A (en) | 2001-05-03 | 2003-12-03 | 텔쥬트 테크놀로지스, 인크. | Wireless medical monitoring apparatus and system |
US20070104840A1 (en) | 2001-05-03 | 2007-05-10 | Singer Michael G | Method and system for the determination of palatability |
US7003346B2 (en) | 2001-05-03 | 2006-02-21 | Singer Michaeal G | Method for illness and disease determination and management |
US7242306B2 (en) | 2001-05-08 | 2007-07-10 | Hill-Rom Services, Inc. | Article locating and tracking apparatus and method |
US6622042B1 (en) | 2001-05-09 | 2003-09-16 | Pacesetter, Inc. | Implantable cardiac stimulation device and method utilizing electrogram spectral analysis for therapy administration |
US6952695B1 (en) | 2001-05-15 | 2005-10-04 | Global Safety Surveillance, Inc. | Spontaneous adverse events reporting |
EP2246799A1 (en) | 2001-05-15 | 2010-11-03 | Psychogenics Inc. | Systems and methods for monitoring behaviour informatics |
US6701271B2 (en) | 2001-05-17 | 2004-03-02 | International Business Machines Corporation | Method and apparatus for using physical characteristic data collected from two or more subjects |
MXPA03010697A (en) | 2001-05-21 | 2005-03-07 | Colder Prod Co | Connector apparatus and method for connecting the same for controlling fluid dispensing. |
US20050065445A1 (en) | 2001-05-22 | 2005-03-24 | Arzbaecher Robert C. | Cardiac arrest monitor and alarm system |
US6816744B2 (en) | 2001-05-29 | 2004-11-09 | Reproductive Health Technologies, Inc. | Device and system for remote for in-clinic trans-abdominal/vaginal/cervical acquisition, and detection, analysis, and communication of maternal uterine and maternal and fetal cardiac and fetal brain activity from electrical signals |
US6653014B2 (en) | 2001-05-30 | 2003-11-25 | Birch Point Medical, Inc. | Power sources for iontophoretic drug delivery systems |
US6795722B2 (en) | 2001-06-18 | 2004-09-21 | Neotech Products, Inc. | Electrode sensor package and application to the skin of a newborn or infant |
US6993378B2 (en) * | 2001-06-25 | 2006-01-31 | Science Applications International Corporation | Identification by analysis of physiometric variation |
US7044911B2 (en) | 2001-06-29 | 2006-05-16 | Philometron, Inc. | Gateway platform for biological monitoring and delivery of therapeutic compounds |
US6553312B2 (en) * | 2001-06-29 | 2003-04-22 | The Regents Of The University Of California | Method and apparatus for ultra precise GPS-based mapping of seeds or vegetation during planting |
IL144110A0 (en) | 2001-07-02 | 2002-05-23 | Sharony Reuven | Methods and apparatus for objective fetal diagnosis |
US6697658B2 (en) * | 2001-07-02 | 2004-02-24 | Masimo Corporation | Low power pulse oximeter |
US7933642B2 (en) | 2001-07-17 | 2011-04-26 | Rud Istvan | Wireless ECG system |
WO2003009221A2 (en) | 2001-07-20 | 2003-01-30 | Hill-Rom Services, Inc. | Badge for a locating and tracking system |
US6595927B2 (en) * | 2001-07-23 | 2003-07-22 | Medtronic, Inc. | Method and system for diagnosing and administering therapy of pulmonary congestion |
US7257438B2 (en) | 2002-07-23 | 2007-08-14 | Datascope Investment Corp. | Patient-worn medical monitoring device |
US7191000B2 (en) * | 2001-07-31 | 2007-03-13 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system for edema |
US20030045922A1 (en) | 2001-08-29 | 2003-03-06 | Nancy Northrop | Skin treatment method and apparatus |
EP1297784B8 (en) | 2001-09-28 | 2011-01-12 | CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Développement | Method and device for pulse rate detection |
DE10148440A1 (en) | 2001-10-01 | 2003-04-17 | Inflow Dynamics Inc | Implantable medical device for monitoring congestive heart failure comprises electrodes for measuring lung and heart tissue impedance, with an increase in impedance above a threshold value triggering an alarm |
US6890285B2 (en) * | 2001-10-01 | 2005-05-10 | Tariq Rahman | Brace compliance monitor |
US20030069510A1 (en) | 2001-10-04 | 2003-04-10 | Semler Herbert J. | Disposable vital signs monitor |
US20090182204A1 (en) | 2001-10-04 | 2009-07-16 | Semler Herbert J | Body composition, circulation, and vital signs monitor and method |
US20030087244A1 (en) | 2001-10-09 | 2003-05-08 | Vitivity, Inc | Diagnosis and treatment of vascular disease |
US20030093298A1 (en) | 2001-10-12 | 2003-05-15 | Javier Hernandez | System and method for providing secure remote access to patient files by authenticating personnel with biometric data |
US6748269B2 (en) | 2001-10-17 | 2004-06-08 | Cardiac Pacemakers, Inc. | Algorithm for discrimination of 1:1 tachycardias |
US6810282B2 (en) | 2001-10-25 | 2004-10-26 | GE Medical Systems Information Technolgies, Inc. | Method and apparatus for dynamically selecting an electrocardiogram compression process based on computerized analysis of cardiac rhythm and contour |
FR2831450B1 (en) | 2001-10-30 | 2004-07-30 | Ela Medical Sa | ACTIVE IMPLANTABLE MEDICAL DEVICE FOR THE TREATMENT OF HEART RATE DISORDERS, INCLUDING IMPROVED MEANS FOR DETECTING ATRIAL ARRHYTHMIAS |
US7054679B2 (en) | 2001-10-31 | 2006-05-30 | Robert Hirsh | Non-invasive method and device to monitor cardiac parameters |
US6577139B2 (en) | 2001-11-06 | 2003-06-10 | Keystone Thermometrics | Impedance converter circuit |
US6894456B2 (en) | 2001-11-07 | 2005-05-17 | Quallion Llc | Implantable medical power module |
US6980851B2 (en) | 2001-11-15 | 2005-12-27 | Cardiac Pacemakers, Inc. | Method and apparatus for determining changes in heart failure status |
DE10156833A1 (en) * | 2001-11-20 | 2003-05-28 | Boehm Stephan | Electrode for biomedical measurements has contact plate connected to line driver high impedance input and current source current output, line driver, current source close to contact plate |
US6643541B2 (en) | 2001-12-07 | 2003-11-04 | Motorola, Inc | Wireless electromyography sensor and system |
US7133716B2 (en) | 2001-12-12 | 2006-11-07 | Fresenius Medical Care Deutschland Gmbh | Determining the hydration status of a patient |
GB0130010D0 (en) | 2001-12-14 | 2002-02-06 | Isis Innovation | Combining measurements from breathing rate sensors |
US20030149349A1 (en) | 2001-12-18 | 2003-08-07 | Jensen Thomas P. | Integral patch type electronic physiological sensor |
US20030143544A1 (en) | 2002-01-09 | 2003-07-31 | Vitivity, Inc. | Diagnosis and treatment of vascular disease |
US6980852B2 (en) | 2002-01-25 | 2005-12-27 | Subqiview Inc. | Film barrier dressing for intravascular tissue monitoring system |
US6912414B2 (en) | 2002-01-29 | 2005-06-28 | Southwest Research Institute | Electrode systems and methods for reducing motion artifact |
US6645153B2 (en) | 2002-02-07 | 2003-11-11 | Pacesetter, Inc. | System and method for evaluating risk of mortality due to congestive heart failure using physiologic sensors |
US7468032B2 (en) | 2002-12-18 | 2008-12-23 | Cardiac Pacemakers, Inc. | Advanced patient management for identifying, displaying and assisting with correlating health-related data |
US7022070B2 (en) | 2002-03-22 | 2006-04-04 | Mini-Mitter Co., Inc. | Method for continuous monitoring of patients to detect the potential onset of sepsis |
US6936006B2 (en) | 2002-03-22 | 2005-08-30 | Novo Nordisk, A/S | Atraumatic insertion of a subcutaneous device |
US8137270B2 (en) | 2003-11-18 | 2012-03-20 | Adidas Ag | Method and system for processing data from ambulatory physiological monitoring |
CA2379268A1 (en) | 2002-03-26 | 2003-09-26 | Hans Kolpin | Skin impedance matched biopotential electrode |
US20030187370A1 (en) | 2002-03-27 | 2003-10-02 | Kodama Roy K. | Uterine contraction sensing system and method |
JP4295627B2 (en) | 2002-03-27 | 2009-07-15 | シーブイアールエックス, インコーポレイテッド | Electrode structure and its use in controlling circulatory system reflection |
US7654901B2 (en) | 2002-04-10 | 2010-02-02 | Breving Joel S | Video game system using bio-feedback devices |
EP1499233A4 (en) | 2002-04-16 | 2009-02-18 | Carematix Inc | Method and apparatus for remotely monitoring the condition of a patient |
US7136703B1 (en) | 2002-04-16 | 2006-11-14 | Pacesetter, Inc. | Programmer and surface ECG system with wireless communication |
WO2003094720A1 (en) | 2002-05-07 | 2003-11-20 | Izmail Batkin | Remote monitoring of cardiac electrical activity using a cell phone device |
US20030221687A1 (en) | 2002-05-09 | 2003-12-04 | William Kaigler | Medication and compliance management system and method |
NO321659B1 (en) | 2002-05-14 | 2006-06-19 | Idex Asa | Volume specific characterization of human skin by electrical immitance |
TW528593B (en) | 2002-05-17 | 2003-04-21 | Jang-Min Yang | Device for monitoring physiological status and method for using the device |
US6922586B2 (en) * | 2002-05-20 | 2005-07-26 | Richard J. Davies | Method and system for detecting electrophysiological changes in pre-cancerous and cancerous tissue |
US6906530B2 (en) | 2002-05-30 | 2005-06-14 | D.J. Geisel Technology, Inc. | Apparatus and method to detect moisture |
US7047067B2 (en) | 2002-05-31 | 2006-05-16 | Uab Research Foundation | Apparatus, methods, and computer program products for evaluating a risk of cardiac arrhythmias from restitution properties |
GB2391625A (en) | 2002-08-09 | 2004-02-11 | Diagnostic Ultrasound Europ B | Instantaneous ultrasonic echo measurement of bladder urine volume with a limited number of ultrasound beams |
WO2003103765A1 (en) | 2002-06-11 | 2003-12-18 | Matos Jeffrey A | System for cardiac resuscitation |
US7096061B2 (en) * | 2002-07-03 | 2006-08-22 | Tel-Aviv University Future Technology Development L.P. | Apparatus for monitoring CHF patients using bio-impedance technique |
US6997879B1 (en) | 2002-07-09 | 2006-02-14 | Pacesetter, Inc. | Methods and devices for reduction of motion-induced noise in optical vascular plethysmography |
US20040014422A1 (en) * | 2002-07-19 | 2004-01-22 | Nokia Corporation | Method and system for handovers using service description data |
US7027862B2 (en) | 2002-07-25 | 2006-04-11 | Medtronic, Inc. | Apparatus and method for transmitting an electrical signal in an implantable medical device |
US20040019292A1 (en) * | 2002-07-29 | 2004-01-29 | Drinan Darrel Dean | Method and apparatus for bioelectric impedance based identification of subjects |
IL151029A0 (en) | 2002-08-01 | 2003-04-10 | Art Medical Instr Ltd | Bio-filter pad for facilitating the detection of an occurrence of a physiological action, and method therefor, and fetal activity monitoring apparatus |
US6879850B2 (en) | 2002-08-16 | 2005-04-12 | Optical Sensors Incorporated | Pulse oximeter with motion detection |
WO2004016168A1 (en) | 2002-08-19 | 2004-02-26 | Czarnek & Orkin Laboratories, Inc. | Capacitive uterine contraction sensor |
US7020508B2 (en) | 2002-08-22 | 2006-03-28 | Bodymedia, Inc. | Apparatus for detecting human physiological and contextual information |
US7294105B1 (en) | 2002-09-03 | 2007-11-13 | Cheetah Omni, Llc | System and method for a wireless medical communication system |
US7118531B2 (en) | 2002-09-24 | 2006-10-10 | The Johns Hopkins University | Ingestible medical payload carrying capsule with wireless communication |
US7736309B2 (en) | 2002-09-27 | 2010-06-15 | Medtronic Minimed, Inc. | Implantable sensor method and system |
AU2003275491A1 (en) | 2002-10-09 | 2004-05-04 | Bodymedia, Inc. | Method and apparatus for auto journaling of continuous or discrete body states utilizing physiological and/or contextual parameters |
US20040073094A1 (en) | 2002-10-15 | 2004-04-15 | Baker Donald A. | Fetal monitoring systems with ambulatory patient units and telemetric links for improved uses |
JP3894092B2 (en) * | 2002-10-18 | 2007-03-14 | フジノン株式会社 | Ultrasound endoscope |
WO2004036390A2 (en) | 2002-10-18 | 2004-04-29 | Trustees Of Boston University | Patient activity monitor |
GB2394294A (en) | 2002-10-18 | 2004-04-21 | Cambridge Neurotechnology Ltd | Cardiac sensor with accelerometer |
GB0224425D0 (en) | 2002-10-21 | 2002-11-27 | Univ Leicester | Method for prediction of cardiac disease |
US6878121B2 (en) | 2002-11-01 | 2005-04-12 | David T. Krausman | Sleep scoring apparatus and method |
AR039364A1 (en) | 2002-11-07 | 2005-02-16 | Carlos Daniel Silva | RESPIRATORY MOVEMENT MONITOR |
FI114199B (en) * | 2002-11-08 | 2004-09-15 | Polar Electro Oy | Method and device to measure stress |
US7130679B2 (en) | 2002-11-20 | 2006-10-31 | Medtronic, Inc. | Organ rejection monitoring |
US20040106951A1 (en) | 2002-11-22 | 2004-06-03 | Edman Carl Frederick | Use of electric fields to minimize rejection of implanted devices and materials |
CA2537451A1 (en) * | 2002-11-22 | 2004-06-10 | Impedimed Pty Limited | Multifrequency bioimpedance determination |
US20040100376A1 (en) | 2002-11-26 | 2004-05-27 | Kimberly-Clark Worldwide, Inc. | Healthcare monitoring system |
WO2004047636A1 (en) | 2002-11-27 | 2004-06-10 | Z-Tech (Canada) Inc. | Apparatus for determining adequacy of electrode-to-skin contact and electrode quality for bioelectrical measurements |
US7072718B2 (en) | 2002-12-03 | 2006-07-04 | Cardiac Pacemakers, Inc. | Antenna systems for implantable medical device telemetry |
US8814793B2 (en) | 2002-12-03 | 2014-08-26 | Neorad As | Respiration monitor |
US7986994B2 (en) | 2002-12-04 | 2011-07-26 | Medtronic, Inc. | Method and apparatus for detecting change in intrathoracic electrical impedance |
US20060155174A1 (en) | 2002-12-16 | 2006-07-13 | Arkady Glukhovsky | Device, system and method for selective activation of in vivo sensors |
US7452334B2 (en) | 2002-12-16 | 2008-11-18 | The Regents Of The University Of Michigan | Antenna stent device for wireless, intraluminal monitoring |
US20040143170A1 (en) | 2002-12-20 | 2004-07-22 | Durousseau Donald R. | Intelligent deception verification system |
US7395117B2 (en) | 2002-12-23 | 2008-07-01 | Cardiac Pacemakers, Inc. | Implantable medical device having long-term wireless capabilities |
US7127541B2 (en) * | 2002-12-23 | 2006-10-24 | Microtune (Texas), L.P. | Automatically establishing a wireless connection between adapters |
GB0230361D0 (en) | 2002-12-27 | 2003-02-05 | Koninkl Philips Electronics Nv | Electrode arrangement |
US20040133079A1 (en) | 2003-01-02 | 2004-07-08 | Mazar Scott Thomas | System and method for predicting patient health within a patient management system |
US7160252B2 (en) * | 2003-01-10 | 2007-01-09 | Medtronic, Inc. | Method and apparatus for detecting respiratory disturbances |
DE10300735A1 (en) | 2003-01-11 | 2004-07-22 | Corscience Gmbh & Co.Kg | Method for detecting a fibrillation state and device for defibrillation |
US7423526B2 (en) | 2003-01-29 | 2008-09-09 | Despotis George J | Integrated patient diagnostic and identification system |
US7445605B2 (en) | 2003-01-31 | 2008-11-04 | The Board Of Trustees Of The Leland Stanford Junior University | Detection of apex motion for monitoring cardiac dysfunction |
US6956572B2 (en) | 2003-02-10 | 2005-10-18 | Siemens Medical Solutions Health Services Corporation | Patient medical parameter user interface system |
AU2004214420A1 (en) | 2003-02-19 | 2004-09-02 | Sicel Technologies Inc. | In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes |
WO2004084720A2 (en) | 2003-03-21 | 2004-10-07 | Welch Allyn, Inc. | Personal status physiologic monitor system and architecture and related monitoring methods |
JP2006521891A (en) * | 2003-03-31 | 2006-09-28 | アルザ・コーポレーシヨン | Electrotransport device having a reservoir housing with flexible conductive fibers |
US20040199056A1 (en) | 2003-04-03 | 2004-10-07 | International Business Machines Corporation | Body monitoring using local area wireless interfaces |
US7134999B2 (en) | 2003-04-04 | 2006-11-14 | Dexcom, Inc. | Optimized sensor geometry for an implantable glucose sensor |
US20040215240A1 (en) | 2003-04-11 | 2004-10-28 | Lovett Eric G. | Reconfigurable subcutaneous cardiac device |
US7130684B2 (en) | 2003-04-30 | 2006-10-31 | Medtronic, Inc. | Method and apparatus for improving ventricular status using the force interval relationship |
US20040225203A1 (en) | 2003-05-06 | 2004-11-11 | Jemison Mae C. | Real-time and simultaneous monitoring of multiple parameters from multiple living beings |
AU2003902187A0 (en) | 2003-05-08 | 2003-05-22 | Aimedics Pty Ltd | Patient monitor |
US20040225199A1 (en) | 2003-05-08 | 2004-11-11 | Evanyk Shane Walter | Advanced physiological monitoring systems and methods |
US7149574B2 (en) | 2003-06-09 | 2006-12-12 | Palo Alto Investors | Treatment of conditions through electrical modulation of the autonomic nervous system |
US7289761B2 (en) * | 2003-06-23 | 2007-10-30 | Cardiac Pacemakers, Inc. | Systems, devices, and methods for selectively preventing data transfer from a medical device |
US7171258B2 (en) | 2003-06-25 | 2007-01-30 | Cardiac Pacemakers, Inc. | Method and apparatus for trending a physiological cardiac parameter |
US20050158539A1 (en) | 2003-06-25 | 2005-07-21 | Andover Coated Products, Inc. | Pressure-sensitive adhesive tapes |
US20050027204A1 (en) * | 2003-06-26 | 2005-02-03 | Kligfield Paul D. | ECG diagnostic system and method |
US7142907B2 (en) | 2003-07-01 | 2006-11-28 | Ge Medical Systems Information Technologies, Inc. | Method and apparatus for algorithm fusion of high-resolution electrocardiograms |
JP4414964B2 (en) | 2003-07-08 | 2010-02-17 | ヴェー ツェー ヘレーウス ゲゼルシャフト ミット ベシュレンクテル ハフツング | Method for producing chlorotris (triphenylphosphane) rhodium (I) |
US20050015095A1 (en) * | 2003-07-15 | 2005-01-20 | Cervitech, Inc. | Insertion instrument for cervical prostheses |
US7320689B2 (en) * | 2003-07-15 | 2008-01-22 | Cervitech, Inc. | Multi-part cervical endoprosthesis with insertion instrument |
US20050027175A1 (en) * | 2003-07-31 | 2005-02-03 | Zhongping Yang | Implantable biosensor |
US20060195020A1 (en) | 2003-08-01 | 2006-08-31 | Martin James S | Methods, systems, and apparatus for measuring a pulse rate |
US20050131288A1 (en) | 2003-08-15 | 2005-06-16 | Turner Christopher T. | Flexible, patient-worn, integrated, self-contained sensor systems for the acquisition and monitoring of physiologic data |
US7616988B2 (en) | 2003-09-18 | 2009-11-10 | Cardiac Pacemakers, Inc. | System and method for detecting an involuntary muscle movement disorder |
WO2005018432A2 (en) | 2003-08-20 | 2005-03-03 | Philometron, Inc. | Hydration monitoring |
US7320675B2 (en) * | 2003-08-21 | 2008-01-22 | Cardiac Pacemakers, Inc. | Method and apparatus for modulating cellular metabolism during post-ischemia or heart failure |
US7194306B1 (en) | 2003-09-05 | 2007-03-20 | Pacesetter, Inc. | Cardiac optimization through low-frequency analysis of hemodynamic variables |
JP2005080720A (en) | 2003-09-05 | 2005-03-31 | Tanita Corp | Bioelectric impedance measuring apparatus |
US20070276273A1 (en) | 2003-09-10 | 2007-11-29 | Watson Jr Richard L | Periumbilical Infant Ecg Sensor and Monitoring System |
EP1667579A4 (en) | 2003-09-12 | 2008-06-11 | Bodymedia Inc | Method and apparatus for measuring heart related parameters |
US20050059867A1 (en) | 2003-09-13 | 2005-03-17 | Cheng Chung Yuan | Method for monitoring temperature of patient |
WO2005027998A2 (en) | 2003-09-16 | 2005-03-31 | Cardiomems, Inc. | Implantable wireless sensor |
US7088242B2 (en) | 2003-09-16 | 2006-08-08 | International Business Machines Corporation | Collective personal articles tracking |
US7129836B2 (en) | 2003-09-23 | 2006-10-31 | Ge Medical Systems Information Technologies, Inc. | Wireless subject monitoring system |
US7225024B2 (en) | 2003-09-30 | 2007-05-29 | Cardiac Pacemakers, Inc. | Sensors having protective eluting coating and method therefor |
JP2005110801A (en) * | 2003-10-03 | 2005-04-28 | Aprica Kassai Inc | Biomedical measurement sensor and biomedical measurement method |
US8428717B2 (en) | 2003-10-14 | 2013-04-23 | Medtronic, Inc. | Method and apparatus for monitoring tissue fluid content for use in an implantable cardiac device |
US8467876B2 (en) | 2003-10-15 | 2013-06-18 | Rmx, Llc | Breathing disorder detection and therapy delivery device and method |
AU2004289288B2 (en) | 2003-11-10 | 2011-07-28 | Philometron, Inc. | Structures and devices for parenteral drug delivery and diagnostic sampling |
CA2683198C (en) | 2003-11-26 | 2016-03-22 | Cardionet, Inc. | System and method for processing and presenting arrhythmia information to facilitate heart arrhythmia identification and treatment |
US7184821B2 (en) | 2003-12-03 | 2007-02-27 | Regents Of The University Of Minnesota | Monitoring thoracic fluid changes |
US20050124901A1 (en) | 2003-12-05 | 2005-06-09 | Misczynski Dale J. | Method and apparatus for electrophysiological and hemodynamic real-time assessment of cardiovascular fitness of a user |
EP1706170A4 (en) | 2003-12-12 | 2010-03-24 | Philometron Inc | Multiple section parenteral drug delivery apparatus |
US20050137626A1 (en) | 2003-12-19 | 2005-06-23 | Pastore Joseph M. | Drug delivery system and method employing external drug delivery device in conjunction with computer network |
US20050137464A1 (en) | 2003-12-23 | 2005-06-23 | Bomba Frank C. | Wireless sensor and sensor initialization device and method |
US20050148895A1 (en) | 2004-01-06 | 2005-07-07 | Misczynski Dale J. | Method and apparatus for ECG derived sleep monitoring of a user |
ATE536801T1 (en) | 2004-01-15 | 2011-12-15 | Koninkl Philips Electronics Nv | ADAPTIVE PHYSIOLOGICAL MONITORING SYSTEM AND METHOD OF USE THEREOF |
CA2555807A1 (en) | 2004-02-12 | 2005-08-25 | Biopeak Corporation | Non-invasive method and apparatus for determining a physiological parameter |
US8068905B2 (en) * | 2004-02-26 | 2011-11-29 | Compumedics Limited | Method and apparatus for continuous electrode impedance monitoring |
US7277741B2 (en) | 2004-03-09 | 2007-10-02 | Nellcor Puritan Bennett Incorporated | Pulse oximetry motion artifact rejection using near infrared absorption by water |
JP2005253840A (en) | 2004-03-15 | 2005-09-22 | Tanita Corp | Skin condition estimating device |
US7395113B2 (en) * | 2004-03-16 | 2008-07-01 | Medtronic, Inc. | Collecting activity information to evaluate therapy |
US7805196B2 (en) | 2004-03-16 | 2010-09-28 | Medtronic, Inc. | Collecting activity information to evaluate therapy |
MXPA06010498A (en) | 2004-03-18 | 2007-03-28 | Helicor Inc | Methods and devices for relieving stress. |
US7474918B2 (en) | 2004-03-24 | 2009-01-06 | Noninvasive Medical Technologies, Inc. | Thoracic impedance monitor and electrode array and method of use |
US20070150008A1 (en) | 2004-03-25 | 2007-06-28 | Koninklijke Philips Electronics, N.V. | Defibrillation electrode having drug delivery capablity |
US20050215844A1 (en) | 2004-03-25 | 2005-09-29 | Ten Eyck Lawrence G | Patient carestation |
US7505814B2 (en) | 2004-03-26 | 2009-03-17 | Pacesetter, Inc. | System and method for evaluating heart failure based on ventricular end-diastolic volume using an implantable medical device |
US20060009697A1 (en) * | 2004-04-07 | 2006-01-12 | Triage Wireless, Inc. | Wireless, internet-based system for measuring vital signs from a plurality of patients in a hospital or medical clinic |
US7238159B2 (en) | 2004-04-07 | 2007-07-03 | Triage Wireless, Inc. | Device, system and method for monitoring vital signs |
US20050228244A1 (en) | 2004-04-07 | 2005-10-13 | Triage Wireless, Inc. | Small-scale, vital-signs monitoring device, system and method |
US20050261598A1 (en) | 2004-04-07 | 2005-11-24 | Triage Wireless, Inc. | Patch sensor system for measuring vital signs |
US20050228238A1 (en) | 2004-04-09 | 2005-10-13 | Arnold Monitzer | Patient parameter automatic acquisition system |
US7470232B2 (en) | 2004-05-04 | 2008-12-30 | General Electric Company | Method and apparatus for non-invasive ultrasonic fetal heart rate monitoring |
WO2005110051A2 (en) | 2004-05-10 | 2005-11-24 | Transoma Medical, Inc. | Portable device for monitoring electrocardiographic signals and indices of blood flow |
US7324845B2 (en) | 2004-05-17 | 2008-01-29 | Beth Israel Deaconess Medical Center | Assessment of sleep quality and sleep disordered breathing based on cardiopulmonary coupling |
US20050261743A1 (en) | 2004-05-19 | 2005-11-24 | Kroll Mark W | System and method for automated fluid monitoring |
KR100592934B1 (en) | 2004-05-21 | 2006-06-23 | 한국전자통신연구원 | Wearable physiological signal detection module and measurement apparatus with the same |
US7333850B2 (en) | 2004-05-28 | 2008-02-19 | University Of Florida Research Foundation, Inc. | Maternal-fetal monitoring system |
US7548785B2 (en) | 2004-06-10 | 2009-06-16 | Pacesetter, Inc. | Collecting and analyzing sensed information as a trend of heart failure progression or regression |
US20050277841A1 (en) | 2004-06-10 | 2005-12-15 | Adnan Shennib | Disposable fetal monitor patch |
US20070270678A1 (en) | 2004-06-18 | 2007-11-22 | Fadem Kalford C | Wireless Electrode for Biopotential Measurement |
US7206630B1 (en) | 2004-06-29 | 2007-04-17 | Cleveland Medical Devices, Inc | Electrode patch and wireless physiological measurement system and method |
US7477934B2 (en) * | 2004-06-29 | 2009-01-13 | Polar Electro Oy | Method of monitoring human relaxation level, and user-operated heart rate monitor |
US7433853B2 (en) * | 2004-07-12 | 2008-10-07 | Cardiac Pacemakers, Inc. | Expert system for patient medical information analysis |
US7319386B2 (en) * | 2004-08-02 | 2008-01-15 | Hill-Rom Services, Inc. | Configurable system for alerting caregivers |
US7356366B2 (en) * | 2004-08-02 | 2008-04-08 | Cardiac Pacemakers, Inc. | Device for monitoring fluid status |
US20060030782A1 (en) | 2004-08-05 | 2006-02-09 | Adnan Shennib | Heart disease detection patch |
US20060030781A1 (en) | 2004-08-05 | 2006-02-09 | Adnan Shennib | Emergency heart sensor patch |
US7387610B2 (en) | 2004-08-19 | 2008-06-17 | Cardiac Pacemakers, Inc. | Thoracic impedance detection with blood resistivity compensation |
US20070299325A1 (en) | 2004-08-20 | 2007-12-27 | Brian Farrell | Physiological status monitoring system |
US20060047215A1 (en) | 2004-09-01 | 2006-03-02 | Welch Allyn, Inc. | Combined sensor assembly |
WO2006029034A2 (en) | 2004-09-02 | 2006-03-16 | Philometron, Inc. | Monitoring platform for detection of hypovolemia, hemorrhage and blood loss |
US20060066449A1 (en) | 2004-09-08 | 2006-03-30 | Industrial Widget Works Company | RFMON: devices and methods for wireless monitoring of patient vital signs through medical sensor readings from passive RFID tags |
US9820658B2 (en) * | 2006-06-30 | 2017-11-21 | Bao Q. Tran | Systems and methods for providing interoperability among healthcare devices |
US8235949B2 (en) * | 2004-09-10 | 2012-08-07 | Medrad, Inc. | Application systems for use with medical devices |
US20060135858A1 (en) | 2004-09-13 | 2006-06-22 | International Business Machines Corporation | Displaying information related to a physical parameter of an individual |
US20060064133A1 (en) | 2004-09-17 | 2006-03-23 | Cardiac Pacemakers, Inc. | System and method for deriving relative physiologic measurements using an external computing device |
US20070106132A1 (en) | 2004-09-28 | 2007-05-10 | Elhag Sammy I | Monitoring device, method and system |
US7917196B2 (en) | 2005-05-09 | 2011-03-29 | Cardiac Pacemakers, Inc. | Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes |
US7840275B2 (en) | 2004-10-01 | 2010-11-23 | Medtronic, Inc. | In-home remote monitor with smart repeater, memory and emergency event management |
US7341560B2 (en) | 2004-10-05 | 2008-03-11 | Rader, Fishman & Grauer Pllc | Apparatuses and methods for non-invasively monitoring blood parameters |
US7609145B2 (en) | 2004-10-06 | 2009-10-27 | Martis Ip Holdings, Llc | Test authorization system |
US20080058656A1 (en) | 2004-10-08 | 2008-03-06 | Costello Benedict J | Electric tomography |
US7996075B2 (en) | 2004-10-20 | 2011-08-09 | Cardionet, Inc. | Monitoring physiological activity using partial state space reconstruction |
US7212849B2 (en) | 2004-10-28 | 2007-05-01 | Cardiac Pacemakers, Inc. | Methods and apparatuses for arrhythmia detection and classification using wireless ECG |
US8768446B2 (en) | 2004-11-02 | 2014-07-01 | Medtronic, Inc. | Clustering with combined physiological signals |
US7917199B2 (en) | 2004-11-02 | 2011-03-29 | Medtronic, Inc. | Patient event marking in combination with physiological signals |
US20080228084A1 (en) | 2004-11-09 | 2008-09-18 | Michel Bedard | Method and Apparatus for Reduction of Spurious Effects on Physiological Measurements |
US7751868B2 (en) | 2004-11-12 | 2010-07-06 | Philips Electronics Ltd | Integrated skin-mounted multifunction device for use in image-guided surgery |
JP2006343306A (en) | 2004-11-15 | 2006-12-21 | Denso Corp | Gas concentration detector |
JP4898697B2 (en) | 2004-11-24 | 2012-03-21 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Telemetry monitoring system for patients by internet protocol |
US20060116592A1 (en) | 2004-12-01 | 2006-06-01 | Medtronic, Inc. | Method and apparatus for detection and monitoring of T-wave alternans |
US7945316B2 (en) | 2004-12-17 | 2011-05-17 | Medtronic, Inc. | System and method for monitoring or treating nervous system disorders |
US8108046B2 (en) | 2004-12-17 | 2012-01-31 | Medtronic, Inc. | System and method for using cardiac events to trigger therapy for treating nervous system disorders |
US8734341B2 (en) | 2004-12-20 | 2014-05-27 | Ipventure, Inc. | Method and apparatus to sense hydration level of a person |
FI20045503A (en) | 2004-12-28 | 2006-06-29 | Polar Electro Oy | Sensor systems, accessories and heart rate monitors |
US7701227B2 (en) * | 2005-01-05 | 2010-04-20 | Rensselaer Polytechnic Institute | High precision voltage source for electrical impedance tomography |
US8577455B2 (en) | 2005-01-18 | 2013-11-05 | Medtronic, Inc. | Method and apparatus for arrhythmia detection in a medical device |
JP2006198334A (en) * | 2005-01-24 | 2006-08-03 | Tanita Corp | Bioelectrical impedance measuring device and body composition measuring apparatus |
JP2006204742A (en) | 2005-01-31 | 2006-08-10 | Konica Minolta Sensing Inc | Method and system for evaluating sleep, its operation program, pulse oxymeter, and system for supporting sleep |
US20080021336A1 (en) * | 2006-04-24 | 2008-01-24 | Dobak John D Iii | Devices and methods for accelerometer-based characterization of cardiac synchrony and dyssynchrony |
JP4731936B2 (en) | 2005-02-09 | 2011-07-27 | 本田技研工業株式会社 | Rotary variable resistor |
EP1871219A4 (en) | 2005-02-22 | 2011-06-01 | Health Smart Ltd | Methods and systems for physiological and psycho-physiological monitoring and uses thereof |
US20060212097A1 (en) | 2005-02-24 | 2006-09-21 | Vijay Varadan | Method and device for treatment of medical conditions and monitoring physical movements |
US7722622B2 (en) | 2005-02-25 | 2010-05-25 | Synthes Usa, Llc | Implant insertion apparatus and method of use |
US7616110B2 (en) | 2005-03-11 | 2009-11-10 | Aframe Digital, Inc. | Mobile wireless customizable health and condition monitor |
US20060252999A1 (en) | 2005-05-03 | 2006-11-09 | Devaul Richard W | Method and system for wearable vital signs and physiology, activity, and environmental monitoring |
US20060224072A1 (en) | 2005-03-31 | 2006-10-05 | Cardiovu, Inc. | Disposable extended wear heart monitor patch |
US20060224079A1 (en) | 2005-03-31 | 2006-10-05 | Washchuk Bohdan O | Edema monitoring system and method utilizing an implantable medical device |
JP2009500047A (en) | 2005-04-14 | 2009-01-08 | イダルゴ リミテッド | Apparatus and method for monitoring |
US8480577B2 (en) | 2005-04-15 | 2013-07-09 | Ivy Biomedical Systems, Inc. | Wireless patient monitoring system |
WO2006111878A1 (en) | 2005-04-20 | 2006-10-26 | Philips Intellectual Property & Standards Gmbh | Patient monitoring system |
US20060241641A1 (en) | 2005-04-22 | 2006-10-26 | Sdgi Holdings, Inc. | Methods and instrumentation for distraction and insertion of implants in a spinal disc space |
US7657317B2 (en) | 2005-04-26 | 2010-02-02 | Boston Scientific Neuromodulation Corporation | Evaluating stimulation therapies and patient satisfaction |
US7991467B2 (en) | 2005-04-26 | 2011-08-02 | Medtronic, Inc. | Remotely enabled pacemaker and implantable subcutaneous cardioverter/defibrillator system |
US7822627B2 (en) | 2005-05-02 | 2010-10-26 | St Martin Edward | Method and system for generating an echocardiogram report |
US7907997B2 (en) | 2005-05-11 | 2011-03-15 | Cardiac Pacemakers, Inc. | Enhancements to the detection of pulmonary edema when using transthoracic impedance |
US9089275B2 (en) | 2005-05-11 | 2015-07-28 | Cardiac Pacemakers, Inc. | Sensitivity and specificity of pulmonary edema detection when using transthoracic impedance |
US8688189B2 (en) | 2005-05-17 | 2014-04-01 | Adnan Shennib | Programmable ECG sensor patch |
EP1948015B1 (en) | 2005-05-18 | 2015-03-04 | Rachelle Van Wyk | System, method, and kit for positioning a monitor transducer on a patient |
US7340296B2 (en) | 2005-05-18 | 2008-03-04 | Cardiac Pacemakers, Inc. | Detection of pleural effusion using transthoracic impedance |
US8900154B2 (en) | 2005-05-24 | 2014-12-02 | Cardiac Pacemakers, Inc. | Prediction of thoracic fluid accumulation |
WO2006130268A1 (en) * | 2005-06-01 | 2006-12-07 | Medtronic, Inc. | Correlating a non-polysomnographic physiological parameter set with sleep states |
US9398853B2 (en) * | 2005-06-03 | 2016-07-26 | LifeWatch Technologies, Ltd. | Communication terminal, medical telemetry system and method for monitoring physiological data |
KR100634544B1 (en) | 2005-06-04 | 2006-10-13 | 삼성전자주식회사 | Apparatus and method for measuring moisture content in skin using portable terminal |
US7387607B2 (en) | 2005-06-06 | 2008-06-17 | Intel Corporation | Wireless medical sensor system |
FR2886532B1 (en) | 2005-06-07 | 2008-03-28 | Commissariat Energie Atomique | METHOD AND SYSTEM FOR DETECTING THE FALL OF A PERSON |
TW200642660A (en) | 2005-06-14 | 2006-12-16 | We Gene Technologies Inc | Auto diagnosing method and device thereof for high mountain disease |
US20060293571A1 (en) | 2005-06-23 | 2006-12-28 | Skanda Systems | Distributed architecture for remote patient monitoring and caring |
US7295879B2 (en) | 2005-06-24 | 2007-11-13 | Kenergy, Inc. | Double helical antenna assembly for a wireless intravascular medical device |
US20070010721A1 (en) * | 2005-06-28 | 2007-01-11 | Chen Thomas C H | Apparatus and system of Internet-enabled wireless medical sensor scale |
US7848787B2 (en) | 2005-07-08 | 2010-12-07 | Biosense Webster, Inc. | Relative impedance measurement |
US20070016089A1 (en) * | 2005-07-15 | 2007-01-18 | Fischell David R | Implantable device for vital signs monitoring |
US20070021678A1 (en) * | 2005-07-19 | 2007-01-25 | Cardiac Pacemakers, Inc. | Methods and apparatus for monitoring physiological responses to steady state activity |
US20070027497A1 (en) | 2005-07-27 | 2007-02-01 | Cyberonics, Inc. | Nerve stimulation for treatment of syncope |
US7813778B2 (en) | 2005-07-29 | 2010-10-12 | Spectros Corporation | Implantable tissue ischemia sensor |
CN100471445C (en) | 2005-08-01 | 2009-03-25 | 周常安 | Paster style physiological monitoring device, system and network |
EP1754441B1 (en) * | 2005-08-17 | 2008-01-09 | Osypka Medical GmbH | Method and apparatus for digital demodulation in the measurement of electrical bioimpedance or bioadmittance |
US8992436B2 (en) | 2005-09-16 | 2015-03-31 | Cardiac Pacemakers, Inc. | Respiration monitoring using respiration rate variability |
US7775983B2 (en) | 2005-09-16 | 2010-08-17 | Cardiac Pacemakers, Inc. | Rapid shallow breathing detection for use in congestive heart failure status determination |
US20080058614A1 (en) | 2005-09-20 | 2008-03-06 | Triage Wireless, Inc. | Wireless, internet-based system for measuring vital signs from a plurality of patients in a hospital or medical clinic |
US20070073361A1 (en) | 2005-09-23 | 2007-03-29 | Bioq, Inc. | Medical device for restoration of autonomic and immune functions impaired by neuropathy |
US20070073132A1 (en) | 2005-09-27 | 2007-03-29 | Michael Vosch | Apparatus and method for monitoring patients |
US20070083092A1 (en) | 2005-10-07 | 2007-04-12 | Rippo Anthony J | External exercise monitor |
US20070082189A1 (en) | 2005-10-11 | 2007-04-12 | Gillette William J | Waterproof, breathable composite material |
JP2007105316A (en) | 2005-10-14 | 2007-04-26 | Konica Minolta Sensing Inc | Bioinformation measuring instrument |
US7420472B2 (en) | 2005-10-16 | 2008-09-02 | Bao Tran | Patient monitoring apparatus |
US8118750B2 (en) | 2005-10-21 | 2012-02-21 | Medtronic, Inc. | Flow sensors for penile tumescence |
US20070123904A1 (en) | 2005-10-31 | 2007-05-31 | Depuy Spine, Inc. | Distraction instrument and method for distracting an intervertebral site |
US20070123903A1 (en) | 2005-10-31 | 2007-05-31 | Depuy Spine, Inc. | Medical Device installation tool and methods of use |
US7942824B1 (en) | 2005-11-04 | 2011-05-17 | Cleveland Medical Devices Inc. | Integrated sleep diagnostic and therapeutic system and method |
US7682313B2 (en) | 2005-11-23 | 2010-03-23 | Vital Sensors Holding Company, Inc. | Implantable pressure monitor |
US7766840B2 (en) | 2005-12-01 | 2010-08-03 | Cardiac Pacemakers, Inc. | Method and system for heart failure status evaluation based on a disordered breathing index |
US8016776B2 (en) | 2005-12-02 | 2011-09-13 | Medtronic, Inc. | Wearable ambulatory data recorder |
US7957809B2 (en) | 2005-12-02 | 2011-06-07 | Medtronic, Inc. | Closed-loop therapy adjustment |
EP1962671A2 (en) | 2005-12-03 | 2008-09-03 | Masimo Corporation | Physiological alarm notification system |
CN103251451B (en) | 2005-12-06 | 2015-06-10 | 圣朱德医疗有限公司房颤分公司 | Assessment of electrode coupling for tissue ablation |
US20070180047A1 (en) | 2005-12-12 | 2007-08-02 | Yanting Dong | System and method for providing authentication of remotely collected external sensor measures |
JP2009519737A (en) | 2005-12-19 | 2009-05-21 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Device for monitoring a person's heart rate and / or heart rate variability and wristwatch including the same function |
US7761158B2 (en) | 2005-12-20 | 2010-07-20 | Cardiac Pacemakers, Inc. | Detection of heart failure decompensation based on cumulative changes in sensor signals |
US20070142715A1 (en) | 2005-12-20 | 2007-06-21 | Triage Wireless, Inc. | Chest strap for measuring vital signs |
US8050774B2 (en) | 2005-12-22 | 2011-11-01 | Boston Scientific Scimed, Inc. | Electrode apparatus, systems and methods |
TWI311067B (en) | 2005-12-27 | 2009-06-21 | Ind Tech Res Inst | Method and apparatus of interactive gaming with emotion perception ability |
US20070162089A1 (en) | 2006-01-09 | 2007-07-12 | Transoma Medical, Inc. | Cross-band communications in an implantable device |
US20070172424A1 (en) | 2006-01-26 | 2007-07-26 | Mark Costin Roser | Enabling drug adherence through closed loop monitoring & communication |
US8160682B2 (en) | 2006-02-06 | 2012-04-17 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive cardiac monitor and methods of using continuously recorded cardiac data |
US20070255184A1 (en) | 2006-02-10 | 2007-11-01 | Adnan Shennib | Disposable labor detection patch |
US20090177145A1 (en) | 2006-02-28 | 2009-07-09 | Malin Ohlander | Medical device and method for monitoring hematocrit and svo2 |
CN101394781B (en) | 2006-03-02 | 2011-05-25 | 皇家飞利浦电子股份有限公司 | Body parameter sensing |
US8200320B2 (en) | 2006-03-03 | 2012-06-12 | PhysioWave, Inc. | Integrated physiologic monitoring systems and methods |
US7668588B2 (en) | 2006-03-03 | 2010-02-23 | PhysioWave, Inc. | Dual-mode physiologic monitoring systems and methods |
US20070208232A1 (en) | 2006-03-03 | 2007-09-06 | Physiowave Inc. | Physiologic monitoring initialization systems and methods |
US20090030292A1 (en) | 2006-03-10 | 2009-01-29 | Daniel Bartnik | Cardiography system and method using automated recognition of hemodynamic parameters and waveform attributes |
DE102006015291B4 (en) | 2006-04-01 | 2015-10-29 | Drägerwerk AG & Co. KGaA | Procedure for setting a patient monitor |
US7359837B2 (en) | 2006-04-27 | 2008-04-15 | Medtronic, Inc. | Peak data retention of signal data in an implantable medical device |
US7818050B2 (en) | 2006-05-02 | 2010-10-19 | Lono Medical Systems, Llc | Passive phonography heart monitor |
US7616980B2 (en) | 2006-05-08 | 2009-11-10 | Tyco Healthcare Group Lp | Radial electrode array |
US7539533B2 (en) | 2006-05-16 | 2009-05-26 | Bao Tran | Mesh network monitoring appliance |
US20070282173A1 (en) | 2006-05-31 | 2007-12-06 | Bily Wang | Vital sign sending method and a sending apparatus thereof |
US7346380B2 (en) | 2006-06-16 | 2008-03-18 | Axelgaard Manufacturing Co., Ltd. | Medical electrode |
US7749164B2 (en) * | 2006-06-28 | 2010-07-06 | The General Electric Company | System and method for the processing of alarm and communication information in centralized patient monitoring |
US7660632B2 (en) | 2006-06-30 | 2010-02-09 | Ric Investments, Llc | Method and apparatus for hypoglossal nerve stimulation |
US8700143B2 (en) * | 2006-07-28 | 2014-04-15 | Medtronic, Inc. | Adaptations to optivol alert algorithm |
WO2008017042A1 (en) | 2006-08-03 | 2008-02-07 | Microchips, Inc. | Cardiac biosensor devices and methods |
US9773060B2 (en) | 2006-09-05 | 2017-09-26 | Cardiac Pacemaker, Inc. | System and method for providing automatic setup of a remote patient care environment |
US20080091089A1 (en) | 2006-10-12 | 2008-04-17 | Kenneth Shane Guillory | Single use, self-contained surface physiological monitor |
US20080215360A1 (en) | 2006-10-24 | 2008-09-04 | Kent Dicks | Systems and methods for medical data interchange interface |
US8214007B2 (en) | 2006-11-01 | 2012-07-03 | Welch Allyn, Inc. | Body worn physiological sensor device having a disposable electrode module |
US8449469B2 (en) | 2006-11-10 | 2013-05-28 | Sotera Wireless, Inc. | Two-part patch sensor for monitoring vital signs |
US20080120784A1 (en) | 2006-11-28 | 2008-05-29 | General Electric Company | Smart bed system and apparatus |
WO2008068695A1 (en) | 2006-12-07 | 2008-06-12 | Koninklijke Philips Electronics N.V. | Handheld, repositionable ecg detector |
US8979755B2 (en) * | 2006-12-08 | 2015-03-17 | The Boeing Company | Devices and systems for remote physiological monitoring |
US8157730B2 (en) | 2006-12-19 | 2012-04-17 | Valencell, Inc. | Physiological and environmental monitoring systems and methods |
US20080171929A1 (en) | 2007-01-11 | 2008-07-17 | Katims Jefferson J | Method for standardizing spacing between electrodes, and medical tape electrodes |
WO2008091683A2 (en) | 2007-01-25 | 2008-07-31 | Senior Vitals, Inc. | System and method for physiological data readings, transmission and presentation |
US20090017910A1 (en) | 2007-06-22 | 2009-01-15 | Broadcom Corporation | Position and motion tracking of an object |
US9044136B2 (en) | 2007-02-16 | 2015-06-02 | Cim Technology Inc. | Wearable mini-size intelligent healthcare system |
US20080221399A1 (en) | 2007-03-05 | 2008-09-11 | Triage Wireless, Inc. | Monitor for measuring vital signs and rendering video images |
US20080220865A1 (en) | 2007-03-06 | 2008-09-11 | Wei Hsu | Interactive playstation controller |
US20080287752A1 (en) | 2007-05-10 | 2008-11-20 | Mayo Foundation For Medical Education And Research | Ear canal physiological parameter monitoring system |
US8750971B2 (en) | 2007-05-24 | 2014-06-10 | Bao Tran | Wireless stroke monitoring |
TW200846061A (en) | 2007-05-25 | 2008-12-01 | Asustek Comp Inc | Game controller |
US9754078B2 (en) | 2007-06-21 | 2017-09-05 | Immersion Corporation | Haptic health feedback monitoring |
US9380966B2 (en) | 2007-06-22 | 2016-07-05 | Vioptix, Inc. | Tissue retractor oximeter |
US20090005016A1 (en) * | 2007-06-29 | 2009-01-01 | Betty Eng | Apparatus and method to maintain a continuous connection of a cellular device and a sensor network |
US20090018456A1 (en) * | 2007-07-11 | 2009-01-15 | Chin-Yeh Hung | Display storage apparatus capable of detecting a pulse |
US8926509B2 (en) | 2007-08-24 | 2015-01-06 | Hmicro, Inc. | Wireless physiological sensor patches and systems |
US20090062670A1 (en) | 2007-08-30 | 2009-03-05 | Gary James Sterling | Heart monitoring body patch and system |
EP2200499B1 (en) | 2007-09-14 | 2019-05-01 | Medtronic Monitoring, Inc. | Multi-sensor patient monitor to detect impending cardiac decompensation |
US20090076559A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent Device for Cardiac Rhythm Management |
US20090076350A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Data Collection in a Multi-Sensor Patient Monitor |
WO2009036326A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent athletic monitor |
WO2009036333A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Dynamic pairing of patients to data collection gateways |
US8249686B2 (en) | 2007-09-14 | 2012-08-21 | Corventis, Inc. | Adherent device for sleep disordered breathing |
US20090076397A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent Emergency Patient Monitor |
WO2009036348A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Medical device automatic start-up upon contact to patient tissue |
US8460189B2 (en) | 2007-09-14 | 2013-06-11 | Corventis, Inc. | Adherent cardiac monitor with advanced sensing capabilities |
EP2194847A1 (en) | 2007-09-14 | 2010-06-16 | Corventis, Inc. | Adherent device with multiple physiological sensors |
WO2009036256A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Injectable physiological monitoring system |
US20090076342A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent Multi-Sensor Device with Empathic Monitoring |
US8260439B2 (en) | 2007-11-16 | 2012-09-04 | Ethicon, Inc. | Nerve stimulation patches and methods for stimulating selected nerves |
EP2257216B1 (en) | 2008-03-12 | 2021-04-28 | Medtronic Monitoring, Inc. | Heart failure decompensation prediction based on cardiac rhythm |
EP2254461A4 (en) | 2008-03-19 | 2012-12-26 | Ericsson Telefon Ab L M | Nfc communications for implanted medical data acquisition devices |
WO2009146214A1 (en) * | 2008-04-18 | 2009-12-03 | Corventis, Inc. | Method and apparatus to measure bioelectric impedance of patient tissue |
US20090292194A1 (en) | 2008-05-23 | 2009-11-26 | Corventis, Inc. | Chiropractic Care Management Systems and Methods |
US20100191310A1 (en) | 2008-07-29 | 2010-07-29 | Corventis, Inc. | Communication-Anchor Loop For Injectable Device |
US20100056881A1 (en) | 2008-08-29 | 2010-03-04 | Corventis, Inc. | Method and Apparatus For Acute Cardiac Monitoring |
US8790259B2 (en) | 2009-10-22 | 2014-07-29 | Corventis, Inc. | Method and apparatus for remote detection and monitoring of functional chronotropic incompetence |
US9451897B2 (en) | 2009-12-14 | 2016-09-27 | Medtronic Monitoring, Inc. | Body adherent patch with electronics for physiologic monitoring |
US8965498B2 (en) | 2010-04-05 | 2015-02-24 | Corventis, Inc. | Method and apparatus for personalized physiologic parameters |
EP3165161B1 (en) | 2010-05-12 | 2020-05-06 | Irhythm Technologies, Inc. | Device features and design elements for long-term adhesion |
-
2009
- 2009-04-20 WO PCT/US2009/041143 patent/WO2009146214A1/en active Application Filing
- 2009-04-20 US US12/426,497 patent/US8412317B2/en active Active
-
2013
- 2013-03-26 US US13/850,678 patent/US8903484B2/en not_active Expired - Fee Related
-
2014
- 2014-11-14 US US14/542,097 patent/US9668667B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5642734A (en) * | 1990-10-04 | 1997-07-01 | Microcor, Inc. | Method and apparatus for noninvasively determining hematocrit |
US5454377A (en) * | 1993-10-08 | 1995-10-03 | The Ohio State University | Method for measuring the myocardial electrical impedance spectrum |
US20060085049A1 (en) * | 2004-10-20 | 2006-04-20 | Nervonix, Inc. | Active electrode, bio-impedance based, tissue discrimination system and methods of use |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014201522A1 (en) * | 2013-06-19 | 2014-12-24 | Ti2 Pty Ltd | Methods and apparatuses for characterisation of body tissue |
AU2014284130B2 (en) * | 2013-06-19 | 2020-02-06 | Ti2 Medical Pty Ltd | Methods and apparatuses for characterisation of body tissue |
Also Published As
Publication number | Publication date |
---|---|
US20150073252A1 (en) | 2015-03-12 |
US20090264792A1 (en) | 2009-10-22 |
US8412317B2 (en) | 2013-04-02 |
US20140012154A1 (en) | 2014-01-09 |
US8903484B2 (en) | 2014-12-02 |
US9668667B2 (en) | 2017-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9668667B2 (en) | Method and apparatus to measure bioelectric impedance of patient tissue | |
USRE46926E1 (en) | Adherent device with multiple physiological sensors | |
US8688190B2 (en) | Adherent device for sleep disordered breathing | |
US9357932B2 (en) | System and methods for wireless body fluid monitoring | |
US9579020B2 (en) | Adherent cardiac monitor with advanced sensing capabilities | |
US9173615B2 (en) | Method and apparatus for personalized physiologic parameters | |
US20160371452A1 (en) | Dynamic pairing of patients to data collection gateways | |
WO2009036319A1 (en) | Adherent emergency patient monitor | |
US20100056881A1 (en) | Method and Apparatus For Acute Cardiac Monitoring | |
WO2009114548A1 (en) | Heart failure decompensation prediction based on cardiac rhythm |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09755576 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 18.01.2011) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09755576 Country of ref document: EP Kind code of ref document: A1 |